10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2015

OR

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number 1-815

E. I. du Pont de Nemours and Company

(Exact Name of Registrant as Specified in Its Charter)

Delaware	51-0014090
(State or other Jurisdiction of	(I.R.S. Employer
Incorporation or Organization)	Identification No.)

1007 Market Street, Wilmington, Delaware 19898

(Address of Principal Executive Offices)

(302) 774-1000

(Registrant’s Telephone Number)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  x   No  o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that registrant was required to submit and post such files.)  Yes  x   No  o

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.  (Check one):

Large Accelerated Filer x	Accelerated Filer o
Non-Accelerated Filer o	Smaller reporting company o

Indicate by check mark whether the Registrant is a shell company (as defined by Rule 12b-2 of the Exchange Act).  Yes  o   No  x

The Registrant had 905,237,000 shares (excludes 87,041,000 shares of treasury stock) of common stock, $0.30 par value, outstanding at April 15, 2015.

E. I. DU PONT DE NEMOURS AND COMPANY

Table of Contents

The terms “DuPont” or the “company” as used herein refer to E. I. du Pont de Nemours and Company and its consolidated subsidiaries, or to E. I. du Pont de Nemours and Company, as the context may indicate. 

			Page
Part I	Financial Information
Item 1.	Consolidated Financial Statements (Unaudited)
	Consolidated Income Statements		3
	Consolidated Statements of Comprehensive Income		4
	Condensed Consolidated Balance Sheets		5
	Condensed Consolidated Statements of Cash Flows		6
	Notes to the Consolidated Financial Statements
	Note 1.	Summary of Significant Accounting Policies	7
	Note 2.	Divestitures and Other Transactions	8
	Note 3.	Employee Separation / Asset Related Charges, Net	8
	Note 4.	Other Income, Net	9
	Note 5.	Income Taxes	9
	Note 6.	Earnings Per Share of Common Stock	10
	Note 7.	Inventories	10
	Note 8.	Other Intangible Assets	11
	Note 9.	Commitments and Contingent Liabilities	12
	Note 10.	Stockholders’ Equity	14
	Note 11.	Financial Instruments	16
	Note 12.	Long-Term Employee Benefits	21
	Note 13.	Segment Information	22
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		23
	Cautionary Statements About Forward-Looking Statements		23
	Recent Developments		23
	Results of Operations		25
	Recent Accounting Pronouncements		26
	Segment Reviews		27
	Liquidity & Capital Resources		29
	Contractual Obligations		30
Item 3.	Quantitative and Qualitative Disclosures About Market Risk		30
Item 4.	Controls and Procedures		31
Part II	Other Information
Item 1.	Legal Proceedings		32
Item 1A.	Risk Factors		32
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds: Issuer Purchases of Equity		33
Item 4.	Mine Safety Disclosures		33
Item 6.	Exhibits		33
Signature			34
Exhibit Index			35

2

PART I.  FINANCIAL INFORMATION

Item 1. CONSOLIDATED FINANCIAL STATEMENTS

E. I. du Pont de Nemours and Company

Consolidated Income Statements (Unaudited)

(Dollars in millions, except per share)

	Three Months Ended
	March 31,
	2015		2014
Net sales	$	9,172	$	10,128
Other income, net	198		17
Total	9,370		10,145
Cost of goods sold	5,553		6,000
Other operating charges	283		286
Selling, general and administrative expenses	1,312		1,436
Research and development expense	499		518
Interest expense	84		103
Employee separation / asset related charges, net	38		—
Total	7,769		8,343
Income before income taxes	1,601		1,802
Provision for income taxes	566		357
Net income	1,035		1,445
Less: Net income attributable to noncontrolling interests	4		6
Net income attributable to DuPont	$	1,031	$	1,439
Basic earnings per share of common stock	$	1.13	$	1.56
Diluted earnings per share of common stock	$	1.13	$	1.54
Dividends per share of common stock	$	0.47	$	0.45

See Notes to the Consolidated Financial Statements beginning on page 7.

3

E. I. du Pont de Nemours and Company

Consolidated Statements of Comprehensive Income (Unaudited)

(Dollars in millions, except per share)

	Three Months Ended
	March 31,
	2015			2014
Net income	$	1,035		$	1,445
Other comprehensive (loss) income, before tax:
Cumulative translation adjustment	(1,189		)	(72		)
Net revaluation and clearance of cash flow hedges to earnings:
Additions and revaluations of derivatives designated as cash flow hedges	(22		)	38
Clearance of hedge results to earnings	7			18
Net revaluation and clearance of cash flow hedges to earnings	(15		)	56
Pension benefit plans:
Net (loss) gain	(4		)	1
Effect of foreign exchange rates	100			—
Reclassifications to net income:
Amortization of prior service (benefit) cost	(2		)	1
Amortization of loss	209			149
Settlement loss	5			—
Pension benefit plans, net	308			151
Other benefit plans:
Reclassifications to net income:
Amortization of prior service benefit	(52		)	(53		)
Amortization of loss	19			14
Other benefit plans, net	(33		)	(39		)
Other comprehensive (loss) income, before tax	(929		)	96
Income tax expense related to items of other comprehensive income	(86		)	(57		)
Other comprehensive (loss) income, net of tax	(1,015		)	39
Comprehensive income	20			1,484
Less: Comprehensive income attributable to noncontrolling interests	4			6
Comprehensive income attributable to DuPont	$	16		$	1,478

See Notes to the Consolidated Financial Statements beginning on page 7.

4

E. I. du Pont de Nemours and Company

Condensed Consolidated Balance Sheets (Unaudited)

(Dollars in millions, except per share)

	March 31, 2015			December 31, 2014
Assets
Current assets
Cash and cash equivalents	$	3,622		$	6,910
Marketable securities	125			124
Accounts and notes receivable, net	7,651			6,005
Inventories	7,051			7,841
Prepaid expenses	366			279
Deferred income taxes	504			589
Total current assets	19,319			21,748
Property, plant and equipment, net of accumulated depreciation    (March 31, 2015 - $20,057; December 31, 2014 - $19,942)	12,873			13,386
Goodwill	4,365			4,529
Other intangible assets	4,307			4,580
Investment in affiliates	929			886
Deferred income taxes	3,244			3,349
Other assets	1,138			1,096
Total	$	46,175		$	49,574
Liabilities and Equity
Current liabilities
Accounts payable	$	3,706		$	4,822
Short-term borrowings and capital lease obligations	1,621			1,423
Income taxes	654			547
Other accrued liabilities	4,751			5,848
Total current liabilities	10,732			12,640
Long-term borrowings and capital lease obligations	8,763			9,271
Other liabilities	13,329			13,819
Deferred income taxes	489			466
Total liabilities	33,313			36,196
Commitments and contingent liabilities
Stockholders’ equity
Preferred stock	237			237
Common stock, $0.30 par value; 1,800,000,000 shares authorized;    Issued at March 31, 2015 - 992,224,000; December 31, 2014 - 992,020,000	298			298
Additional paid-in capital	11,311			11,174
Reinvested earnings	17,405			17,045
Accumulated other comprehensive loss	(9,722		)	(8,707		)
Common stock held in treasury, at cost (87,041,000 shares at March 31, 2015 and December 31, 2014)	(6,727		)	(6,727		)
Total DuPont stockholders’ equity	12,802			13,320
Noncontrolling interests	60			58
Total equity	12,862			13,378
Total	$	46,175		$	49,574

See Notes to the Consolidated Financial Statements beginning on page 7.

5

E. I. du Pont de Nemours and Company

Condensed Consolidated Statements of Cash Flows (Unaudited)

(Dollars in millions)

	Three Months Ended
	March 31,
	2015			2014
Operating activities
Net income	$	1,035		$	1,445
Adjustments to reconcile net income to cash used for operating activities:
Depreciation	306			312
Amortization of intangible assets	140			125
Net periodic pension benefit cost	147			100
Contributions to pension plans	(124		)	(101		)
Other operating activities - net	(2		)	212
Change in operating assets and liabilities - net	(3,625		)	(4,514		)
Cash used for operating activities	(2,123		)	(2,421		)
Investing activities
Purchases of property, plant and equipment	(565		)	(320		)
Investments in affiliates	(45		)	(22		)
Proceeds from sales of businesses - net	16			—
Proceeds from sales of assets - net	9			7
Purchases of short-term financial instruments	(125		)	(57		)
Proceeds from maturities and sales of short-term financial instruments	125			137
Foreign currency exchange contract settlements	442			15
Other investing activities - net	3			4
Cash used for investing activities	(140		)	(236		)
Financing activities
Dividends paid to stockholders	(429		)	(420		)
Net increase (decrease) in short-term (less than 90 days) borrowings	980			(8		)
Long-term and other borrowings:
Receipts	120			61
Payments	(1,409		)	(1,180		)
Repurchase / prepayments of common stock	(282		)	(1,061		)
Proceeds from exercise of stock options	170			153
Other financing activities - net	(1		)	(14		)
Cash used for financing activities	(851		)	(2,469		)
Effect of exchange rate changes on cash	(174		)	(33		)
Decrease in cash and cash equivalents	$	(3,288	)	$	(5,159	)
Cash and cash equivalents at beginning of period	6,910			8,941
Cash and cash equivalents at end of period	$	3,622		$	3,782

See Notes to the Consolidated Financial Statements beginning on page 7.

6

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in millions, except per share)

Note 1.  Summary of Significant Accounting Policies

Interim Financial Statements

The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (GAAP) for interim financial information and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X.  In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair statement of the results for interim periods have been included.  Results for interim periods should not be considered indicative of results for a full year.  These interim Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and Notes thereto contained in the company’s Annual Report on Form 10-K for the year ended December 31, 2014, collectively referred to as the “2014 Annual Report”.  The Consolidated Financial Statements include the accounts of the company and all of its subsidiaries in which a controlling interest is maintained, as well as variable interest entities for which DuPont is the primary beneficiary. 

Basis of Presentation

Certain reclassifications of prior year's data have been made to conform to current year's presentation.

The company’s cost structure has been impacted by the global, multi-year initiative to redesign its global organization and operating model to improve productivity and agility across all businesses and functions. Effective December 31, 2014, in order to better align to the transforming company’s organization and resulting cost structure, certain costs were reclassified from other operating charges to selling, general and administrative expenses. Prior year data has been reclassified to conform to current year presentation.   Other operating charges primarily include, costs associated with the Performance Chemical separation, product claim charges and non-capitalizable costs associated with capital projects. Selling, general and administrative expense primarily includes selling and marketing expenses, commissions, functional costs, and business management expenses.

Foreign Currency Translation

The company's worldwide operations utilize the U.S. dollar (USD) or local currency as the functional currency, where applicable. The company identifies its separate and distinct foreign entities and groups the foreign entities into two categories: 1) extension of the parent (USD functional currency) and 2) self-contained (local functional currency). If a foreign entity does not clearly align with either category, factors are evaluated and a judgment is made to determine the functional currency.

For foreign entities where the USD is the functional currency, all foreign currency asset and liability amounts are remeasured into USD at end-of-period exchange rates, except for inventories, prepaid expenses, property, plant and equipment, goodwill and other intangible assets, which are remeasured at historical rates. Foreign currency income and expenses are remeasured at average exchange rates in effect during the year, except for expenses related to balance sheet amounts remeasured at historical exchange rates. Exchange gains and losses arising from remeasurement of foreign currency-denominated monetary assets and liabilities are included in income in the period in which they occur.

For foreign entities where the local currency is the functional currency, assets and liabilities denominated in local currencies are translated into USD at end-of-period exchange rates and the resultant translation adjustments are reported, net of their related tax effects, as a component of accumulated other comprehensive income (loss) in equity. Assets and liabilities denominated in other than the local currency are remeasured into the local currency prior to translation into USD and the resultant exchange gains or losses are included in income in the period in which they occur. Income and expenses are translated into USD at average exchange rates in effect during the period.

The company changes the functional currency of its separate and distinct foreign entities only when significant changes in economic facts and circumstances indicate clearly that the functional currency has changed. As a result of the planned separation of its Performance Chemicals segment, coupled with the Company’s redesign initiative, the functional currency at certain of the company’s foreign entities is being re-evaluated which, in some cases, has resulted in a change in the foreign entities’ functional currency during the first quarter of 2015.

Venezuelan Foreign Currency

Venezuela is considered a highly inflationary economy under GAAP and the USD is the functional currency for the company's subsidiaries in Venezuela. The official exchange rate continues to be set through the National Center for Foreign Commerce (CENCOEX, previously CADIVI). Based on its evaluation of the restrictions and limitations affecting the availability of specific exchange rate mechanisms, management concluded in the second quarter of 2014 that the SICAD 2 auction process would be the most likely mechanism available. As a result, in the second quarter of 2014, the company changed from the official exchange rate to the SICAD 2 exchange rate.

7

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in millions, except per share)

During the first quarter of 2015, the Venezuelan government enacted additional changes to the country’s foreign exchange systems including the replacement of SICAD 2 and introduction of the SIMADI (Foreign Exchange Marginal System) auction process. Given the replacement of SICAD 2 with SIMADI, management has concluded that the SIMADI auction process would be the most likely exchange mechanism available. As a result, effective in the first quarter of 2015, the company changed from the SICAD 2 to the SIMADI exchange rate, to remeasure its Bolivar Fuertes (VEF) denominated net monetary assets which resulted in a pre-tax charge of $3 recorded within other income, net in the company’s interim Consolidated Income Statements for the three months ended March 31, 2015. The remaining net monetary assets and non-monetary assets are immaterial at March 31, 2015.

Recent Accounting Pronouncements

In February 2015, the FASB issued ASU No. 2015-02 Consolidation (Topic 810), Amendments to the Consolidation Analysis. The amendments under the new guidance modify the evaluation of whether limited partnerships and similar legal entities are variable interest entities (VIEs) or voting interest entities and eliminate the presumption that a general partner should consolidate a limited partnership. The ASU is effective for public business entities for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2015. Early adoption is permitted, including adoption in an interim period. A reporting entity also may apply the amendments retrospectively. The company is currently evaluating the impact of adopting this guidance on its financial position and results of operations.

In May 2014, the FASB and the International Accounting Standards Board (IASB) jointly issued ASU No. 2014-9, Revenue from Contracts with Customers (Topic 606), which clarifies the principles for recognizing revenue and develops a common revenue standard for GAAP and International Financial Reporting Standards (IFRS). The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. The ASU is effective for public entities for annual and interim periods beginning after December 15, 2016. The FASB proposed that a deferral of the effective date is necessary to provide adequate time to effectively implement the new revenue standard. It is important to note that the FASB’s proposed deferral is not a final decision. The company is currently evaluating the impact of adopting this guidance on its financial position and results of operations.

In April 2014, the FASB issued authoritative guidance amending existing requirements for reporting discontinued operations.  Under the new guidance, discontinued operations reporting will be limited to disposal transactions that represent strategic shifts having a major effect on operations and financial results. The amended guidance also enhances disclosures and requires assets and liabilities of a discontinued operation to be classified as such for all periods presented in the financial statements. Public entities will apply the amended guidance prospectively to all disposals occurring within annual periods beginning on or after December 15, 2014 and interim periods within those years. The company adopted this standard on January 1, 2015. Due to the change in requirements for reporting discontinued operations described above, presentation and disclosures of future disposal transactions after adoption may be different than under previous standards.

Note 2. Divestitures and Other Transactions

Performance Chemicals

On October 24, 2013, DuPont announced that it intends to separate its Performance Chemicals segment through a U.S. tax-free spin-off to shareholders, subject to customary closing conditions. The company expects to complete the separation on July 1, 2015, subject to final approval from DuPont's Board of Directors. During the three months ended March 31, 2015 and 2014, respectively, the company incurred $81 and $16 of costs associated with the transaction which were reported in other operating charges in the company's interim Consolidated Income Statements. These transaction costs primarily relate to professional fees associated with preparation of regulatory filings and separation activities within finance, legal and information system functions.

Note 3. Employee Separation / Asset Related Charges, Net

During first quarter of 2015, a $38 pre-tax impairment charge was recorded in employee separation / asset related charges, net within the Other segment. The majority relates to a cost basis investment in which the assessment resulted from the venture's revised operating plan reflecting underperformance of its European wheat based ethanol facility and deteriorating European ethanol market conditions. One of the primary investors has communicated they would not fund the revised operating plan of the investee. As a result, the carrying value of our 6 percent cost basis investment in this venture exceeded its fair value by $37, such that an impairment charge was required.

8

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in millions, except per share)

2014 Restructuring Program

At March 31, 2015, total liabilities related to the 2014 restructuring program were $223. A complete discussion of restructuring initiatives is included in the company's 2014 Annual Report in Note 3, "Employee Separation / Asset Related Charges, Net."

Account balances for the 2014 restructuring program are summarized below:

	Employee Separation Costs			Other Non-Personnel Charges 1			Total
Balance at December 31, 2014	$	264		$	4		$	268
Payments	(38		)	(1		)	(39		)
Net translation adjustment	(6		)	—			(6		)
Balance as of March 31, 2015	$	220		$	3		$	223

¹  Other non-personnel charges consist of contractual obligation costs.

Note 4.  Other Income, Net

	Three Months Ended
	March 31,
	2015		2014
Royalty income	$	39	$	39
Interest income	25		28
Equity in earnings of affiliates, net	9		13
Net gain on sales of other assets	6		7
Net exchange gains (losses)1	64		(96		)
Miscellaneous income and expenses, net 2	55		26
Other income, net	$	198	$	17

¹ The company routinely uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes on net monetary asset positions. The net pre-tax exchange gains (losses) are recorded in other income, net and the related tax impact is recorded in provision for income taxes on the company's interim Consolidated Income Statements. The increase in pre-tax exchange gains over prior year was driven by gains on foreign currency contracts due to strengthening of the USD versus global currencies partially offset by losses on the related foreign currency-denominated monetary assets and liabilities. The $64 net exchange gain for the three months ended March 31, 2015, includes a $(40) pre-tax exchange loss, $(38) after-tax, associated with the devaluation of the Ukrainian hryvnia. The $(96) net exchange loss for the three months ended March 31, 2014, includes a $(39) pre-tax exchange loss, $(27) after-tax, associated with the devaluation of the Ukrainian hryvnia.

²   Miscellaneous income and expenses, net, includes interest items, certain insurance recoveries and litigation settlements and other items.

Note 5.  Income Taxes

In the first quarter 2015, the company recorded a tax provision of $566, including $212 of tax expense associated with the company’s policy of hedging the foreign currency-denominated monetary assets and liabilities of its operations and gains or losses on foreign currency contracts.

In the first quarter 2014, the company recorded a tax provision of $357, including $28 of tax benefit associated with the company's policy of hedging the foreign currency-denominated monetary assets and liabilities of its operations and gains or losses on foreign currency contracts.

Each year the company files hundreds of tax returns in the various national, state and local income taxing jurisdictions in which it operates. These tax returns are subject to examination and possible challenge by the tax authorities. Positions challenged by the tax authorities may be settled or appealed by the company. As a result, there is an uncertainty in income taxes recognized in the company’s financial statements in accordance with accounting for income taxes and accounting for uncertainty in income taxes. It is reasonably possible that net reductions to the company’s global unrecognized tax benefits could be in the range of $100 to $125 within the next twelve months with the majority due to the settlement of uncertain tax positions with various tax authorities.

9

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in millions, except per share)

Note 6.  Earnings Per Share of Common Stock

Set forth below is a reconciliation of the numerator and denominator for basic and diluted earnings per share calculations for the periods indicated:

	Three Months Ended
	March 31,
	2015			2014
Numerator:
Net income attributable to DuPont	$	1,031		$	1,439
Preferred dividends	(2		)	(2		)
Net income available to common stockholders	$	1,029		$	1,437
Denominator:
Weighted-average number of common shares outstanding - Basic	906,835,000			923,461,000
Dilutive effect of the company’s employee compensation plans	6,984,000			7,271,000
Weighted-average number of common shares outstanding - Diluted	913,819,000			930,732,000

There were no antidilutive stock options in the three months ended March 31, 2015 and March 31, 2014, respectively.

Note 7. Inventories

	March 31, 2015			December 31, 2014
Finished products	$	4,529		$	4,628
Semi-finished products	1,877			2,451
Raw materials, stores and supplies	1,138			1,255
	7,544			8,334
Adjustment of inventories to a last-in, first-out (LIFO) basis	(493		)	(493		)
Total	$	7,051		$	7,841

10

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in millions, except per share)

Note 8.  Other Intangible Assets

The gross carrying amounts and accumulated amortization of other intangible assets by major class are as follows: 

	March 31, 2015							December 31, 2014
	Gross		Accumulated Amortization			Net		Gross		Accumulated Amortization			Net
Intangible assets subject to amortization (Definite-lived):
Customer lists	$	1,612	$	(475	)	$	1,137	$	1,706	$	(470	)	$	1,236
Patents	470		(202		)	268		493		(199		)	294
Purchased and licensed technology	1,772		(1,142		)	630		1,789		(1,074		)	715
Trademarks	31		(14		)	17		31		(14		)	17
Other 1	210		(90		)	120		207		(88		)	119
	4,095		(1,923		)	2,172		4,226		(1,845		)	2,381
Intangible assets not subject to amortization (Indefinite-lived):
In-process research and development	25		—			25		29		—			29
Microbial cell factories	306		—			306		306		—			306
Pioneer germplasm	1,063		—			1,063		1,064		—			1,064
Trademarks/tradenames	741		—			741		800		—			800
	2,135		—			2,135		2,199		—			2,199
Total	$	6,230	$	(1,923	)	$	4,307	$	6,425	$	(1,845	)	$	4,580

¹   Primarily consists of sales and grower networks, marketing and manufacturing alliances and noncompetition agreements.       

The aggregate pre-tax amortization expense for definite-lived intangible assets was $140 and $125 for the three months ended March 31, 2015 and 2014, respectively. The estimated aggregate pre-tax amortization expense for the remainder of 2015 and each of the next five years is approximately $217, $353, $218, $218, $203 and $184, respectively.

11

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in millions, except per share)

Note 9.  Commitments and Contingent Liabilities

Guarantees

Indemnifications

In connection with acquisitions and divestitures, the company has indemnified respective parties against certain liabilities that may arise in connection with these transactions and business activities prior to the completion of the transaction. The term of these indemnifications, which typically pertain to environmental, tax and product liabilities, is generally indefinite. In addition, the company indemnifies its duly elected or appointed directors and officers to the fullest extent permitted by Delaware law, against liabilities incurred as a result of their activities for the company, such as adverse judgments relating to litigation matters. If the indemnified party were to incur a liability or have a liability increase as a result of a successful claim, pursuant to the terms of the indemnification, the company would be required to reimburse the indemnified party. The maximum amount of potential future payments is generally unlimited.

Obligations for Equity Affiliates & Others

The company has directly guaranteed various debt obligations under agreements with third parties related to equity affiliates, customers and suppliers. At March 31, 2015 and December 31, 2014, the company had directly guaranteed $498 and $513, respectively, of such obligations. These amounts represent the maximum potential amount of future (undiscounted) payments that the company could be required to make under the guarantees. The company would be required to perform on these guarantees in the event of default by the guaranteed party.

The company assesses the payment/performance risk by assigning default rates based on the duration of the guarantees. These default rates are assigned based on the external credit rating of the counterparty or through internal credit analysis and historical default history for counterparties that do not have published credit ratings. For counterparties without an external rating or available credit history, a cumulative average default rate is used.

In certain cases, the company has recourse to assets held as collateral, as well as personal guarantees from customers and suppliers. Assuming liquidation, these assets are estimated to cover 47 percent of the $315 of guaranteed obligations of customers and suppliers. Set forth below are the company's guaranteed obligations at March 31, 2015:

	Short-Term		Long-Term		Total
Obligations for customers and suppliers1:
Bank borrowings (terms up to 7 years)	$	230	$	84	$	314
Leases on equipment and facilities (terms up to 4 years)	—		1		1
Obligations for equity affiliates2:
Bank borrowings (terms up to 1 year)	183		—		183
Total	$	413	$	85	$	498

¹  Existing guarantees for customers and suppliers, as part of contractual agreements.

² Existing guarantees for equity affiliates' liquidity needs in normal operations.

Imprelis^® 

The company has received claims and lawsuits alleging that the use of Imprelis^® herbicide caused damage to certain trees. Sales of Imprelis^® were suspended in August 2011 and the product was last applied during the 2011 spring application season. The lawsuits seeking class action status were consolidated in multidistrict litigation in federal court in Philadelphia, Pennsylvania. In February 2014, the court entered the final order dismissing these lawsuits as a result of the class action settlement.

As part of the settlement, DuPont paid about $7 in plaintiffs' attorney fees and expenses. In addition, DuPont is providing a warranty against new damage, if any, caused by the use of Imprelis^® on class members' properties through May 2015. Certain class members opted out of the class action settlement and made independent claims or filed suit in various state courts, the majority of which were removed to federal court in Philadelphia. In the third quarter 2014, the company settled or reached settlements in principle for the majority of these claims and lawsuits. About 37 lawsuits are pending claiming property and related damage at March 31, 2015. This represents a decrease of 3 from the number of lawsuits pending at December 31, 2014.

The company has established review processes to verify and evaluate damage claims. There are several variables that impact the evaluation process including the number of trees on a property, the species of tree with reported damage, the height of the tree, the extent of damage and the possibility for trees to naturally recover over time. Upon receiving claims, DuPont verifies their accuracy and validity which often requires physical review of the property.

12

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in millions, except per share)

DuPont recorded income of $35 for insurance recoveries, within other operating charges in the interim Consolidated Income Statements, for the three months ended March 31, 2015. At March 31, 2015, DuPont had an accrual balance of $231 related to these claims and insurance receivables of $25.

Insurance recoveries are recognized when collection of payment is considered probable. The remaining coverage under the insurance program is $300 for costs and expenses. DuPont has submitted requests for payment to its insurance carriers for costs associated with this matter. The timing and outcome remain uncertain.

Litigation

The company is subject to various legal proceedings arising out of the normal course of its business including product liability, intellectual property, commercial, environmental and antitrust lawsuits. It is not possible to predict the outcome of these various proceedings. Although considerable uncertainty exists, management does not anticipate that the ultimate disposition of these matters will have a material adverse effect on the company's results of operations, consolidated financial position or liquidity.  However, the ultimate liabilities could be material to results of operations in the period recognized.  

PFOA 

DuPont used PFOA (collectively, perfluorooctanoic acids and its salts, including the ammonium salt), as a processing aid to manufacture some fluoropolymer resins at various sites around the world including its Washington Works plant in West Virginia. At March 31, 2015, DuPont has an accrual balance of $14 related to the PFOA matters discussed below.

The accrual includes charges related to DuPont's obligations under agreements with the U.S. Environmental Protection Agency and voluntary commitments to the New Jersey Department of Environmental Protection.  These obligations and voluntary commitments include surveying, sampling and testing drinking water in and around certain company sites and offering treatment or an alternative supply of drinking water if tests indicate the presence of PFOA in drinking water at or greater than the national Provisional Health Advisory.

Drinking Water Actions

In August 2001, a class action, captioned Leach v DuPont, was filed in West Virginia state court alleging that residents living near the Washington Works facility had suffered, or may suffer, deleterious health effects from exposure to PFOA in drinking water.

DuPont and attorneys for the class reached a settlement in 2004 that binds about 80,000 residents. In 2005, DuPont paid the plaintiffs’ attorneys’ fees and expenses of $23 and made a payment of $70, which class counsel designated to fund a community health project.  The company funded a series of health studies which were completed in October 2012 by an independent science panel of experts (the C8 Science Panel). The studies were conducted in communities exposed to PFOA to evaluate available scientific evidence on whether any probable link exists, as defined in the settlement agreement, between exposure to PFOA and human disease.

The C8 Science Panel found probable links, as defined in the settlement agreement, between exposure to PFOA and pregnancy-induced hypertension, including preeclampsia; kidney cancer; testicular cancer; thyroid disease; ulcerative colitis; and diagnosed high cholesterol.

In May 2013, a panel of three independent medical doctors released its initial recommendations for screening and diagnostic testing of eligible class members. In September 2014, the medical panel recommended follow-up screening and diagnostic testing three years after initial testing, based on individual results. The medical panel has not communicated its anticipated schedule for completion of its protocol. The company is obligated to fund up to $235 for a medical monitoring program for eligible class members and, in addition, administrative costs associated with the program, including class counsel fees.  In January 2012, the company put $1 in an escrow account to fund medical monitoring as required by the settlement agreement.  The court appointed Director of Medical Monitoring has established the program to implement the medical panel's recommendations and the registration process, as well as eligibility screening, is ongoing. Diagnostic screening and testing has begun and associated payments to service providers are being disbursed from the escrow account.

In addition, under the settlement agreement, the company must continue to provide water treatment designed to reduce the level of PFOA in water to six area water districts, including the Little Hocking Water Association (LHWA), and private well users.

Class members may pursue personal injury claims against DuPont only for those human diseases for which the C8 Science Panel determined a probable link exists. At March 31, 2015, there were approximately 3,500 lawsuits filed in various federal and state courts in Ohio and West Virginia, an increase of about 600 over December 31, 2014. In accordance with a stipulation reached in

13

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in millions, except per share)

the third quarter 2014 and other court procedures, these lawsuits have been or will be served and consolidated in multi-district litigation in Ohio federal court (MDL). Based on information currently available to the company the majority of the lawsuits allege personal injury claims associated with high cholesterol and thyroid disease from exposure to PFOA in drinking water.  There are 32 lawsuits alleging wrongful death. While attorneys for the plaintiffs have indicated that additional lawsuits may be filed, the company expects the rate of such filings to substantially decrease. In 2014, six plaintiffs from the MDL were selected for individual trial. The first trial is scheduled to begin in September 2015, and the second in November 2015. DuPont denies the allegations in these lawsuits and is defending itself vigorously.

Additional Actions

An Ohio action brought by the LHWA is ongoing. In addition to general claims of PFOA contamination of drinking water, the action claims “imminent and substantial endangerment to health and or the environment” under the Resource Conservation and Recovery Act (RCRA). In the second quarter 2014, DuPont filed a motion for summary judgment and LHWA moved for partial summary judgment. In the first quarter of 2015, the court granted in part and denied in part both parties’ motions. As a result, the litigation process will continue with respect to certain of the plaintiffs’ claims.

PFOA Summary

While it is probable that the company will incur costs related to funding the medical monitoring program, such costs cannot be reasonably estimated due to uncertainties surrounding the level of participation by eligible class members and the scope of testing. DuPont believes that it is reasonably possible that it could incur losses related to the other PFOA matters discussed above; however, a range of such losses, if any, cannot be reasonably estimated at this time, due to the uniqueness of the individual MDL plaintiff's claims and the company's defenses to those claims both as to potential liability and damages on an individual claims basis, among other factors.

Environmental

The company is also subject to contingencies pursuant to environmental laws and regulations that in the future may require the company to take further action to correct the effects on the environment of prior disposal practices or releases of chemical or petroleum substances by the company or other parties. The company accrues for environmental remediation activities consistent with the policy as described in the company's 2014 Annual Report in Note 1, “Summary of Significant Accounting Policies.” Much of this liability results from the Comprehensive Environmental Response, Compensation and Liability Act (CERCLA, often referred to as Superfund), Resource Conservation and Recovery Act (RCRA) and similar state and global laws. These laws require the company to undertake certain investigative, remediation and restoration activities at sites where the company conducts or once conducted operations or at sites where company-generated waste was disposed. The accrual also includes estimated costs related to a number of sites identified by the company for which it is probable that environmental remediation will be required, but which are not currently the subject of enforcement activities.

Remediation activities vary substantially in duration and cost from site to site. These activities, and their associated costs, depend on the mix of unique site characteristics, evolving remediation technologies, diverse regulatory agencies and enforcement policies, as well as the presence or absence of potentially responsible parties. At March 31, 2015, the Condensed Consolidated Balance Sheet included a liability of $482, relating to these matters and, in management's opinion, is appropriate based on existing facts and circumstances. The average time frame over which the accrued or presently unrecognized amounts may be paid, based on past history, is estimated to be 15-20 years. Considerable uncertainty exists with respect to these costs and, under adverse changes in circumstances, the potential liability may range up to $1,100 above the amount accrued as of March 31, 2015.

Note 10.  Stockholders’Equity

Share Repurchase Program

In January 2014, the company's Board of Directors authorized a $5,000 share buyback plan that replaced the 2011 plan. In March 2015, the company purchased and retired 3.6 million shares in the open market which offset the dilution from employee compensation plans in the first quarter 2015. As of March 31, 2015, the company has purchased 33.7 million shares at a total cost of $2,282 under the plan. There is no required completion date for the remaining stock purchases.

14

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in millions, except per share)

Other Comprehensive (Loss) Income

A summary of the changes in other comprehensive (loss) income for the three months ended March 31, 2015 and 2014 is provided as follows:

	Three Months Ended									Three Months Ended									Affected Line Item in Consolidated Income Statements1
	March 31, 2015									March 31, 2014
	Pre-Tax			Tax			After-Tax			Pre-Tax			Tax			After-Tax
Cumulative translation adjustment	$	(1,189	)	$	—		$	(1,189	)	$	(72	)	$	—		$	(72	)	See (4) below
Net revaluation and clearance of cash flow hedges to earnings:
Additions and revaluations of derivatives designated as cash flow hedges	(22		)	6			(16		)	38			(14		)	24			See (2) below
Clearance of hedge results to earnings:
Foreign currency contracts	(8		)	3			(5		)	1			—			1			Net sales
Commodity contracts	15			(6		)	9			17			(7		)	10			Cost of goods sold
Net revaluation and clearance of cash flow hedges to earnings	(15		)	3			(12		)	56			(21		)	35
Pension benefit plans:
Net (loss) gain	(4		)	1			(3		)	1			—			1			See (2) below
Effect of foreign exchange rates	100			(27		)	73			—			—			—			See (2) below
Reclassifications to net income:
Amortization of prior service (benefit) cost	(2		)	1			(1		)	1			—			1			See (3) below
Amortization of loss	209			(74		)	135			149			(51		)	98			See (3) below
Settlement loss	5			(2		)	3			—			—			—			See (3) below
Pension benefit plans, net	308			(101		)	207			151			(51		)	100
Other benefit plans:
Reclassifications to net income:
Amortization of prior service benefit	(52		)	19			(33		)	(53		)	19			(34		)	See (3) below
Amortization of loss	19			(7		)	12			14			(4		)	10			See (3) below
Other benefit plans, net	(33		)	12			(21		)	(39		)	15			(24		)
Other comprehensive (loss) income	$	(929	)	$	(86	)	$	(1,015	)	$	96		$	(57	)	$	39

¹  Represents the income statement line item within the interim Consolidated Income Statement affected by the pre-tax reclassification out of other comprehensive (loss) income.

²  These amounts represent changes in accumulated other comprehensive loss excluding changes due to reclassifying amounts to the interim Consolidated Income Statements.

³  These accumulated other comprehensive loss components are included in the computation of net periodic benefit cost of the company's pension and other long-term employee benefit plans. See Note 12 for additional information.

⁴  The increase over prior year is primarily driven by the strengthening USD against the Euro and Brazilian real.

15

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in millions, except per share)

The changes and after-tax balances of components comprising accumulated other comprehensive loss are summarized below:

	Cumulative Translation Adjustment			Net Revaluation and Clearance of Cash Flow Hedges to Earnings			Pension Benefit Plans			Other Benefit Plans			Unrealized Gain on Securities		Total
2015
Balance January 1, 2015	$	(1,016	)	$	(6	)	$	(7,949	)	$	262		$	2	$	(8,707	)
Other comprehensive (loss) income before reclassifications	(1,189		)	(16		)	70			—			—		(1,135		)
Amounts reclassified from accumulated other comprehensive loss	—			4			137			(21		)	—		120
Balance March 31, 2015	$	(2,205	)	$	(18	)	$	(7,742	)	$	241		$	2	$	(9,722	)

	Cumulative Translation Adjustment			Net Revaluation and Clearance of Cash Flow Hedges to Earnings			Pension Benefit Plans			Other Benefit Plans			Unrealized Gain on Securities		Total
2014
Balance January 1, 2014	$	(140	)	$	(48	)	$	(5,749	)	$	494		$	2	$	(5,441	)
Other comprehensive (loss) income before reclassifications	(72		)	24			1			—			—		(47		)
Amounts reclassified from accumulated other comprehensive loss	—			11			99			(24		)	—		86
Balance March 31, 2014	$	(212	)	$	(13	)	$	(5,649	)	$	470		$	2	$	(5,402	)

Note 11. Financial Instruments

Debt

The estimated fair value of the company's total debt including interest rate financial instruments was determined using level 2 inputs within the fair value hierarchy, as described in the company's 2014 Annual Report in Note 1,“Summary of Significant Accounting Policies.”Based on quoted market prices for the same or similar issues or on current rates offered to the company for debt of the same remaining maturities, the fair value of the company's debt was approximately$11,168and$11,394as ofMarch 31, 2015andDecember 31, 2014, respectively.

Cash Equivalents

The fair value of cash equivalents approximates its stated value.  The estimated fair value of the company's cash equivalents was determined using level 1 and level 2 inputs within the fair value hierarchy, as described in the company's 2014 Annual Report in Note 1,“Summary of Significant Accounting Policies.”  Level 1 measurements are based on observable net asset values and level 2 measurements are based on current interest rates for similar investments with comparable credit risk and time to maturity.  The company held $0 and $1,436 of money market funds (level 1 measurements) as of March 31, 2015 and December 31, 2014, respectively.  The company held $1,700 and $3,293 of other cash equivalents (level 2 measurements) as of March 31, 2015 and December 31, 2014, respectively.     

Derivative Instruments

Objectives and Strategies for Holding Derivative Instruments

In the ordinary course of business, the company enters into contractual arrangements (derivatives) to reduce its exposure to foreign currency, interest rate and commodity price risks. The company has established a variety of derivative programs to be utilized for financial risk management. These programs reflect varying levels of exposure coverage and time horizons based on an assessment of risk.

Derivative programs have procedures and controls and are approved by the Corporate Financial Risk Management Committee, consistent with the company's financial risk management policies and guidelines. Derivative instruments used are forwards, options, futures and swaps. The company has not designated any nonderivatives as hedging instruments.

16

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in millions, except per share)

The company's financial risk management procedures also address counterparty credit approval, limits and routine exposure monitoring and reporting. The counterparties to these contractual arrangements are major financial institutions and major commodity exchanges. The company is exposed to credit loss in the event of nonperformance by these counterparties. The company utilizes collateral support annex agreements with certain counterparties to limit its exposure to credit losses. The company's derivative assets and liabilities are reported on a gross basis in the Condensed Consolidated Balance Sheets. The company anticipates performance by counterparties to these contracts and therefore no material loss is expected. Market and counterparty credit risks associated with these instruments are regularly reported to management.

The notional amounts of the company's derivative instruments were as follows:

	March 31, 2015		December 31, 2014
Derivatives designated as hedging instruments:
Interest rate swaps	$	—	$	1,000
Foreign currency contracts	71		434
Commodity contracts	265		388
Derivatives not designated as hedging instruments:
Foreign currency contracts	8,959		10,586
Commodity contracts	86		166

Foreign Currency Risk

The company's objective in managing exposure to foreign currency fluctuations is to reduce earnings and cash flow volatility associated with foreign currency rate changes. Accordingly, the company enters into various contracts that change in value as foreign exchange rates change to protect the value of its existing foreign currency-denominated assets, liabilities, commitments and cash flows.

The company routinely uses forward exchange and option contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities of its operations. The primary business objective of this hedging program is to maintain an approximately balanced position in foreign currencies so that exchange gains and losses resulting from exchange rate changes, net of related tax effects, are minimized. The company also uses foreign currency exchange contracts to offset a portion of the company's exposure to certain foreign currency-denominated revenues so that gains and losses on these contracts offset changes in the USD value of the related foreign currency-denominated revenues. The objective of the hedge program is to reduce earnings and cash flow volatility related to changes in foreign currency exchange rates.

Commodity Price Risk

Commodity price risk management programs serve to reduce exposure to price fluctuations on purchases of inventory such as copper, corn, soybeans and soybean meal. The company enters into over-the-counter and exchange-traded derivative commodity instruments to hedge the commodity price risk associated with agricultural commodity exposures.

Cash Flow Hedges

Foreign Currency Contracts

The company uses foreign currency exchange instruments such as forwards and options to offset a portion of the company's exposure to certain foreign currency-denominated revenues so that gains and losses on these contracts offset changes in the USD value of the related foreign currency-denominated revenues. In addition, the company occasionally uses forward exchange contracts to offset a portion of the company's exposure to certain foreign currency-denominated transactions such as capital expenditures.

Commodity Contracts

The company enters into over-the-counter and exchange-traded derivative commodity instruments, including options, futures and swaps, to hedge the commodity price risk associated with agriculture commodity exposures.

While each risk management program has a different time maturity period, most programs currently do not extend beyond the next two-year period. Cash flow hedge results are reclassified into earnings during the same period in which the related exposure impacts earnings. Reclassifications are made sooner if it appears that a forecasted transaction is not probable of occuring. The following table summarizes the after-tax effect of cash flow hedges on accumulated other comprehensive loss for the three months ended March 31, 2015 and 2014:

17

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in millions, except per share)

	Three Months Ended
	March 31,
	2015			2014
Beginning balance	$	(6	)	$	(48	)
Additions and revaluations of derivatives designated as cash flow hedges	(16		)	24
Clearance of hedge results to earnings	4			11
Ending balance	$	(18	)	$	(13	)

At March 31, 2015, an after-tax net loss of $4 is expected to be reclassified from accumulated other comprehensive loss into earnings over the next 12 months.

Derivatives not Designated in Hedging Relationships

Foreign Currency Contracts

The company routinely uses forward exchange and options contracts to reduce its net exposure, by currency, related to foreign currency-denominated monetary assets and liabilities of its operations so that exchange gains and losses resulting from exchange rate changes are minimized. The netting of such exposures precludes the use of hedge accounting; however, the required revaluation of the forward contracts and the associated foreign currency-denominated monetary assets and liabilities intends to achieve a minimal earnings impact, after taxes.

Commodity Contracts

The company utilizes options, futures and swaps that are not designated as hedging instruments to reduce exposure to commodity price fluctuations on purchases of inventory such as corn, soybeans and soybean meal.

18

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in millions, except per share)

Fair Values of Derivative Instruments

The table below presents the fair values of the company's derivative assets and liabilities within the fair value hierarchy, as described in the company's 2014 Annual Report in Note 1, “Summary of Significant Accounting Policies.”

		Fair Value Using Level 2 Inputs
	Balance Sheet Location	March 31, 2015		December 31, 2014
Asset derivatives:
Derivatives designated as hedging instruments:
Interest rate swaps1	Accounts and notes receivable, net	$	—	$	1
Foreign currency contracts	Accounts and notes receivable, net	2		10
		2		11
Derivatives not designated as hedging instruments:
Foreign currency contracts2	Accounts and notes receivable, net	67		254
Total asset derivatives3		$	69	$	265
Cash collateral1,2	Other accrued liabilities	$	80	$	47
Liability derivatives:
Derivatives designated as hedging instruments:
Foreign currency contracts	Other accrued liabilities	$	3	$	10
Derivatives not designated as hedging instruments:
Foreign currency contracts	Other accrued liabilities	47		62
Commodity contracts	Other accrued liabilities	1		1
		48		63
Total liability derivatives3		$	51	$	73

¹  Cash collateral held as of March 31, 2015 and December 31, 2014 represents $0 and $6, respectively, related to interest rate swap derivatives designated as hedging instruments.

²  Cash collateral held as of March 31, 2015 and December 31, 2014 represents $80 and $41, respectively, related to foreign currency derivatives not designated as hedging instruments.

³  The company's derivative assets and liabilities subject to enforceable master netting arrangements totaled $45 at March 31, 2015 and $67 at December 31, 2014.

19

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in millions, except per share)

Effect of Derivative Instruments

	Amount of Gain (Loss) Recognized in OCI1 (Effective Portion)						Amount of Gain (Loss) Recognized in Income2
Three Months Ended March 31,	2015			2014			2015			2014			Income Statement Classification
Derivatives designated as hedging instruments:
Fair value hedges:
Interest rate swaps	$	—		$	—		$	(1	)	$	(7	)	Interest expense
Cash flow hedges:
Foreign currency contracts	(2		)	(1		)	8			(1		)	Net sales
Commodity contracts	(20		)	39			(15		)	(17		)	Cost of goods sold
	(22		)	38			(8		)	(25		)
Derivatives not designated as hedging instruments:
Foreign currency contracts	—			—			268			(46		)	Other income, net3
Commodity contracts	—			—			2			(24		)	Cost of goods sold
	—			—			270			(70		)
Total derivatives	$	(22	)	$	38		$	262		$	(95	)

¹   OCI is defined as other comprehensive income (loss).

²   For cash flow hedges, this represents the effective portion of the gain (loss) reclassified from accumulated OCI into income during the period. For the three months ended March 31, 2015 and 2014, there was no material ineffectiveness with regard to the company's cash flow hedges.

³   Gain (loss) recognized in other income, net, was partially offset by the related gain (loss) on the foreign currency-denominated monetary assets and liabilities of the company's operations, which were $(204) and $(50) for the three months ended March 31, 2015 and 2014.

20

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in millions, except per share)

Note 12. Long-Term Employee Benefits

Pension Plans

In determining the U.S. pension plan 2015 net periodic benefit costs, the company updated the expected return on plan assets assumption from 8.75 percent to 8.50 percent.

The following sets forth the components of the company’s net periodic benefit cost for pensions:  

	Three Months Ended
	March 31,
	2015			2014
Service cost	$	66		$	60
Interest cost	273			292
Expected return on plan assets	(404		)	(402		)
Amortization of loss	209			149
Amortization of prior service (benefit) cost	(2		)	1
Settlement loss	5			—
Net periodic benefit cost	$	147		$	100

Other Long-Term Employee Benefit Plans

The following sets forth the components of the company’s net periodic benefit cost for other long-term employee benefits:  

	Three Months Ended
	March 31,
	2015			2014
Service cost	$	4		$	4
Interest cost	28			31
Amortization of loss	19			14
Amortization of prior service benefit	(52		)	(53		)
Net periodic benefit cost	$	(1	)	$	(4	)

21

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in millions, except per share)

Note 13.  Segment Information

Segment sales include transfers to another business segment. Segment pre-tax operating income (loss) (PTOI) is defined as income (loss) before income taxes excluding non-operating pension and other postretirement employee benefit costs, exchange gains (losses), corporate expenses and interest.

Viton^® fluoroelastomer products (Viton^®) will be included in the Performance Chemicals separation and therefore the results are reported within Performance Chemicals. Viton^® was previously reported within Performance Materials. Reclassifications of prior year data have been made to conform to current year classifications.

Three Months Ended March 31,	Agriculture1			Electronics & Communications		Industrial Biosciences		Nutrition & Health		Performance Chemicals		Performance Materials		Safety & Protection		Other				Total
2015
Segment sales	$	3,937		$	521	$	285	$	813	$	1,364	$	1,411	$	909	$	1			$	9,241
Less: Transfers	—			4		5		—		29		30		1		—				69
Net sales	3,937			517		280		813		1,335		1,381		908		1				9,172
PTOI	1,174		2	85		56		89		129		327		184		(103		)	3	1,941
2014
Segment sales	$	4,394		$	580	$	301	$	861	$	1,591	$	1,534	$	947	$	1			$	10,209
Less: Transfers	3			3		3		—		57		14		1		—				81
Net sales	4,391			577		298		861		1,534		1,520		946		1				10,128
PTOI	1,442			75		56		93		206		293		175		(92		)		2,248

¹  As of March 31, 2015, Agriculture net assets were $9,005, an increase of $2,310 from $6,695 at December 31, 2014. The increase was primarily due to higher trade receivables due to normal seasonality in the sales and cash collections cycle.

² Included $35 of insurance recoveries during the three months ended March 31, 2015 recorded in other operating charges for recovery of costs for customer claims related to the use of the Imprelis^® herbicide. See Note 9 for additional information.

³  Included a $(37) pre-tax impairment charge during the three months ended March 31, 2015 recorded in employee separation / asset related charges, net for a cost basis investment. See Note 3 for additional information.

Reconciliation to Consolidated Income Statements 

	Three Months Ended March 31,
	2015			2014
Total segment PTOI	$	1,941		$	2,248
Non-operating pension and other postretirement employee benefit costs	(75		)	(30		)
Net exchange gains (losses)2	64			(96		)
Corporate expenses1	(245		)	(217		)
Interest expense	(84		)	(103		)
Income before income taxes	$	1,601		$	1,802

¹  Included transaction costs associated with the separation of the Performance Chemicals segment of $(81) and $(16) in the three months ended March 31, 2015 and 2014, respectively, which were recorded in other operating charges in the company's interim Consolidated Income Statements.

²  Included a charge of $(40) associated with remeasuring the company's Ukranian hryvnia net monetary assets in the three months ended March 31, 2015, which was recorded in other income, net in the company's interim Consolidated Income Statements.

22

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Cautionary Statements About Forward-Looking Statements

This report contains forward-looking statements which may be identified by their use of words like “plans,” “expects,” “will,” “anticipates,” “believes,” “intends,” “projects,” “estimates” or other words of similar meaning. All statements that address expectations or projections about the future, including statements about the company's strategy for growth, product development, regulatory approval, market position, anticipated benefits of recent acquisitions, timing of anticipated benefits from restructuring actions, outcome of contingencies, such as litigation and environmental matters, expenditures and financial results, are forward-looking statements.

Forward-looking statements are based on certain assumptions and expectations of future events which may not be accurate or realized. Forward-looking statements also involve risks and uncertainties, many of which are beyond the company's control. Some of the important factors that could cause the company's actual results to differ materially from those projected in any such forward-looking statements are:

• Fluctuations in energy and raw material prices;

• Failure to develop and market new products and optimally manage product life cycles;

• Outcome of significant litigation and environmental matters, including those related to divested businesses;

• Failure to appropriately manage process safety and product stewardship issues;

• Effect of changes in tax, environmental and other laws and regulations or political conditions in the United States of America (U.S.) and other countries in which the company operates;

• Conditions in the global economy and global capital markets, including economic factors, such as inflation, deflation, fluctuations in currency rates, interest rates and commodity prices;

• Ability to appropriately respond to market acceptance, government rules, regulations and policies affecting products based on biotechnology;

• Impact of business disruptions, including supply disruptions, and security threats, regardless of cause, including acts of sabotage, cyber-attacks, terrorism or war, weather events and natural disasters;

• Ability to discover, develop and protect new technologies and enforce the company's intellectual property rights; and

• Successful integration of acquired businesses and separation of underperforming or non-strategic assets or businesses, including the proposed spin-off of the Performance Chemicals segment.

For some of the important factors that could cause the company's actual results to differ materially from those projected in any such forward-looking statements, see the Risk Factors discussion set forth under Part I, Item 1A of the company's 2014 Annual Report.

Recent Developments

Separation of Performance Chemicals

In October 2013, DuPont announced that it intends to separate its Performance Chemicals segment through a U.S. tax-free spin-off to shareholders, subject to customary closing conditions. In April 2015, an amendment to the Form 10 registration statement related to the spin-off will be filed with the SEC. The amended Form 10 will include financial information for the year ended December 31, 2014 and certain pro forma information for the new public company to be created upon completion of the pending separation of DuPont's Performance Chemicals segment. The new public company will be named The Chemours Company (Chemours). The company expects to complete the separation on July 1, 2015, subject to final approval from DuPont's Board of Directors.

As part of the separation, DuPont incurred $81 million and $16 million in transaction costs, which were recorded in other operating charges in the interim Consolidated Income Statements for the three months ended March 31, 2015 and 2014, respectively. The company expects to incur total costs related to the separation in 2015 estimated at about $350 million. These transaction costs primarily relate to professional fees associated with preparation of regulatory filings and separation activities within finance, legal and information system functions.

The company expects to receive dividend proceeds from Chemours prior to separation, the payment of which is anticipated to be financed by debt obtained by Chemours in the second quarter of 2015. DuPont anticipates receiving total dividend proceeds of approximately $4 billion, pending the final credit ratings and underlying business conditions for Chemours. DuPont intends to return an amount equal to all or substantially all of this Chemours dividend to DuPont shareholders via share repurchases over the 12 to 18 month period following the separation, with a portion to be returned in 2015.

23

As a result of the separation of its Performance Chemicals segment, coupled with the company’s redesign initiative, the functional currency at certain of the company’s foreign entities is being re-evaluated which, in some cases, resulted in a change in the foreign entities’ functional currency.

Redesign Initiative

In June 2014, DuPont announced its global, multi-year initiative to redesign its global organization and operating model to reduce costs and improve productivity and agility across all businesses and functions. DuPont commenced a restructuring plan to realign and rebalance staff function support, enhance operational efficiency, and to reduce residual costs associated with the separation of its Performance Chemicals segment. The Company continues to make significant progress in this effort with total cost savings expected to increase to $0.40 per share for 2015. The Company expects to yield savings of approximately $1 billion on a run-rate basis by the fourth quarter of 2015 and $1.3 billion by 2017.

24

Results of Operations

Overview

The following is a summary of the results of operations for the three months ended March 31, 2015:

• Net Sales were $9.2 billion, versus $10.1 billion in the same period prior year, a 9 percent decline primarily attributable to a 6 percent negative impact from currency and the absence of sales from portfolio changes in the prior year.

• Total segment pre-tax operating income (PTOI) of $1,941 million was $307 million or 14 percent below last year, reflecting a negative currency impact of about $300 million and a decline in Agriculture and Performance Chemicals PTOI. The company expects the previously estimated negative currency impact to increase from about $0.60 to $0.80, largely impacting the Agriculture segment in the first half of the year. The company is working aggresively to mitigate the stronger currency headwinds including the increased cost savings from the operational redesign and other corporate and business actions.

• Net Income was $1,035 million, 28 percent below the same period last year primarily reflecting lower segment PTOI and higher income taxes.

• Cost savings from the strategic redesign of the company’s operating model improved earnings $0.10 per share versus the first quarter prior year. The Company continues to make significant progress in this effort with total cost savings expected to increase to $0.40 per share for 2015.

Net Sales

Net sales for the first quarter were $9.2 billion versus $10.1 billion in the prior year, principally attributable to a 6 percent negative currency impact, largely from a weakness in the Euro, Russian ruble, Brazilian real and eastern European currencies; a 2 percent impact from the absence of sales from portfolio changes; and 1 percent lower volume. Local prices and product mix were flat as higher prices in Agriculture were offset by lower prices in the other segments. Volume reflects declines in Agriculture and Performance Chemicals, partly offset by increases in Performance Materials, Safety & Protection, Nutrition & Health and Industrial Biosciences. Total company sales in developing markets were $2.6 billion, down 15 percent, reflecting a 10 percent negative currency impact and 5 percent lower volume. Developing markets include China, India and countries located in Latin America, Eastern and Central Europe, Middle East, Africa and Southeast Asia.

The table below shows a regional breakdown of net sales based on location of customers and percentage variances from the prior year: 

	Three Months Ended March 31, 2015				Percent Change Due to:
	Net Sales ($ Billions)		Percent Change vs. 2014		Local Price and Product Mix		Currency		Volume		Portfolio and Other
Worldwide	$	9.2	(9	)	—		(6	)	(1	)	(2	)
U.S. & Canada	4.3		(3	)	(1	)	—		—		(2	)
Europe, Middle East & Africa (EMEA)	2.4		(18	)	3		(16	)	(3	)	(2	)
Asia Pacific	1.7		(6	)	(1	)	(3	)	—		(2	)
Latin America	0.8		(18	)	(1	)	(6	)	(9	)	(2	)

Other Income, Net

Other income, net, totaled $198 million for the first quarter 2015, an increase of $181 million compared to $17 million in the prior year primarily due to pretax exchange gains on foreign exchange contracts, gains on litigation agreement and sale of assets. The most significant component of the increase in other income was an increase in pre-tax exchange gains, which was driven by gains on foreign currency contracts due to strengthening of the U.S. dollar versus global currencies partially offset by losses on the related foreign currency-denominated monetary assets and liabilities. See Notes 4 and 11 to the interim Consolidated Financial Statements for further discussion of the company's policy of hedging the foreign currency-denominated monetary assets and liabilities.

Additional information related to the company's other income, net, is included in Note 4 to the interim Consolidated Financial Statements.

25

Cost of Goods Sold (COGS)

COGS totaled $5.6 billion in the first quarter 2015 versus $6.0 billion in the prior year, a 7 percent decrease, principally due to the currency impact of a stronger U.S. dollar and divestitures. COGS as a percent of net sales increased to 61 percent from 59 percent last year primarily reflecting currency impact which decreased sales by 6 percent and COGS by 3 percent.

Other Operating Charges

Other operating charges were $283 million in the first quarter 2015, essentially flat versus $286 million in the prior year, as increased separation transaction costs were offset by insurance recoveries, the stronger U.S. dollar and decreased costs from portfolio changes.

Selling, General and Administrative Expenses (SG&A)

SG&A totaled $1.3 billion for the first quarter 2015 versus $1.4 billion in the prior year. The decrease was primarily due to savings from the company's operational redesign initiative and lower sales commissions. SG&A was 14 percent of net sales for the three months ended March 31, 2015 and 2014.

Research and Development Expense (R&D)

R&D totaled $499 million and $518 million for the first quarter 2015 and 2014, respectively. The decrease was primarily due to lower spending and the impact of currency. R&D was 5 percent of net sales for the first quarter 2015 and 2014.

Interest Expense

Interest expense totaled $84 million in the first quarter 2015, compared to $103 million in 2014. The decrease was primarily due to lower average borrowings.

Employee Separation / Asset Related Charges, Net

Employee separation / asset related charges, net totaled $38 million in the first quarter 2015. During first quarter of 2015, a $38 million pre-tax impairment charge was recorded in employee separation / asset related charges, net within the Other segment. See Note 3 to the interim Consolidated Financial Statements for additional information.

Provision for Income Taxes

The company's effective tax rate for the first quarter 2015 was 35.4 percent as compared to 19.8 percent in 2014. The increase in the effective tax rate is driven by the hedging program gains which are largely taxable in the U.S., where as the offsetting exchange losses on the re-measurement of the net monetary asset positions are often not tax deductible in their local jurisdictions. In addition transaction costs related to the Performance Chemicals segment, the Ukraine hryvnia re-measurement and geographic mix of earnings also contributed to the increase in the effective tax rate.

See Note 5 to the interim Consolidated Financial Statements for additional information.

Recent Accounting Pronouncements

See Note 1 to the interim Consolidated Financial Statements for a description of recent accounting pronouncements.

26

Segment Reviews

Summarized below are comments on individual segment sales and PTOI for the three month period ended March 31, 2015 compared with the same period in 2014. Segment PTOI is defined as income (loss) before income taxes excluding non-operating pension and other postretirement employee benefit costs, exchange gains (losses), corporate expenses and interest. All references to prices are based on local price unless otherwise specified. A reconciliation of segment sales to consolidated net sales and segment PTOI to income before income taxes for the three month periods ended March 31, 2015 and 2014 is included in Note 13 to the interim Consolidated Financial Statements.

Viton^® fluoroelastomer products (Viton^®) will be included in the Performance Chemicals separation and therefore the results are reported within Performance Chemicals. Viton^® was previously reported within Performance Materials. Reclassifications of prior year data have been made to conform to current year classifications.

The following table summarizes first quarter 2015 segment sales and related variances versus prior year:

	Three Months Ended
	March 31, 2015				Percentage Change Due to:
	Segment Sales ($ Billions)		Percent Change vs. 2014		Local Price and Product Mix		Currency		Volume		Portfolio and Other
Agriculture	$	3.9	(10	)	3		(8	)	(5	)	—
Electronics & Communications	0.5		(10	)	(5	)	(2	)	(3	)	—
Industrial Biosciences	0.3		(5	)	—		(6	)	1		—
Nutrition & Health	0.8		(6	)	—		(8	)	2		—
Performance Chemicals	1.4		(14	)	(3	)	(3	)	(6	)	(2	)
Performance Materials	1.4		(8	)	(3	)	(5	)	8		(8	)
Safety & Protection	0.9		(4	)	(1	)	(4	)	6		(5	)

Agriculture - First quarter 2015 segment sales of $3,937 million decreased $457 million, or 10 percent, driven by the negative impact of currency and decreased volumes, partially offset by increases in pricing due to improved mix of Pioneer’s new corn hybrids and soybean varieties, and pricing actions in Europe and Asia to mitigate the impact of a stronger dollar. Decreased volumes are due to expected reductions in global corn planted area, lower insecticide demand in Latin America due to reduced insect pressure and timing of seed shipments.

The first quarter 2015 PTOI of $1,174 million decreased $268 million, or 19 percent, driven by the negative impact of currency and lower sales, partially offset by productivity improvements, disciplined cost actions and insurance recoveries of $35 million for recovery of costs for customer claims related to the use of the Imprelis^® herbicide. In addition, the insect control business has been impacted by the shutdown of the LaPorte manufacturing facility in Texas resulting in a shortfall in the supply of methomyl and oxamyl.

Electronics & Communications - First quarter 2015 segment sales of $521 million decreased $59 million, or 10 percent, as volume growth in consumer electronics was more than offset by pass-through of lower metals prices, competitive pressures impacting Solamet^® paste and the negative impact of currency. PTOI of $85 million increased $10 million, or 13 percent, driven by increased demand in consumer electronics and productivity gains which were partially offset by the above mentioned competitive pressures and negative impact of currency.

Industrial Biosciences - First quarter 2015 segment sales of $285 million decreased $16 million, or 5 percent, driven by the negative impact of currency, partially offset by increased volumes. Increased enzyme demand, principally in food markets, was mostly offset by lower biomaterial sales. PTOI of $56 million was even with prior year as the above decrease in sales was offset by improved product mix and lower input costs.

Nutrition & Health - First quarter 2015 segment sales of $813 million decreased $48 million, or 6 percent, driven by an 8 percent negative impact of currency partially offset by volume growth. Volume growth in probiotics, cultures and texturants was partially offset by lower volumes in specialty proteins. PTOI of $89 million decreased $4 million, or 4 percent, as volume gains and improved product mix were more than offset by the negative impact of currency.

27

Performance Chemicals - First quarter 2015 segment sales of $1,364 million decreased $227 million, or 14 percent, and PTOI of $129 million decreased $77 million, or 37 percent, driven by lower prices and volumes for titanium dioxide, the negative impact of currency and the impact of portfolio changes.

Performance Materials - First quarter 2015 segment sales of $1,411 million decreased $123 million, or 8 percent, driven by the portfolio changes from the sale of Glass Laminating Solutions/Vinyls, the negative impact of currency and decreased ethylene pricing. Partially offsetting the declines are increased volumes of ethylene and increased demand in automotive markets primarily in North America and Asia Pacific. Prior year ethylene sales were constrained in advance of a scheduled outage at the Orange, Texas ethylene unit. PTOI of $327 million increased $34 million, or 12 percent, driven by volume growth for ethylene and improved product mix, partially offset by lower ethylene prices and the negative impact of currency.

Safety & Protection - First quarter 2015 segment sales of $909 million decreased 4 percent due to 6 percent volume growth driven by increased demand for Tyvek^® protective material, Kevlar^® high strength materials and Nomex^® thermal resistant fiber, which was more than offset by the negative impact of currency as well as the portfolio impact of the Sontara^® divestiture. PTOI of $184 million increased $9 million, or 5 percent, primarily due to volume growth and productivity improvements partially offset by the negative impact of currency. A benefit in connection with the advancement of an ongoing claim was partially offset by higher costs associated with lower plant utilization at the Chambers Works facility in New Jersey.

28

Liquidity & Capital Resources

Information related to the company's liquidity and capital resources can be found in the company's 2014 Annual Report, Part II, Item 7. Managment's Discussion and Analysis of Financial Condition and Results of Operations, Liquidity and Capital Resources. Discussion below provides the updates to this information for the three months ended March 31, 2015.

(Dollars in millions)	March 31, 2015		December 31, 2014
Cash, cash equivalents and marketable securities	$	3,747	$	7,034
Total debt	10,384		10,694

Total debt as of March 31, 2015 was $10.4 billion, a decrease of $0.3 billion from $10.7 billion as of December 31, 2014.  The decrease was primarily due to the repayment of long-term debt, partially offset by an increase in commercial paper.

The company's cash, cash equivalents and marketable securities at March 31, 2015 and December 31, 2014 are $3.7 billion and $7.0 billion, respectively. The decrease was primarily due to cash used to fund seasonal working capital needs.

Summary of Cash Flows 

Cash used for operating activities was $2.1 billion for the three months ended March 31, 2015 compared to $2.4 billion during the same period last year. The $0.3 billion change was primarily due to lower year-over-year increases in working capital, coupled with lower earnings, and the negative currency impact that offsets cash provided by foreign currency exchange contract settlements is included in investing activities.

Cash used for investing activities was $0.1 billion for the three months ended March 31, 2015 compared to $0.2 billion for the same period last year. The $0.1 billion change was primarily due to cash provided by foreign currency exchange contract settlements offset by an adjustment to properly reflect purchases of property, plant and equipment on a cash basis. The impact of the adjustment was not material to prior periods.

Cash used for financing activities was $0.9 billion for the three months ended March 31, 2015 compared to $2.5 billion for the same period last year. The $1.6 billion decrease was due primarily to an increase in short-term borrowings and lower common stock repurchases offset with higher long-term debt repayments.

Dividends paid to shareholders during the three months ended March 31, 2015 totaled $0.4 billion. In January 2015, the Board of Directors declared a first quarter common stock dividend of $0.47 per share. In April 2015, the Board of Directors declared a second quarter common stock dividend of $0.49 per share, a four percent increase over the January 2015 dividend. With the first and second quarter dividends, the company has paid quarterly consecutive dividends since the company’s first dividend in the fourth quarter 1904. DuPont expects that the sum of DuPont’s and Chemours’ aggregate third quarter dividend will be equivalent to DuPont’s aggregate quarterly dividend immediately prior to separation. Chemours expects to declare a quarterly dividend in the aggregate amount of $100 million in total for the third quarter 2015.

In January 2014, the company's Board of Directors authorized a $5 billion share buyback plan. In March 2015, the company purchased and retired 3.6 million shares in the open market which offset the dilution from employee compensation plans in the first quarter 2015. As of March 31, 2015, the company has purchased 33.7 million shares at a total cost of $2.3 billion under the plan. There is no required completion date for the remaining stock purchases.

The company expects to receive dividend proceeds from Chemours prior to separation, the payment of which is anticipated to be financed by debt obtained by Chemours in the second quarter of 2015. DuPont anticipates receiving total dividend proceeds of approximately $4 billion, pending the final credit ratings and underlying market conditions for Chemours. DuPont intends to return an amount equal to all or substantially all of this Chemours dividend to DuPont shareholders via share repurchases over the 12 to 18 month period following the separation, with a portion to be returned in 2015.

See Part II, Item 2 and Note 10 to the interim Consolidated Financial Statements for additional information.

Guarantees and Off-Balance Sheet Arrangements

For detailed information related to Guarantees, Indemnifications, and Obligations for Equity Affiliates and Others, see the company's 2014 Annual Report, Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations, Off- Balance Sheet Arrangements, and Note 9 to the interim Consolidated Financial Statements.

29

Contractual Obligations

Information related to the company's contractual obligations at December 31, 2014 can be found in the company's 2014 Annual Report, Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations, Off-Balance Sheet Arrangements. The company's long-term debt obligations at March 31, 2015 decreased by $1.5 billion versus prior year-end primarily due to $1.4 billion of debt principal maturities.

Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

See Note 11, “Financial Instruments”, to the interim Consolidated Financial Statements. See also Part II, Item 7A. Quantitative and Qualitative Disclosures About Market Risk, of the company's 2014 Annual Report for information on the company's utilization of financial instruments and an analysis of the sensitivity of these instruments.

30

Item 4.CONTROLS AND PROCEDURES

a)        Evaluation of Disclosure Controls and Procedures

The company maintains a system of disclosure controls and procedures to give reasonable assurance that information required to be disclosed in the company's reports filed or submitted under the Securities Exchange Act of 1934 (Exchange Act) is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission. These controls and procedures also give reasonable assurance that information required to be disclosed in such reports is accumulated and communicated to management to allow timely decisions regarding required disclosures.

As of March 31, 2015, the company's Chief Executive Officer (CEO) and Chief Financial Officer (CFO), together with management, conducted an evaluation of the effectiveness of the company's disclosure controls and procedures pursuant to Rules 13a-15(e) and 15d-15(e) of the Exchange Act. Based on that evaluation, the CEO and CFO concluded that these disclosure controls and procedures are effective.

b)Changes in Internal Control over Financial Reporting

There has been no change in the company's internal control over financial reporting that occurred during the quarter ended March 31, 2015 that has materially affected, or is reasonably likely to materially affect, the company's internal control over financial reporting.

31

PART II.  OTHER INFORMATION

Item 1. LEGAL PROCEEDINGS

The company is subject to various litigation matters, including, but not limited to, product liability, patent infringement, antitrust claims, and claims for third party property damage or personal injury stemming from alleged environmental torts. Information regarding certain of these matters is set forth below and in Note 9 to the interim Consolidated Financial Statements.

Litigation

Imprelis^® Herbicide Claims Process

Information related to this matter is included in Note 9 to the interim Consolidated Financial Statements under the heading Imprelis^®.

PFOA: Environmental and Litigation Proceedings

For purposes of this report, the term PFOA means collectively perfluorooctanoic acid and its salts, including the ammonium salt and does not distinguish between the two forms. Information related to this matter is included in Note 9 to the interim Consolidated Financial Statements under the heading PFOA.

Environmental Proceedings

LaPorte Plant, LaPorte, Texas

The U.S. Environmental Protection Agency (EPA) conducted a multimedia inspection at the LaPorte facility in January 2008. DuPont, EPA and the Department of Justice (DOJ) began discussions in the Fall 2011 relating to the management of certain materials in the facility's waste water treatment system, hazardous waste management, flare and air emissions. These negotiations continue.

LaPorte Plant, LaPorte, Texas - Crop Protection

On November 15, 2014 there was a release of methyl mercaptan at the company’s LaPorte facility.  The release occurred at the site’s Crop Protection unit resulting in four employee fatalities inside the unit. DuPont is continuing its investigation into the incident. Several governmental agencies also are conducting their own investigations. DuPont is cooperating with these agency reviews.

Sabine Plant, Orange, Texas

In June 2012, DuPont began discussions with DOJ and EPA related to a multimedia inspection that EPA conducted at the Sabine facility in March 2009. The discussions involve the management of materials in the facility's waste water treatment system, hazardous waste management, flare and air emissions.

Yerkes Plant, Buffalo, New York

In March 2015, DuPont began discussions with the EPA related to alleged violations at the Yerkes facility of a Risk Management Plan (RMP) and General Duty Clause under the Clean Air Act (CAA). The allegations stem from a 2010 incident at the facility during which a welding contractor ignited residual vapors in an empty storage vessel.

Item 1A. RISK FACTORS

There have been no material changes in the company's risk factors discussed in Part I, Item 1A, Risk Factors, in the company's 2014 Annual Report.

32

Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Issuer Purchases of Equity

In January 2014, the company's Board of Directors authorized a $5 billion share buyback plan. There is no required completion date for purchases under this plan.

In March 2015, the company purchased and retired 3.6 million shares in the open market under the $5 billion share buyback plan.

See Part I, Item 2 on page 29 of this report and Note 10 to the interim Consolidated Financial Statements for additional information.

The following table summarizes information with respect to the company's purchase of its common stock during the three months ended March 31, 2015:

Month	Total Number of Shares Purchased	Average Price Paid per Share	Total Number of Shares Purchased as Part of Publicly Announced Program	Approximate Value of Shares that May Yet Be Purchased Under the Program(1) (Dollars in millions)
March:
Open Market Purchases	3,579,472	$78.86	3,579,472
Total	3,579,472		3,579,472	$	2,718

¹  Represents approximate value of shares that may yet be purchased under the 2014 plan.

Item 4. MINE SAFETY DISCLOSURES

Information regarding mine safety and other regulatory actions at the company's surface mine in Starke, Florida is included in Exhibit 95 to this report.

Item 6. EXHIBITS

Exhibits: The list of exhibits in the Exhibit Index to this report is incorporated herein by reference.

33

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

E. I. DU PONT DE NEMOURS AND COMPANY
(Registrant)
Date:	April 21, 2015
By:	/s/ Nicholas C. Fanandakis
	Nicholas C. Fanandakis
	Executive Vice President and
	Chief Financial Officer
	(As Duly Authorized Officer and
	Principal Financial and Accounting Officer)

34

EXHIBIT INDEX

Exhibit Number	Description
3.1	Company’s Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the company’s Annual Report on Form 10-K (Commission file number 1-815) for the year ended December 31, 2012).
3.2	Company’s Bylaws, as last amended effective August 12, 2013 (incorporated by reference to Exhibit 3.2 to the company’s Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended September 30, 2013).
4	The company agrees to provide the Commission, on request, copies of instruments defining the rights of holders of long-term debt of the company and its subsidiaries.
10.1*	The DuPont Stock Accumulation and Deferred Compensation Plan for Directors, as last amended effective January 1, 2009 (incorporated by reference to Exhibit 10.1 to the company's Annual Report on Form 10-K (Commission file number 1-815) for the year ended December 31, 2013).
10.2*	Company’s Supplemental Retirement Income Plan, as last amended effective June 4, 1996 (incorporated by reference to Exhibit 10.2 to the company’s Annual Report on Form 10-K (Commission file number 1-815) for the year ended December 31, 2011).
10.3*	Company’s Pension Restoration Plan, as last amended effective May 15, 2014 (incorporated by reference to Exhibit 10.3 to the company's Annual Report on 10-K (Commission number 1-815) for the year ended December 31, 2014).
10.4*	Company’s Rules for Lump Sum Payments, as last amended effective December 20, 2007 (incorporated by reference to Exhibit 10.4 to the company’s Quarterly Report on Form 10-Q (Commission file number 1-815)for the period ended June 30, 2011).
10.5*	Company’s Stock Performance Plan, as last amended effective January 25, 2007 (incorporated by reference to Exhibit 10.5 to the company’s Annual Report on Form 10-K (Commission file number 1-815) for the year ended December 31, 2011).
10.6*	Company’s Equity and Incentive Plan, as amended October 23, 2014 (incorporated by reference to Exhibit 10.6 to the company's Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended September 30, 2014.
10.7*	Form of Award Terms under the company’s Equity and Incentive Plan (incorporated by reference to Exhibit 10.7 to the company’s Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended June 30, 2013).
10.8*	Company’s Retirement Savings Restoration Plan, as last amended effective May 15, 2014. (incorporated by reference to Exhibit 10.8 to the company's Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended June 30, 2014).
10.9*	Company’s Retirement Income Plan for Directors, as last amended January 2011 (incorporated by reference to Exhibit 10.9 to the company's Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended March 31, 2012).
10.10*	Company's Senior Executive Severance Plan, adopted on August 12, 2013 (incorporated by reference to Exhibit 10.11 to the company's Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended September 30, 2013). The company agrees to furnish supplementally a copy of any omitted schedules to the Commission upon request.

35

Exhibit Number	Description
10.11*	Supplemental Deferral Terms for Deferred Long Term Incentive Awards and Deferred Variable Compensation Awards (incorporated by reference to Exhibit 10.12 to the company's Annual Report on Form 10-K (Commission file number 1-815) for the year ended December 31, 2013).
10.12*	Form of 2014 Award Terms under the Company's Equity and Incentive Plan (incorporated by reference to Exhibit 10.13 to the company's Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended March 31, 2014).
10.13*	Company’s Management Deferred Compensation Plan, as last amended effective April 15, 2014 (incorporated by reference to Exhibit 10.13 to the company's Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended June 30, 2014).
10.14*	Consulting Agreement dated October 22, 2014, by and between E.I. du Pont Nemours and Company and Thomas M. Connelly (incorporate by reference to Exhibit 10.4 to the company's Quarterly Report on 10-Q (Commission file number 1-815) for the period ended September 30, 2014).
10.15*	Form of 2015 Award Terms under the Company's Equity and Incentive Plan.
12	Computation of Ratio of Earnings to Fixed Charges.
18.1	Preferability Letter of Independent Registered Public Accounting Firm (incorporated by reference to Exhibit 18.1 to the company's Quarterly Report on Form 10-Q for the period ended September 30, 2014).
31.1	Rule 13a-14(a)/15d-14(a) Certification of the company’s Principal Executive Officer.
31.2	Rule 13a-14(a)/15d-14(a) Certification of the company’s Principal Financial Officer.
32.1	Section 1350 Certification of the company’s Principal Executive Officer. The information contained in this Exhibit shall not be deemed filed with the Securities and Exchange Commission nor incorporated by reference in any registration statement filed by the registrant under the Securities Act of 1933, as amended.
32.2	Section 1350 Certification of the company’s Principal Financial Officer. The information contained in this Exhibit shall not be deemed filed with the Securities and Exchange Commission nor incorporated by reference in any registration statement filed by the registrant under the Securities Act of 1933, as amended.
95	Mine Safety Disclosures.
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document

______________________________________

*Management contract or compensatory plan or arrangement.

36

EX-10.15

Exhibit 10.15

AWARD TERMS OF

PERFORMANCE-BASED RESTRICTED STOCK UNITS GRANTED UNDER THE

DUPONT EQUITY AND INCENTIVE PLAN

FOR GRANTEES LOCATED IN THE U.S.

Introduction You have been granted performance-based Restricted Stock Units (“Units”) under the E. I. du Pont de Nemours and Company Equity and Incentive Plan (“Plan”), subject to the following Award Terms. This grant is also subject to the terms of the Plan, which is hereby incorporated by reference. However, to the extent that an Award Term conflicts with the Plan, the Plan shall govern. Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in these Award Terms, including any appendices to these Award Terms (hereinafter, collectively referred to as the “Agreement”). A copy of the Plan, and other Plan-related materials, such as the Plan prospectus, are available at:

www1.lvs.dupont.com/employeebenefits/sharesandstockoption.html.

Grant Award         You must expressly accept the terms and conditions of your Award as set

Acceptance        forth in this Agreement. To accept, log on to Merrill Lynch Benefits

OnLine at www.benefits.ml.com, select Equity Plan > Grant

Information > Pending Acceptance.

IF YOU DO NOT ACCEPT YOUR UNITS IN THE MANNER INSTRUCTED BY THE COMPANY, YOUR UNITS WILL BE SUBJECT TO CANCELLATION.

Date of GrantFebruary 4, 2015 (“Date of Grant”)

Type of AwardUnits

Dividend Equivalents Dividends payable on the total number of shares represented by your Units (including whole and fractional Units) will be allocated to your account in the form of Units (whole and fractional) based upon the closing stock price on the date of the dividend payment. Dividend equivalent units will be determined after the end of the Performance Period and credited to your account at that time based on the performance-adjusted number of Units in your account. Dividend equivalent units will be calculated by taking the final performance-adjusted Units and calculating the dividend equivalent units for the first dividend payment date for the Performance Period. The resulting number of dividend equivalent units from the first dividend payment date will be added to the final performance-adjusted number of Units before calculating the dividend equivalent units for the second dividend payment date during the Performance Period. This process will be repeated for each subsequent dividend payment date during the Performance Period.

Performance Period January 1,2015 - December 31, 2017

Vesting Terms You may not sell, gift, or otherwise transfer or dispose of any of the Units.

If you remain an active employee from the Date of Grant through the last day of the Performance Period, the number of Units that have vested as of the end of the Performance Period, if any, will be based on the achievement of the Performance Metrics set forth below. Except as set forth below, if you terminate employment after the Date of Grant but prior to the last day of the Performance Period, unvested Units will be forfeited.

Performance Metrics The final number of Units earned is based upon the Company’s After-tax Operating Earnings (OE) and Total Shareholder Return (TSR) relative to the TSR of a group of its peer companies.

Performance and payout are determined independently for each metric. The final overall Award is the sum of the two elements

OE Payout %  x Target Award x 50% + TSR Payout % x Target Award x 50% = Final Award

1.After-tax Operating Earnings Growth¹

Externally reported After-tax Operating Earnings from continuing operations is measured as: Net Income - Significant Items - Non-operating Pension/OPEB costs (Other Post-Employment Benefits).

• After-tax Operating Earnings Growth is measured as annual growth over the prior year for the three-year Performance Period. The base period for measurement is the fiscal year preceding the Performance Period (ending 12/31/2014) and measured annually through 12/31/2017. The resulting three-year payout factor is the average of the percent of target award earned each year.

• The resulting payout factor is 50% of the Award.

¹ The definition of After-tax Operating Earnings is and shall continue to be consistent with the After-tax Operating Earnings as presented in external communications to investors.

2.    Total Shareholder Return (TSR)

TSR represents the total return on a company’s common stock to an investor (stock price appreciation plus dividends).

TSR Percentile Ranking Goal	Percent of Target Award Earned
< 25th	0%
25th*	25% (threshold)
50th*	100% (target)
75th*	200% (maximum)

*Interim points are interpolated on a straight-line basis

For this purpose, TSR is determined as follows:

TSR =	Change in Stock Price + Dividends Paid
	Beginning Stock Price

• Beginning Stock Price: average closing price of the Stock over the 20 trading days immediately prior to the first day of the Performance Period.

• Ending Stock Price: average closing price of the Stock over the last 20 trading days of the Performance Period.

• Change in Stock Price: difference between the Beginning Stock Price and the Ending Stock Price.

• Dividends Paid: total of all dividends paid on one share of Stock during the applicable calendar quarter(s) during the Performance Period, provided that dividends shall be treated as though they are reinvested on day of payment based on closing price of the Stock on that day.

• Based on the table above, the Company’s percentile rank in TSR against its peer companies is translated into a percentage (of target) payout for 50% of the Award.

Payment As soon as practicable during your first taxable year ending after the last day of the Performance Period, vested Units (including dividend equivalent units accruing after the end of the Performance Period and prior to the payment date), if any, will be paid to you or your beneficiary (or estate if there is no beneficiary), as applicable, in one share of Stock for each whole Unit and a cash payment for any fraction of a Unit. The value of each fractional Unit will be based on the average high and low prices of Stock as reported on the Composite Tape of the New York Stock Exchange as of the effective date of payment.

Code Section 409AThe Units are intended to be exempt from or compliant with Code

Section 409A and the U.S. Treasury Regulations relating thereto so as not to subject you to the payment of additional taxes and interest under

Code Section 409A or other adverse tax consequences. In furtherance of this intent, the provisions of this Agreement will be interpreted, operated, and administered in a manner consistent with these intentions. The Committee may modify the terms of this Agreement, the Plan or both, without your consent, in the manner that the Committee may determine to be necessary or advisable in order to comply with Code Section 409A or to mitigate any additional tax, interest and/or penalties or other adverse tax consequences that may apply under Code Section 409A if compliance is not practical. This section does not create an obligation on the part of the Company to modify the terms of this Agreement or the Plan and does not guarantee that the Units or the delivery of shares of Stock upon vesting/settlement of the Units will not be subject to taxes, interest and penalties or any other adverse tax consequences under Code Section 409A. In no event whatsoever shall the Company be liable to any party for any additional tax, interest or penalties that may be imposed on you by Code Section 409A or any damages for failing to comply with Code Section 409A.

Termination

of Employment

Under 55/10 Rule	If you terminate employment after attainment of age 55 with at least 10 years of service and either (i) you are an active employee for six months following the Date of Grant or (ii) you have been notified by the Company or, if different, your employer (the “Employer”), that your employment with the Company or Employer will terminate because of either lack of work or divestiture to an entity less than 50% owned by DuPont, the Units will remain subject to the Vesting Terms and will be paid in accordance with the Payment provisions above. However, the number of Units will be prorated based on the number of months you were employed from the Date of Grant through the end of the Performance Period.
Due to Lack of Work, Divestiture to Entity Less Than 50% Owned by DuPont, Disability, or Death	If you terminate employment due to (i) disability; (ii) death; (iii) lack of work; or (iv) divestiture to an entity less than 50% owned by the Company, the Units will remain subject to the Vesting Terms and will be paid in accordance with the Payment provisions above. However, the number of Units will be prorated based on the number of months you were employed from the Date of Grant through the end of the Performance Period.
Due to Any Other Reason (such as voluntary termination)	Units will be forfeited as of the date on which you terminate employment.

Restricted Conduct If you engage in any of the restricted conduct described in subparagraphs (i) through (iv) below for any reason, in addition to all remedies in law and/or equity available to the Company, you shall forfeit all Units (whether or not vested) and shall immediately pay to the Company, with respect to previously vested Units, a cash amount equal to the Fair Market Value of the Stock plus the cash payment for any fraction of a Unit received, without regard to any Tax-Related Items (as defined below) that may have been deducted from such amount. For purposes of subparagraphs (i) through (v) below, “Company” shall mean E. I. du Pont de Nemours and Company and/or any of its Subsidiaries or Affiliates that have employed you or retained your services.

(i) Non-Disclosure of Confidential Information. During the course of your employment with the Company and thereafter, you shall not use or disclose, except on behalf of the Company and pursuant to the Company’s directions, any Company “Confidential Information” (i.e., information concerning the Company and / or its business that is not generally known outside the Company, which includes, but is not limited to, (a) trade secrets; (b) intellectual property, including but not limited to inventions, invention disclosures and patent applications; (c) information regarding the Company’s present and/or future products, developments, processes and systems, budgets, proposals, marketing plans, financial data and projections, suppliers, vendors, inventions, formulas, data bases, know how, ideas, developments, experiments, improvements, computer programs, software, technology, blue prints, specifications and compilations of information; (d) information about employees and employee relations, including but not limited to training manuals and procedures, recruitment method and procedures, recruitment and distribution techniques, business plans and projections, employment contracts and employee handbooks; (e) information on customers or potential customers, including but not limited to customers’ names, sales records, prices, particularities, preferences and manner of doing business, and other terms of sales and Company cost information; and (f) information received in confidence by the Company from third parties. Information regarding products, services or technological innovations in development, in test marketing or being marketed or promoted in a discrete geographic region, which information the Company is considering for broader use, shall be deemed not generally known until such broader use is actually commercially implemented.); and/or

(ii) Solicitation of Employees. During your employment and for a period of one year following the termination of your employment for any reason, you shall not recruit, solicit or induce, or cause, allow, permit or aid others to recruit, solicit or induce, any employee, agent or consultant of the Company to terminate his/her employment or association with the Company; and/or

(iii) Solicitation of Customers. During your employment and for a period of one year following the termination of your employment for any reason, you shall not directly or indirectly, on behalf of yourself or any other person, company or entity, call on, contact, service or solicit competing business from customers or prospective customers of Company if, within the two years prior to the termination of your

employment, you had or made contact with the customer, or received or had access to Confidential Information about the customer; and/or

(iv) Non-Competition. During your employment and for a period of one year following the termination of your employment for any reason, you shall not, directly or indirectly, in any capacity, (a) compete or engage in a business similar to that of Company, (b) compete or engage in a business similar to that which the Company has plans to engage, or has engaged in during the two years prior to your termination, if, within this two-year period, you received or had access to Confidential Information regarding the proposed plans or the business in which Company engaged; or (c) take any action to invest in (other than a non-controlling ownership of securities issued by publicly held corporations), own, manage, operate, control, participate in, be employed or engaged by or be connected in any manner with any partnership, corporation or other business or entity engaging in a business similar to Company.

(v) Geographic Scope. You acknowledge that due to the broad scope of Company's customer base, the following geographic scope for subsections (iii) - (iv) of this Restricted Conduct section is necessary. Your non-competition and non-solicitation obligations under this Agreement shall include: (a) any territory in which you performed your duties for the Company; (b) any territory in which Company has customers about which you received or had access to Confidential Information during your employment; (c) any territory in which you solicited customers; or (d) any territory in which Company plans to expand its market share about which you received or had access to Confidential Information during your employment with Company.

Recoupment Policy This Award shall be subject to the Company’s Incentive Compensation Clawback Policy (as it may be amended from time to time), the terms of which are incorporated herein by reference.

Repayment/

Forfeiture Any benefits you may receive hereunder shall be subject to repayment or forfeiture as may be required to comply with the requirements of the U.S. Securities and Exchange Commission or any applicable law, including the requirements of the Dodd-Frank Wall Street Reform and Consumer Protection Act, or any securities exchange on which the Stock is traded, as may be in effect from time to time.

Deferral If you are an officer of the Company, you may defer the settlement of this Award in accordance with the procedures established by the Company for that purpose.

WithholdingYou acknowledge that the Company and/or your employer (the

“Employer”) (1) make no representations or undertakings regarding the treatment of any income tax, social insurance, payroll tax, fringe benefits tax, payment on account or other tax-related items related to the Plan and legally applicable to you (“Tax-Related Items”) in connection with any aspect of the Units, including, but not limited to, the grant, vesting or settlement of the Units, the subsequent sale of shares of Stock acquired pursuant to such settlement and the receipt of any dividends and/or any

dividend equivalent units; and (2) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the Units to reduce or eliminate your liability for Tax-Related Items or achieve any particular tax result. Further, if you are subject to Tax-Related Items in more than one jurisdiction, the Company and/or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.

Prior to any relevant taxable or tax withholding event, as applicable, you agree to make adequate arrangements satisfactory to the Company and/or the Employer to satisfy all Tax-Related Items. In this regard, you authorize the Company and/or the Employer, or their respective agents, at their discretion, to satisfy the obligations with regard to all Tax-Related Items by one or a combination of the following: (i) withholding from your wages or other cash compensation paid to you by the Company and/or the Employer; or (ii) withholding from proceeds of the sale of shares of Stock acquired upon settlement of the Units either through a voluntary sale or through a mandatory sale arranged by the Company (on your behalf pursuant to this authorization without further consent); or (iii) withholding in shares of Stock to be issued upon settlement of the Units.

If the obligation for Tax-Related Items is satisfied by withholding in shares of Stock, for tax purposes, you are deemed to have been issued the full number of shares of Stock subject to the vested Units, notwithstanding that a number of the shares of Stock are held back solely for the purpose of paying the Tax-Related Items.

Finally, you agree to pay to the Company or the Employer, any amount of Tax-Related Items that the Company or the Employer may be required to withhold or account for as a result of your participation in the Plan that cannot be satisfied by the means previously described. The Company may refuse to issue or deliver the shares or the proceeds of the sale of shares of Stock, if you fail to comply with your obligations in connection with the Tax-Related Items.

Notwithstanding anything in this section to the contrary, to avoid a prohibited acceleration under Code Section 409A, if shares of Stock subject to the Units will be withheld (or sold on your behalf) to satisfy any Tax Related Items arising prior to the date of settlement of the Units for any portion of the Units that is considered nonqualified deferred compensation subject to Code Section 409A, then the number of shares withheld (or sold on your behalf) shall not exceed the number of shares that equals the liability for Tax-Related Items.

Severability The provisions of this Agreement are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.

WaiverYou acknowledge that a waiver by the Company of breach of any provision of

this Agreement shall not operate or be construed as a waiver

of any other provision of this Agreement, or of any subsequent breach by you or any other participant.

Imposition of Other

Requirements The Company reserves the right to impose other requirements on your participation in this Agreement, on the Units and on any shares of Stock acquired under the Plan, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require you to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.

AWARD TERMS OF

TIME-VESTED RESTRICTED STOCK UNITS GRANTED UNDER THE

DUPONT EQUITY AND INCENTIVE PLAN

FOR GRANTEES LOCATED IN THE U.S.

Introduction You have been granted time-vested Restricted Stock Units under the E. I. du Pont de Nemours and Company Equity and Incentive Plan (“Plan”), subject to the following Award Terms. This grant is also subject to the terms of the Plan, which is hereby incorporated by reference. However, to the extent that an Award Term conflicts with the Plan, the Plan shall govern. Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in these Award Terms, including any appendices to these Award Terms (hereinafter, collectively referred to as the “Agreement”). A copy of the Plan, and other Plan-related materials, such as the Plan prospectus, are available at:

www1.lvs.dupont.com/employeebenefits/sharesandstockoption.html.

Grant Award         You must expressly accept the terms and conditions of your Award as set

Acceptance        forth in this Agreement. To accept, log on to Merrill Lynch Benefits

OnLine at www.benefits.ml.com, select Equity Plan > Grant

Information > Pending Acceptance.

IF YOU DO NOT ACCEPT YOUR RESTRICTED STOCK UNITS IN THE MANNER INSTRUCTED BY THE COMPANY, YOUR RESTRICTED STOCK UNITS WILL BE SUBJECT TO CANCELLATION.

Date of GrantFebruary 4, 2015 (“Date of Grant”)

Type of AwardsTime-vested Restricted Stock Units

Dividend Equivalents Dividends payable on the shares represented by your Restricted Stock Units (including whole and fractional Restricted Stock Units) will be allocated to your account in the form of additional Restricted Stock Units (whole and fractional) based upon the closing Stock price on the date of the dividend payment.

Restricted Period You may not sell, gift, or otherwise transfer or dispose of any of the Restricted Stock Units during the “Restricted Period.” The Restricted Period commences on the Date of Grant and lapses as set forth herein.

On February 4, 2016, the Restricted Period will lapse with respect to one-third (1/3) of the Restricted Stock Units, including dividend equivalents (rounded to a whole number of units).

On February 4, 2017, the Restricted Period will lapse with respect toone-third (1/3) of the Restricted Stock Units, including dividend equivalents (rounded to a whole number of units).

On February 4, 2018, the Restricted Period will lapse with respect to the remainingRestricted Stock Units, including dividend equivalents.

Termination

of Employment

Under 55/10 Rule	If you terminate employment after attainment of age 55 with at least 10 years of service and either (i) you are an active employee for six months following the Date of Grant or (ii) you have been notified by the Company or, if different, your employer (the “Employer”), that your employment with the Company or Employer will terminate because of either lack of work or divestiture to an entity less than 50% owned by DuPont, the Restricted Stock Units will remain subject to the Restricted Period set forth above.
Due to Lack of Work, Divestiture to Entity Less Than 50% Owned by DuPont, Disability, or Death	The Restricted Period on all units will lapse.
Due to Any Other Reason (such as voluntary termination)	Restricted Stock Units that are subject to a Restricted Period will be forfeited.

Payment Except in the case of termination due to lack of work, divestiture to an entity less than 50% owned by DuPont, disability or death, Restricted Stock Units shall be paid to you when the Restricted Period lapses in accordance with the schedule set forth under “Restricted Period.” In the case of termination due to lack of work, divestiture to an entity less than 50% owned by DuPont, disability or death, Restricted Stock Units shall be paid to you or your beneficiary (or estate if there is no beneficiary), as applicable, within sixty days of the date on which the Restricted Period lapses as a result of the termination. Restricted Stock Units are payable in one share of Stock for each whole unit and a cash payment for any fraction of a unit. The value of each fractional unit will be based on the average high and low prices of Stock as reported on the Composite Tape of the New York Stock Exchange as of the effective date of payment.

Code Section 409A To the extent that an amount that is considered “nonqualified deferred compensation” subject to Code Section 409A (“deferred compensation”) is payable on account of your termination of employment, no amounts shall be paid hereunder on account thereof unless such termination of employment constitutes a “separation from service,” within the meaning of Code Section 409A. If you are a “specified employee,” within the meaning of Code Section 409A, no amount that is deferred compensation shall be paid or delivered, on account of your separation from service, earlier than the date that is six months after such separation from service. Amounts otherwise payable during that six month period shall be paid on the date that is six months and one day after your separation from service.

The Restricted Stock Units are intended to be exempt from or compliant with Code Section 409A and the U.S. Treasury Regulations relating thereto so as not to subject you to the payment of additional taxes and interest under Code Section 409A or other adverse tax consequences. In furtherance of this intent, the

provisions of this Agreement will be interpreted, operated, and administered in a manner consistent with these intentions. The Committee may modify the terms of this Agreement, the Plan or both, without your consent, in the manner that the Committee may determine to be necessary or advisable in order to comply with Code Section 409A or to mitigate any additional tax, interest and/or penalties or other adverse tax consequences that may apply under Code Section 409A if compliance is not practical. This section does not create an obligation on the part of the Company to modify the terms of this Agreement or the Plan and does not guarantee that the Restricted Stock Units or the delivery of shares of Stock upon vesting/settlement of the Restricted Stock Units will not be subject to taxes, interest and penalties or any other adverse tax consequences under Code Section 409A. In no event whatsoever shall the Company be liable to any party for any additional tax, interest or penalties that may be imposed on you by Code Section 409A or any damages for failing to comply with Code Section 409A.

Restricted Conduct If you engage in any of the restricted conduct described in subparagraphs (i) through (iv) below for any reason, in addition to all remedies in law and/or equity available to the Company, you shall forfeit all Restricted Stock Units (whether or not vested) and shall immediately pay to the Company, with respect to previously vested Restricted Stock Units, a cash amount equal to the Fair Market Value of the Stock plus the cash payment for any fraction of a unit received, without regard to any Tax-Related Items (as defined below) that may have been deducted from such amount. For purposes of subparagraphs (i) through (v) below, “Company” shall mean E. I. du Pont de Nemours and Company and/or any of its Subsidiaries or Affiliates that have employed you or retained your services.

(i) Non-Disclosure of Confidential Information. During the course of your employment with the Company and thereafter, you shall not use or disclose, except on behalf of the Company and pursuant to the Company’s directions, any Company “Confidential Information” (i.e., information concerning the Company and / or its business that is not generally known outside the Company, which includes, but is not limited to, (a) trade secrets; (b) intellectual property, including but not limited to inventions, invention disclosures and patent applications; (c) information regarding the Company’s present and/or future products, developments, processes and systems, budgets, proposals, marketing plans, financial data and projections, suppliers, vendors, inventions, formulas, data bases, know how, ideas, developments, experiments, improvements, computer programs, software, technology, blue prints, specifications and compilations of information; (d) information about employees and employee relations, including but not limited to training manuals and procedures, recruitment method and procedures, recruitment and distribution techniques, business plans and projections, employment contracts and employee handbooks; (e) information on customers or potential customers, including but not limited to customers’ names, sales records, prices, particularities, preferences and manner of doing business, and other terms of sales and Company cost information; and (f) information received in confidence by the Company from third parties. Information regarding products, services or technological innovations in development, in test marketing or being marketed or promoted in a discrete geographic region, which information the Company is considering for broader use, shall be deemed not generally known until such broader use is actually commercially implemented.); and/or

(ii) Solicitation of Employees. During your employment and for a period of one year following the termination of your employment for any reason, you shall not recruit, solicit or induce, or cause, allow, permit or aid others to recruit, solicit or induce, any employee, agent or consultant of the Company to terminate his/her employment or association with the Company; and/or

(iii) Solicitation of Customers. During your employment and for a period of one year following the termination of your employment for any reason, you shall not directly or indirectly, on behalf of yourself or any other person, company or entity, call on, contact, service or solicit competing business from customers or prospective customers of Company if, within the two years prior to the termination of your employment, you had or made contact with the customer, or received or had access to Confidential Information about the customer; and/or

(iv) Non-Competition. During your employment and for a period of one year following the termination of your employment for any reason, you shall not, directly or indirectly, in any capacity, (a) compete or engage in a business similar to that of Company, (b) compete or engage in a business similar to that which the Company has plans to engage, or has engaged in during the two years prior to your termination, if, within this two-year period, you received or had access to Confidential Information regarding the proposed plans or the business in which Company engaged; or (c) take any action to invest in (other than a non-controlling ownership of securities issued by publicly held corporations), own, manage, operate, control, participate in, be employed or engaged by or be connected in any manner with any partnership, corporation or other business or entity engaging in a business similar to Company.

(v) Geographic Scope. You acknowledge that due to the broad scope of Company's customer base, the following geographic scope for subsections (iii) - (iv) of this Restricted Conduct section is necessary. Your non-competition and non-solicitation obligations under this Agreement shall include: (a) any territory in which you performed your duties for the Company; (b) any territory in which Company has customers about which you received or had access to Confidential Information during your employment; (c) any territory in which you solicited customers; or (d) any territory in which Company plans to expand its market share about which you received or had access to Confidential Information during your employment with Company.

Recoupment Policy This Award shall be subject to the Company’s Incentive Compensation Clawback Policy (as it may be amended from time to time), the terms of which are incorporated herein by reference.

Repayment/

Forfeiture Any benefits you may receive hereunder shall be subject to repayment or forfeiture as may be required to comply with the requirements of the U.S. Securities and Exchange Commission or any applicable law, including the requirements of the Dodd-Frank Wall Street Reform and Consumer Protection Act, or any securities exchange on which the Stock is traded, as may be in effect from time to time.

Deferral If you are an officer of the Company, you may defer the settlement of this Award in accordance with the procedures established by the Company for that purpose.

Withholding You acknowledge that the Company and/or your employer (the “Employer”) (1) make no representations or undertakings regarding the treatment of any income tax, social insurance, payroll tax, fringe benefits tax, payment on account or other tax-related items related to the Plan and legally applicable to you (“Tax-Related Items”) in connection with any aspect of the Restricted Stock Units, including, but not limited to, the grant, vesting or settlement of the Restricted Stock Units, the subsequent sale of shares of Stock acquired pursuant to such settlement and the receipt of any dividends and/or any dividend equivalents; and (2) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the Restricted Stock Units to reduce or eliminate your liability for Tax-Related Items or achieve any particular tax result. Further, if you are subject to Tax-Related Items in more than one jurisdiction, the Company and/or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.

Prior to any relevant taxable or tax withholding event, as applicable, you agree to make adequate arrangements satisfactory to the Company and/or the Employer to satisfy all Tax-Related Items. In this regard, you authorize the Company and/or the Employer, or their respective agents, at their discretion, to satisfy the obligations with regard to all Tax-Related Items by one or a combination of the following: (i) withholding from your wages or other cash compensation paid to you by the Company and/or the Employer; or (ii) withholding from proceeds of the sale of shares of Stock acquired upon settlement of the Restricted Stock Units either through a voluntary sale or through a mandatory sale arranged by the Company (on your behalf pursuant to this authorization without further consent); or (iii) withholding in shares of Stock to be issued upon settlement of the Restricted Stock Units.

If the obligation for Tax-Related Items is satisfied by withholding in shares of Stock, for tax purposes, you are deemed to have been issued the full number of shares of Stock subject to the vested Restricted Stock Units, notwithstanding that a number of the shares of Stock are held back solely for the purpose of paying the Tax-Related Items.

Finally, you agree to pay to the Company or the Employer, any amount of Tax-Related Items that the Company or the Employer may be required to withhold or account for as a result of your participation in the Plan that cannot be satisfied by the means previously described. The Company may refuse to issue or deliver the shares or the proceeds of the sale of shares of Stock, if you fail to comply with your obligations in connection with the Tax-Related Items.

Notwithstanding anything in this section to the contrary, to avoid a prohibited acceleration under Code Section 409A, if shares of Stock subject to the Restricted Stock Units will be withheld (or sold on your behalf) to satisfy any Tax Related Items arising prior to the date of settlement of the Restricted Stock Units for any portion of the Restricted Stock Units that is considered nonqualified deferred compensation subject to Code Section 409A, then the number of shares withheld (or sold on your behalf) shall not exceed the number of shares that equals the liability for Tax-Related Items.

Severability The provisions of this Agreement are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.

Waiver You acknowledge that a waiver by the Company of breach of any provision of this Agreement shall not operate or be construed as a waiver of any other provision of this Agreement, or of any subsequent breach by you or any other participant.

Imposition of Other

Requirements The Company reserves the right to impose other requirements on your participation in this Agreement, on the Restricted Stock Units and on any shares of Stock acquired under the Plan, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require you to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.

AWARD TERMS OF

OPTIONS GRANTED UNDER THE

DUPONT EQUITY AND INCENTIVE PLAN

FOR GRANTEES LOCATED IN THE U.S.

Introduction You have been granted stock options under the E. I. du Pont de Nemours and Company Equity and Incentive Plan (“Plan”), subject to the following Award Terms. This grant is also subject to the terms of the Plan, which is hereby incorporated by reference. However, to the extent that an Award Term conflicts with the Plan, the Plan shall govern. Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in these Award Terms, including any appendices to these Award Terms (hereinafter, collectively referred to as the “Agreement”). A copy of the Plan, and other Plan-related materials, such as the Plan prospectus, are available at:

www1.lvs.dupont.com/employeebenefits/sharesandstockoption.html.

Grant Award         You must expressly accept the terms and conditions of your Award as set

Acceptance        forth in this Agreement. To accept, log on to Merrill Lynch Benefits

OnLine at www.benefits.ml.com, select Equity Plan > Grant

Information > Pending Acceptance.

IF YOU DO NOT ACCEPT YOUR AWARD IN THE MANNER INSTRUCTED BY THE COMPANY, YOUR AWARD WILL BE SUBJECT TO CANCELLATION.

Date of GrantFebruary 4, 2015 (“Date of Grant”)

Type of OptionsNon-qualified stock options (“Options”)

Exercise Price $73.74

Expiration Date The Options will expire no later than February 3, 2022, or two years after the date of your death if earlier. However, the Options may expire sooner. Please refer to “Termination of Employment” below.

Vesting Schedule One-third (1/3) of theOptions (rounded to a whole number of shares) will become exercisable on February 4, 2016.

One-third (1/3) of the Options (rounded to a whole number of shares) will become exercisable on February 4, 2017.

The remainingOptions will become exercisable on February 4, 2018.

Termination

of Employment

Under 55/10 Rule	If you terminate employment after attainment of age 55 with at least 10 years of service and either (i) you are an active employee for six months following the Date of Grant or (ii) you have been notified by the Company or, if different, your employer (the “Employer”), that your employment with the Company or Employer will terminate because of either lack of work or divestiture to an entity less than 50% owned by DuPont, the Options will be exercisable through the Expiration Date set forth above. After that date, any unexercised Options will expire. Any unvested Options as of the date of termination will continue to vest in accordance with the Vesting Schedule set forth above.
Due to Lack of Work, Divestiture to Entity Less Than 50% Owned by DuPont, or Disability	The Options will be exercisable through the date that is one year after the date of your termination of employment, or, if earlier, the Expiration Date set forth above. After that date, any unexercised Options will expire. Any unvested Options as of the date of termination will continue to vest in accordance with the Vesting Schedule set forth above.
Due to Death	The Options will be exercisable through the date that is two years after the date of your termination of employment or, if earlier, the Expiration Date set forth above.After that date, any unexercised Options will expire. Any unvested Options as of the date of termination will be automatically vested.
Due to Any Other Reason (such as voluntary termination)	Options must be exercised by the date on which you terminate employment.

Restricted ConductIf you engage in any of the restricted conduct described in subparagraphs (i) through (iv)

below for any reason, in addition to all remedies in law and/or equity available to the Company, you shall forfeit all Options (whether or not vested) and shall immediately pay to the Company, with respect to previously exercised Options, an amount equal to (x) the per share Fair Market Value of the Stock on the date on which the Stock was issued with respect to the applicable previously exercised Options times (y) the number of shares of Stock underlying such previously exercised Options, without regard to any Tax-Related Items (as defined below) that may have been deducted from such amount. For purposes of subparagraphs (i) through (v) below, “Company” shall mean E. I. du

Pont de Nemours and Company and/or any of its Subsidiaries or Affiliates that have employed you or retained your services.

(i) Non-Disclosure of Confidential Information. During the course of your employment with the Company and thereafter, you shall not use or disclose, except on behalf of the Company and pursuant to the Company’s directions, any Company “Confidential Information” (i.e., information concerning the Company and / or its business that is not generally known outside the Company, which includes, but is not limited to, (a) trade secrets; (b) intellectual property, including but not limited to inventions, invention disclosures and patent applications; (c) information regarding the Company’s present and/or future products, developments, processes and systems, budgets, proposals, marketing plans, financial data and projections, suppliers, vendors, inventions, formulas, data bases, know how, ideas, developments, experiments, improvements, computer programs, software, technology, blue prints, specifications and compilations of information; (d) information about employees and employee relations, including but not limited to training manuals and procedures, recruitment method and procedures, recruitment and distribution techniques, business plans and projections, employment contracts and employee handbooks; (e) information on customers or potential customers, including but not limited to customers’ names, sales records, prices, particularities, preferences and manner of doing business, and other terms of sales and Company cost information; and (f) information received in confidence by the Company from third parties. Information regarding products, services or technological innovations in development, in test marketing or being marketed or promoted in a discrete geographic region, which information the Company is considering for broader use, shall be deemed not generally known until such broader use is actually commercially implemented.); and/or

(ii) Solicitation of Employees. During your employment and for a period of one year following the termination of your employment for any reason, you shall not recruit, solicit or induce, or cause, allow, permit or aid others to recruit, solicit or induce, any employee, agent or consultant of the Company to terminate his/her employment or association with the Company; and/or

(iii) Solicitation of Customers. During your employment and for a period of one year following the termination of your employment for any reason, you shall not directly or indirectly, on behalf of yourself or any other person, company or entity, call on, contact, service or solicit competing business from customers or prospective customers of Company if, within the two years prior to the termination of your employment, you had or made contact with the customer, or received or had access to Confidential Information about the customer; and/or

(iv) Non-Competition. During your employment and for a period of one year following the termination of your employment for any reason, you shall not, directly or indirectly, in any capacity, (a) compete or engage in a business similar to that of Company, (b) compete or engage

in a business similar to that which the Company has plans to engage, or has engaged in during the two years prior to your termination, if, within this two-year period, you received or had access to Confidential Information regarding the proposed plans or the business in which Company engaged; or (c) take any action to invest in (other than a non-controlling ownership of securities issued by publicly held corporations), own, manage, operate, control, participate in, be employed or engaged by or be connected in any manner with any partnership, corporation or other business or entity engaging in a business similar to Company.

(v) Geographic Scope. You acknowledge that due to the broad scope of Company’s customer base, the following geographic scope for subsections (iii) - (iv) of this Restricted Conduct section is necessary. Your non-competition and non-solicitation obligations under this Agreement shall include: (a) any territory in which you performed your duties for the Company; (b) any territory in which Company has customers about which you received or had access to Confidential Information during your employment; (c) any territory in which you solicited customers; or (d) any territory in which Company plans to expand its market share about which you received or had access to Confidential Information during your employment with Company.

Recoupment Policy This Award shall be subject to the Company’s Incentive Compensation Clawback Policy (as it may be amended from time to time), the terms of which are incorporated herein by reference.

Repayment/

Forfeiture Any benefits you may receive hereunder shall be subject to repayment or forfeiture as may be required to comply with the requirements of the U.S. Securities and Exchange Commission or any applicable law, including the requirements of the Dodd-Frank Wall Street Reform and Consumer Protection Act, or any securities exchange on which the Stock is traded, as may be in effect from time to time.

Exercise Methods There are four exercise methods from which to choose. Due to local legal requirements, not all methods are available in all countries.

Withholding You acknowledge that the Company and/or the Employer (1) make no representations or undertakings regarding the treatment of any income tax, social insurance, payroll tax, fringe benefits tax, payment on account or other tax-related items related to the Plan and legally applicable to you (“Tax-Related Items”) in connection with any aspect of the Options, including, but not limited to, the grant, vesting or exercise of the Options, the subsequent sale of shares of Stock acquired pursuant to such exercise and the receipt of any dividends; and (2) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the Options to reduce or eliminate your liability for Tax-Related Items or achieve any particular tax result. Further, if you are subject to Tax-Related Items in more than one jurisdiction, the Company and/or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.

Prior to any relevant taxable or tax withholding event, as applicable, you agree to make adequate arrangements satisfactory to the Company and/or the Employer to satisfy all Tax-Related Items. In this regard, you authorize the Company and/or the Employer, or their respective agents, at their discretion, to satisfy the obligations with regard to all Tax-Related Items by one or a combination of the following: (i) withholding from your wages or other cash compensation paid to you by the Company and/or the Employer; or (ii) withholding from proceeds of the sale of shares of Stock acquired upon exercise of the Options either through a voluntary sale or through a mandatory sale arranged by the Company (on your behalf pursuant to this authorization without further consent).

Finally, you agree to pay to the Company or the Employer, any amount of Tax-Related Items that the Company or the Employer may be required to withhold or account for as a result of your participation in the Plan that cannot be satisfied by the means previously described. The Company may refuse to issue or deliver the shares or the proceeds of the sale of shares of Stock, if you fail to comply with your obligations in connection with the Tax-Related Items

Non-transferability You may not transfer these Options, except by will or laws of descent and distribution. The Options are exercisable during your lifetime only by you or your guardian or legal representative.

Severability The provisions of this Agreement are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.

Waiver You acknowledge that a waiver by the Company of breach of any provision of this Agreement shall not operate or be construed as a waiver of any other provision of this Agreement, or of any subsequent breach by you or any other participant.

Imposition of Other

Requirements The Company reserves the right to impose other requirements on your participation in this Agreement, on the Options and on any shares of Stock acquired under the Plan, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require you to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.

EX-12

Exhibit 12

E.  I.  DU  PONT  DE  NEMOURS  AND  COMPANY

COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES

(Dollars in millions)

	Three Months Ended March 31,
	2015			2014
Income before income taxes	$	1,601		$	1,802
Adjustment for companies accounted for by the    equity method	4			41
Less: Capitalized interest	(20		)	(11		)
Add: Amortization of capitalized interest	9			9
	1,594			1,841
Fixed charges:
Interest and debt expense	84			103
Capitalized interest	20			11
Rental expense representative of interest factor	27			25
	131			139
Total adjusted earnings available for payment of     fixed charges	$	1,725		$	1,980
Number of times fixed charges earned	13.2			14.2

EX-31.1

Exhibit 31.1

CERTIFICATIONS

I, Ellen J. Kullman, certify that:

1. I have reviewed this report on Form 10-Q for the period ended March 31, 2015 of E. I. du Pont de Nemours and Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent function):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:	April 21, 2015
By:	/s/ Ellen J. Kullman
	Ellen J. Kullman
	Chief Executive Officer and
	Chair of the Board

EX-31.2

Exhibit 31.2

CERTIFICATIONS

I, Nicholas C. Fanandakis, certify that:

1. I have reviewed this report on Form 10-Q for the period ended March 31, 2015 of E. I. du Pont de Nemours and Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent function):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:	April 21, 2015
By:	/s/ Nicholas C. Fanandakis
	Nicholas C. Fanandakis
	Executive Vice President and
	Chief Financial Officer

EX-32.1

Exhibit 32.1

Certification of CEO Pursuant to

18 U.S.C. Section 1350,

As Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of E. I. du Pont de Nemours and Company (the “Company”) on Form 10-Q for the period ended March 31, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Ellen J. Kullman, as Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Ellen J. Kullman

Ellen J. Kullman

Chief Executive Officer

April 21, 2015

EX-32.2

Exhibit 32.2

Certification of CFO Pursuant to

18 U.S.C. Section 1350,

As Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of E. I. du Pont de Nemours and Company (the “Company”) on Form 10-Q for the period ended March 31, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Nicholas C. Fanandakis, as Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Nicholas C. Fanandakis

Nicholas C. Fanandakis

Chief Financial Officer

April 21, 2015

EX-95

Exhibit 95

MINE SAFETY DISCLOSURES

The company owns and operates a surface mine near Starke, Florida. The following table provides information about citations, orders and notices issued from the Mine Safety and Health Administration (MSHA) under the Federal Mine Safety and Health Act of 1977 (Mine Act) for the quarter ended March 31, 2015.

Mine (MSHA Identification Number)	Section 104 S&S1  Citations (#)	Section104(b) Orders (#)	Section 104(d) Citations and Orders (#)	Section 110(b)(2) Violations (#)	Section 107(a) Orders (#)	Total Dollar Value of MSHA Assessments Proposed ($)		Total Number of Mining Related Fatalities (#)	Received Notice of Pattern of Violations Under Section 104(e) (yes/no)	Received Notice of Potential to Have Pattern Under Section 104(e) (yes/no)	Legal Actions Pending as of Last Day of Period (#)	Legal Actions Initiated During Period (#)	Legal Actions Resolved During Period (#)
Starke, FL (0800225)	—	—	—	—	—	$	914	—	No	No	—	—	6	2

¹  S&S refers to significant and substantial violations of mandatory health or safety standards under section 104 of the Mine Act.

²  In first quarter 2015, 6 legal actions were resolved which resulted in 1 S&S designation from citations issued in 2014 being deleted.

XML

Financial Instruments

3 Months Ended

Mar. 31, 2015

Financial Instruments Disclosure [Abstract]

Financial Instruments

Financial Instruments

Debt

The estimated fair value of the company's total debt including interest rate financial instruments was determined using level 2 inputs within the fair value hierarchy, as described in the company's 2014 Annual Report in Note 1,“Summary of Significant Accounting Policies.”Based on quoted market prices for the same or similar issues or on current rates offered to the company for debt of the same remaining maturities, the fair value of the company's debt was approximately$11,168and$11,394as ofMarch 31, 2015andDecember 31, 2014, respectively.

Cash Equivalents

The fair value of cash equivalents approximates its stated value.  The estimated fair value of the company's cash equivalents was determined using level 1 and level 2 inputs within the fair value hierarchy, as described in the company's 2014 Annual Report in Note 1,“Summary of Significant Accounting Policies.”  Level 1 measurements are based on observable net asset values and level 2 measurements are based on current interest rates for similar investments with comparable credit risk and time to maturity.  The company held $0 and $1,436 of money market funds (level 1 measurements) as of March 31, 2015 and December 31, 2014, respectively.  The company held $1,700 and $3,293 of other cash equivalents (level 2 measurements) as of March 31, 2015 and December 31, 2014, respectively.     

Derivative Instruments

Objectives and Strategies for Holding Derivative Instruments

In the ordinary course of business, the company enters into contractual arrangements (derivatives) to reduce its exposure to foreign currency, interest rate and commodity price risks. The company has established a variety of derivative programs to be utilized for financial risk management. These programs reflect varying levels of exposure coverage and time horizons based on an assessment of risk.

Derivative programs have procedures and controls and are approved by the Corporate Financial Risk Management Committee, consistent with the company's financial risk management policies and guidelines. Derivative instruments used are forwards, options, futures and swaps. The company has not designated any nonderivatives as hedging instruments.

The company's financial risk management procedures also address counterparty credit approval, limits and routine exposure monitoring and reporting. The counterparties to these contractual arrangements are major financial institutions and major commodity exchanges. The company is exposed to credit loss in the event of nonperformance by these counterparties. The company utilizes collateral support annex agreements with certain counterparties to limit its exposure to credit losses. The company's derivative assets and liabilities are reported on a gross basis in the Condensed Consolidated Balance Sheets. The company anticipates performance by counterparties to these contracts and therefore no material loss is expected. Market and counterparty credit risks associated with these instruments are regularly reported to management.

The notional amounts of the company's derivative instruments were as follows:

	March 31, 2015		December 31, 2014
Derivatives designated as hedging instruments:
Interest rate swaps	$	—	$	1,000
Foreign currency contracts	71		434
Commodity contracts	265		388
Derivatives not designated as hedging instruments:
Foreign currency contracts	8,959		10,586
Commodity contracts	86		166

Foreign Currency Risk

The company's objective in managing exposure to foreign currency fluctuations is to reduce earnings and cash flow volatility associated with foreign currency rate changes. Accordingly, the company enters into various contracts that change in value as foreign exchange rates change to protect the value of its existing foreign currency-denominated assets, liabilities, commitments and cash flows.

The company routinely uses forward exchange and option contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities of its operations. The primary business objective of this hedging program is to maintain an approximately balanced position in foreign currencies so that exchange gains and losses resulting from exchange rate changes, net of related tax effects, are minimized. The company also uses foreign currency exchange contracts to offset a portion of the company's exposure to certain foreign currency-denominated revenues so that gains and losses on these contracts offset changes in the USD value of the related foreign currency-denominated revenues. The objective of the hedge program is to reduce earnings and cash flow volatility related to changes in foreign currency exchange rates.

Commodity Price Risk

Commodity price risk management programs serve to reduce exposure to price fluctuations on purchases of inventory such as copper, corn, soybeans and soybean meal. The company enters into over-the-counter and exchange-traded derivative commodity instruments to hedge the commodity price risk associated with agricultural commodity exposures.

Cash Flow Hedges

Foreign Currency Contracts

The company uses foreign currency exchange instruments such as forwards and options to offset a portion of the company's exposure to certain foreign currency-denominated revenues so that gains and losses on these contracts offset changes in the USD value of the related foreign currency-denominated revenues. In addition, the company occasionally uses forward exchange contracts to offset a portion of the company's exposure to certain foreign currency-denominated transactions such as capital expenditures.

Commodity Contracts

The company enters into over-the-counter and exchange-traded derivative commodity instruments, including options, futures and swaps, to hedge the commodity price risk associated with agriculture commodity exposures.

While each risk management program has a different time maturity period, most programs currently do not extend beyond the next two-year period. Cash flow hedge results are reclassified into earnings during the same period in which the related exposure impacts earnings. Reclassifications are made sooner if it appears that a forecasted transaction is not probable of occuring. The following table summarizes the after-tax effect of cash flow hedges on accumulated other comprehensive loss for the three months ended March 31, 2015 and 2014:

	Three Months Ended
	March 31,
	2015			2014
Beginning balance	$	(6	)	$	(48	)
Additions and revaluations of derivatives designated as cash flow hedges	(16		)	24
Clearance of hedge results to earnings	4			11
Ending balance	$	(18	)	$	(13	)

At March 31, 2015, an after-tax net loss of $4 is expected to be reclassified from accumulated other comprehensive loss into earnings over the next 12 months.

Derivatives not Designated in Hedging Relationships

Foreign Currency Contracts

The company routinely uses forward exchange and options contracts to reduce its net exposure, by currency, related to foreign currency-denominated monetary assets and liabilities of its operations so that exchange gains and losses resulting from exchange rate changes are minimized. The netting of such exposures precludes the use of hedge accounting; however, the required revaluation of the forward contracts and the associated foreign currency-denominated monetary assets and liabilities intends to achieve a minimal earnings impact, after taxes.

Commodity Contracts

The company utilizes options, futures and swaps that are not designated as hedging instruments to reduce exposure to commodity price fluctuations on purchases of inventory such as corn, soybeans and soybean meal.

Fair Values of Derivative Instruments

The table below presents the fair values of the company's derivative assets and liabilities within the fair value hierarchy, as described in the company's 2014 Annual Report in Note 1, “Summary of Significant Accounting Policies.”

		Fair Value Using Level 2 Inputs
	Balance Sheet Location	March 31, 2015		December 31, 2014
Asset derivatives:
Derivatives designated as hedging instruments:
Interest rate swaps1	Accounts and notes receivable, net	$	—	$	1
Foreign currency contracts	Accounts and notes receivable, net	2		10
		2		11
Derivatives not designated as hedging instruments:
Foreign currency contracts2	Accounts and notes receivable, net	67		254
Total asset derivatives3		$	69	$	265
Cash collateral1,2	Other accrued liabilities	$	80	$	47
Liability derivatives:
Derivatives designated as hedging instruments:
Foreign currency contracts	Other accrued liabilities	$	3	$	10
Derivatives not designated as hedging instruments:
Foreign currency contracts	Other accrued liabilities	47		62
Commodity contracts	Other accrued liabilities	1		1
		48		63
Total liability derivatives3		$	51	$	73

¹  Cash collateral held as of March 31, 2015 and December 31, 2014 represents $0 and $6, respectively, related to interest rate swap derivatives designated as hedging instruments.

²  Cash collateral held as of March 31, 2015 and December 31, 2014 represents $80 and $41, respectively, related to foreign currency derivatives not designated as hedging instruments.

³  The company's derivative assets and liabilities subject to enforceable master netting arrangements totaled $45 at March 31, 2015 and $67 at December 31, 2014.

Effect of Derivative Instruments

	Amount of Gain (Loss) Recognized in OCI1 (Effective Portion)						Amount of Gain (Loss) Recognized in Income2
Three Months Ended March 31,	2015			2014			2015			2014			Income Statement Classification
Derivatives designated as hedging instruments:
Fair value hedges:
Interest rate swaps	$	—		$	—		$	(1	)	$	(7	)	Interest expense
Cash flow hedges:
Foreign currency contracts	(2		)	(1		)	8			(1		)	Net sales
Commodity contracts	(20		)	39			(15		)	(17		)	Cost of goods sold
	(22		)	38			(8		)	(25		)
Derivatives not designated as hedging instruments:
Foreign currency contracts	—			—			268			(46		)	Other income, net3
Commodity contracts	—			—			2			(24		)	Cost of goods sold
	—			—			270			(70		)
Total derivatives	$	(22	)	$	38		$	262		$	(95	)

¹   OCI is defined as other comprehensive income (loss).

²   For cash flow hedges, this represents the effective portion of the gain (loss) reclassified from accumulated OCI into income during the period. For the three months ended March 31, 2015 and 2014, there was no material ineffectiveness with regard to the company's cash flow hedges.

³   Gain (loss) recognized in other income, net, was partially offset by the related gain (loss) on the foreign currency-denominated monetary assets and liabilities of the company's operations, which were $(204) and $(50) for the three months ended March 31, 2015 and 2014.

XML

Long-Term Employee Benefits Long Term Employee Benefits Defined Benefit Plans (Narrative) (Details) (United States Pension Plan of US Entity [Member])	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
United States Pension Plan of US Entity [Member]
Defined Benefit Plan Disclosure [Line Items]
Net periodic benefits costs, expected return on plan assets assumption	8.50%	8.75%

XML

Condensed Consolidated Balance Sheets (USD $) In Millions, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Assets
Cash and cash equivalents	$ 3,622	$ 6,910
Marketable securities	125	124
Accounts and notes receivable, net	7,651	6,005
Inventories	7,051	7,841
Prepaid expenses	366	279
Deferred income taxes	504	589
Total current assets	19,319	21,748
Property, plant and equipment, net of accumulated depreciation (March 31, 2015 - $20,057; December 31, 2014 - $19,942)	12,873	13,386
Goodwill	4,365	4,529
Other intangible assets	4,307	4,580
Investment in affiliates	929	886
Deferred income taxes	3,244	3,349
Other assets	1,138	1,096
Total	46,175	49,574
Liabilities and Equity
Accounts payable	3,706	4,822
Short-term borrowings and capital lease obligations	1,621	1,423
Income taxes	654	547
Other accrued liabilities	4,751	5,848
Total current liabilities	10,732	12,640
Long-term borrowings and capital lease obligations	8,763	9,271
Other liabilities	13,329	13,819
Deferred income taxes	489	466
Total liabilities	33,313	36,196
Commitments and contingent liabilities
Stockholders' equity
Preferred stock	237	237
Common stock, $0.30 par value; 1,800,000,000 shares authorized; Issued at March 31, 2015 - 992,224,000; December 31, 2014 - 992,020,000	298	298
Additional paid-in capital	11,311	11,174
Reinvested earnings	17,405	17,045
Accumulated other comprehensive loss	(9,722)	(8,707)
Common stock held in treasury, at cost (87,041,000 shares at March 31, 2015 and December 31, 2014)	(6,727)	(6,727)
Total DuPont stockholders' equity	12,802	13,320
Noncontrolling interests	60	58
Total equity	12,862	13,378
Total	$ 46,175	$ 49,574

XML

Other Income, Net

3 Months Ended

Mar. 31, 2015

Other Income and Expenses [Abstract]

Other Income, Net

Other Income, Net

	Three Months Ended
	March 31,
	2015		2014
Royalty income	$	39	$	39
Interest income	25		28
Equity in earnings of affiliates, net	9		13
Net gain on sales of other assets	6		7
Net exchange gains (losses)1	64		(96		)
Miscellaneous income and expenses, net 2	55		26
Other income, net	$	198	$	17

¹ The company routinely uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes on net monetary asset positions. The net pre-tax exchange gains (losses) are recorded in other income, net and the related tax impact is recorded in provision for income taxes on the company's interim Consolidated Income Statements. The increase in pre-tax exchange gains over prior year was driven by gains on foreign currency contracts due to strengthening of the USD versus global currencies partially offset by losses on the related foreign currency-denominated monetary assets and liabilities. The $64 net exchange gain for the three months ended March 31, 2015, includes a $(40) pre-tax exchange loss, $(38) after-tax, associated with the devaluation of the Ukrainian hryvnia. The $(96) net exchange loss for the three months ended March 31, 2014, includes a $(39) pre-tax exchange loss, $(27) after-tax, associated with the devaluation of the Ukrainian hryvnia.

²   Miscellaneous income and expenses, net, includes interest items, certain insurance recoveries and litigation settlements and other items.

XML

Inventories (Tables)

3 Months Ended

Mar. 31, 2015

Inventory, Net [Abstract]

Schedule of Inventories

	March 31, 2015			December 31, 2014
Finished products	$	4,529		$	4,628
Semi-finished products	1,877			2,451
Raw materials, stores and supplies	1,138			1,255
	7,544			8,334
Adjustment of inventories to a last-in, first-out (LIFO) basis	(493		)	(493		)
Total	$	7,051		$	7,841

XML

Segment Information (Reconciliation to Consolidated Income Statements) (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015		Mar. 31, 2014
Segment Information
Total segment PTOI	$ 1,941		$ 2,248
Non operating pension and other post retirement employee benefit costs	(75)		(30)
Net exchange gains (losses)	64	[1]	(96)
Corporate expenses	(245)	[2]	(217)
Interest expense	(84)		(103)
Income before income taxes	1,601		1,802
Corporate Expenses [Member]
Segment Information
Separation related transaction costs	(81)		(16)
Foreign currency loss due to devaluation of Ukrainian hryvnia [Member]
Segment Information
Net exchange gains (losses)	$ (40)		$ (39)

[1] Included a charge of $(40) associated with remeasuring the company's Ukranian hryvnia net monetary assets in the three months ended March 31, 2015, which was recorded in other income, net in the company's interim Consolidated Income Statements.

[2] Included transaction costs associated with the separation of the Performance Chemicals segment of $(81) and $(16) in the three months ended March 31, 2015 and 2014, respectively, which were recorded in other operating charges in the company's interim Consolidated Income Statements.

XML

Long-Term Employee Benefits

3 Months Ended

Mar. 31, 2015

General Discussion of Pension and Other Postretirement Benefits [Abstract]

Long-Term Employee Benefits

Long-Term Employee Benefits

Pension Plans

In determining the U.S. pension plan 2015 net periodic benefit costs, the company updated the expected return on plan assets assumption from 8.75 percent to 8.50 percent.

The following sets forth the components of the company’s net periodic benefit cost for pensions:  

	Three Months Ended
	March 31,
	2015			2014
Service cost	$	66		$	60
Interest cost	273			292
Expected return on plan assets	(404		)	(402		)
Amortization of loss	209			149
Amortization of prior service (benefit) cost	(2		)	1
Settlement loss	5			—
Net periodic benefit cost	$	147		$	100

Other Long-Term Employee Benefit Plans

The following sets forth the components of the company’s net periodic benefit cost for other long-term employee benefits:  

	Three Months Ended
	March 31,
	2015			2014
Service cost	$	4		$	4
Interest cost	28			31
Amortization of loss	19			14
Amortization of prior service benefit	(52		)	(53		)
Net periodic benefit cost	$	(1	)	$	(4	)

XML

Financial Instruments (Cash Equivalents) (Narrative) (Details) (USD $) In Millions, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Fair Value, Inputs, Level 1 [Member]
Fair value of cash equivalents	$ 0	$ 1,436
Fair Value, Inputs, Level 2 [Member]
Fair value of cash equivalents	$ 1,700	$ 3,293

XML

Other Intangible Assets (Schedule of Other Intangible Assets) (Details) (USD $) In Millions, unless otherwise specified	Mar. 31, 2015		Dec. 31, 2014
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]
Definite-lived Intangible Assets, Gross	$ 4,095		$ 4,226
Definite-lived Intangible Assets, Accumulated Amortization	(1,923)		(1,845)
Definite-lived Intangible Assets, Net	2,172		2,381
Indefinite-lived Intangible Assets	2,135		2,199
Total Intangible Assets, Gross	6,230		6,425
Total Intangible Assets, Accumulated Amortization	(1,923)		(1,845)
Intangible Assets Net Excluding Goodwill	4,307		4,580
In Process Research and Development [Member]
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]
Indefinite-lived Intangible Assets	25		29
Microbial Cell Factories [Member]
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]
Indefinite-lived Intangible Assets	306		306
Pioneer Germplasm [Member]
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]
Indefinite-lived Intangible Assets	1,063		1,064
Trademarks/Tradenames [Member]
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]
Indefinite-lived Intangible Assets	741		800
Customer Lists [Member]
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]
Definite-lived Intangible Assets, Gross	1,612		1,706
Definite-lived Intangible Assets, Accumulated Amortization	(475)		(470)
Definite-lived Intangible Assets, Net	1,137		1,236
Patents [Member]
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]
Definite-lived Intangible Assets, Gross	470		493
Definite-lived Intangible Assets, Accumulated Amortization	(202)		(199)
Definite-lived Intangible Assets, Net	268		294
Purchased and Licensed Technology [Member]
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]
Definite-lived Intangible Assets, Gross	1,772		1,789
Definite-lived Intangible Assets, Accumulated Amortization	(1,142)		(1,074)
Definite-lived Intangible Assets, Net	630		715
Trademarks [Member]
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]
Definite-lived Intangible Assets, Gross	31		31
Definite-lived Intangible Assets, Accumulated Amortization	(14)		(14)
Definite-lived Intangible Assets, Net	17		17
Other [Member]
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]
Definite-lived Intangible Assets, Gross	210	[1]	207	[1]
Definite-lived Intangible Assets, Accumulated Amortization	(90)	[1]	(88)	[1]
Definite-lived Intangible Assets, Net	$ 120	[1]	$ 119	[1]

[1] Primarily consists of sales and grower networks, marketing and manufacturing alliances and noncompetition agreements.

XML

Stockholders' Equity (Tables)

3 Months Ended

Mar. 31, 2015

Stockholders' Equity Note [Abstract]

Schedule of Comprehensive Income (Loss)

	Three Months Ended									Three Months Ended									Affected Line Item in Consolidated Income Statements1
	March 31, 2015									March 31, 2014
	Pre-Tax			Tax			After-Tax			Pre-Tax			Tax			After-Tax
Cumulative translation adjustment	$	(1,189	)	$	—		$	(1,189	)	$	(72	)	$	—		$	(72	)	See (4) below
Net revaluation and clearance of cash flow hedges to earnings:
Additions and revaluations of derivatives designated as cash flow hedges	(22		)	6			(16		)	38			(14		)	24			See (2) below
Clearance of hedge results to earnings:
Foreign currency contracts	(8		)	3			(5		)	1			—			1			Net sales
Commodity contracts	15			(6		)	9			17			(7		)	10			Cost of goods sold
Net revaluation and clearance of cash flow hedges to earnings	(15		)	3			(12		)	56			(21		)	35
Pension benefit plans:
Net (loss) gain	(4		)	1			(3		)	1			—			1			See (2) below
Effect of foreign exchange rates	100			(27		)	73			—			—			—			See (2) below
Reclassifications to net income:
Amortization of prior service (benefit) cost	(2		)	1			(1		)	1			—			1			See (3) below
Amortization of loss	209			(74		)	135			149			(51		)	98			See (3) below
Settlement loss	5			(2		)	3			—			—			—			See (3) below
Pension benefit plans, net	308			(101		)	207			151			(51		)	100
Other benefit plans:
Reclassifications to net income:
Amortization of prior service benefit	(52		)	19			(33		)	(53		)	19			(34		)	See (3) below
Amortization of loss	19			(7		)	12			14			(4		)	10			See (3) below
Other benefit plans, net	(33		)	12			(21		)	(39		)	15			(24		)
Other comprehensive (loss) income	$	(929	)	$	(86	)	$	(1,015	)	$	96		$	(57	)	$	39

¹  Represents the income statement line item within the interim Consolidated Income Statement affected by the pre-tax reclassification out of other comprehensive (loss) income.

²  These amounts represent changes in accumulated other comprehensive loss excluding changes due to reclassifying amounts to the interim Consolidated Income Statements.

³  These accumulated other comprehensive loss components are included in the computation of net periodic benefit cost of the company's pension and other long-term employee benefit plans. See Note 12 for additional information.

⁴  The increase over prior year is primarily driven by the strengthening USD against the Euro and Brazilian real.

Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]

	Cumulative Translation Adjustment			Net Revaluation and Clearance of Cash Flow Hedges to Earnings			Pension Benefit Plans			Other Benefit Plans			Unrealized Gain on Securities		Total
2015
Balance January 1, 2015	$	(1,016	)	$	(6	)	$	(7,949	)	$	262		$	2	$	(8,707	)
Other comprehensive (loss) income before reclassifications	(1,189		)	(16		)	70			—			—		(1,135		)
Amounts reclassified from accumulated other comprehensive loss	—			4			137			(21		)	—		120
Balance March 31, 2015	$	(2,205	)	$	(18	)	$	(7,742	)	$	241		$	2	$	(9,722	)

	Cumulative Translation Adjustment			Net Revaluation and Clearance of Cash Flow Hedges to Earnings			Pension Benefit Plans			Other Benefit Plans			Unrealized Gain on Securities		Total
2014
Balance January 1, 2014	$	(140	)	$	(48	)	$	(5,749	)	$	494		$	2	$	(5,441	)
Other comprehensive (loss) income before reclassifications	(72		)	24			1			—			—		(47		)
Amounts reclassified from accumulated other comprehensive loss	—			11			99			(24		)	—		86
Balance March 31, 2014	$	(212	)	$	(13	)	$	(5,649	)	$	470		$	2	$	(5,402	)

XML

Commitments and Contingent Liabilities (Tables)

3 Months Ended

Mar. 31, 2015

Commitments and Contingencies Disclosure [Abstract]

Schedule of Guaranteed Obligations

	Short-Term		Long-Term		Total
Obligations for customers and suppliers1:
Bank borrowings (terms up to 7 years)	$	230	$	84	$	314
Leases on equipment and facilities (terms up to 4 years)	—		1		1
Obligations for equity affiliates2:
Bank borrowings (terms up to 1 year)	183		—		183
Total	$	413	$	85	$	498

¹  Existing guarantees for customers and suppliers, as part of contractual agreements.

² Existing guarantees for equity affiliates' liquidity needs in normal operations.

XML

Stockholder's Equity (Schedule of Accumulated Other Comprehensive Loss) (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Components of Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive loss, beginning balance	$ (8,707)	$ (5,441)
Other comprehensive loss before reclassifications	(1,135)	(47)
Amounts reclassified from accumulated other comprehensive loss	120	86
Accumulated other comprehensive loss, ending balance	(9,722)	(5,402)
Cumulative Translation Adjustment [Member]
Components of Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive loss, beginning balance	(1,016)	(140)
Other comprehensive loss, before reclassifications, CTA	(1,189)	(72)
Amounts reclassified from accumulated other comprehensive loss	0	0
Accumulated other comprehensive loss, ending balance	(2,205)	(212)
Net Revaluation and Clearance of Cash Flow Hedges to Earnings
Components of Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive loss, beginning balance	(6)	(48)
Other comprehensive (loss) income, before reclassifications, cash flow hedges	(16)	24
Amounts reclassified from accumulated other comprehensive loss, cash flow hedges	4	11
Accumulated other comprehensive loss, ending balance	(18)	(13)
Pension Plans [Member]
Components of Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive loss, beginning balance	(7,949)	(5,749)
Other comprehensive income, before reclassifications, pension and other benefit plans	70	1
Amounts reclassified from accumulated other comprehensive loss, pension and other benefit plans	137	99
Accumulated other comprehensive loss, ending balance	(7,742)	(5,649)
Other Long-Term Employee Benefit Plans [Member]
Components of Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive loss, beginning balance	262	494
Other comprehensive income, before reclassifications, pension and other benefit plans	0	0
Amounts reclassified from accumulated other comprehensive loss, pension and other benefit plans	(21)	(24)
Accumulated other comprehensive loss, ending balance	241	470
Unrealized Gain on Securities
Components of Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive loss, beginning balance	2	2
Other comprehensive income (loss), before reclassifications, securities	0	0
Amounts reclassified from accumulated other comprehensive loss, securities	0	0
Accumulated other comprehensive loss, ending balance	$ 2	$ 2

XML

Other Income, Net (Schedule of Other Income) (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015		Mar. 31, 2014
Component of Other Income [Line Items]
Net exchange gains (losses)	$ 64	[1]	$ (96)
Total	198		17
Other Income [Member]
Component of Other Income [Line Items]
Royalty income	39		39
Interest income	25		28
Equity in earnings of affiliates, net	9		13
Net gain on sales of other assets	6		7
Net exchange gains (losses)	64	[2]	(96)	[2]
Miscellaneous income and expenses, net	55	[3]	26	[3]
Total	198		17
Foreign currency loss due to devaluation of Ukrainian hryvnia [Member]
Component of Other Income [Line Items]
Net exchange gains (losses)	(40)		(39)
Net exchange gains (losses), after tax	$ (38)		$ (27)

[1] Included a charge of $(40) associated with remeasuring the company's Ukranian hryvnia net monetary assets in the three months ended March 31, 2015, which was recorded in other income, net in the company's interim Consolidated Income Statements.

[2] The company routinely uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes on net monetary asset positions. The net pre-tax exchange gains (losses) are recorded in other income, net and the related tax impact is recorded in provision for income taxes on the company's interim Consolidated Income Statements. The increase in pre-tax exchange gains over prior year was driven by gains on foreign currency contracts due to strengthening of the USD versus global currencies partially offset by losses on the related foreign currency-denominated monetary assets and liabilities. The $64 net exchange gain for the three months ended March 31, 2015, includes a $(40) pre-tax exchange loss, $(38) after-tax, associated with the devaluation of the Ukrainian hryvnia. The $(96) net exchange loss for the three months ended March 31, 2014, includes a $(39) pre-tax exchange loss, $(27) after-tax, associated with the devaluation of the Ukrainian hryvnia

[3] Miscellaneous income and expenses, net, includes interest items, certain insurance recoveries and litigation settlements and other items.

XML

Commitments and Contingent Liabilities (Guarantees) (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015		Dec. 31, 2014
Guarantor Obligations [Line Items]
Guarantee obligations	$ 498		$ 513
Customer and Supplier Guarantee [Member]
Guarantor Obligations [Line Items]
Guarantee obligations	315
Collateral assets and personal guarantees percentage	47.00%
Customer and Supplier Guarantee, Bank Borrowings [Member]
Guarantor Obligations [Line Items]
Guarantee obligations	314	[1]
Guaranteed obligations, maximum term	7	[1]
Customer and Supplier Guarantee, Leases on Equipment and Facilities [Member]
Guarantor Obligations [Line Items]
Guarantee obligations	1	[1]
Guaranteed obligations, maximum term	4	[1]
Equity Affiliates, Bank Borrowings [Member]
Guarantor Obligations [Line Items]
Guarantee obligations	183	[2]
Guaranteed obligations, maximum term	1	[2]
Guarantee Obligations, Long Term [Member]
Guarantor Obligations [Line Items]
Guarantee obligations	85
Guarantee Obligations, Long Term [Member] | Customer and Supplier Guarantee, Bank Borrowings [Member]
Guarantor Obligations [Line Items]
Guarantee obligations	84	[1]
Guarantee Obligations, Long Term [Member] | Customer and Supplier Guarantee, Leases on Equipment and Facilities [Member]
Guarantor Obligations [Line Items]
Guarantee obligations	1	[1]
Guarantee Obligations, Long Term [Member] | Equity Affiliates, Bank Borrowings [Member]
Guarantor Obligations [Line Items]
Guarantee obligations	0	[2]
Guaranteed Obligations Short Term [Member]
Guarantor Obligations [Line Items]
Guarantee obligations	413
Guaranteed Obligations Short Term [Member] | Customer and Supplier Guarantee, Bank Borrowings [Member]
Guarantor Obligations [Line Items]
Guarantee obligations	230	[1]
Guaranteed Obligations Short Term [Member] | Customer and Supplier Guarantee, Leases on Equipment and Facilities [Member]
Guarantor Obligations [Line Items]
Guarantee obligations	0	[1]
Guaranteed Obligations Short Term [Member] | Equity Affiliates, Bank Borrowings [Member]
Guarantor Obligations [Line Items]
Guarantee obligations	$ 183	[2]

[1] Existing guarantees for customers and suppliers, as part of contractual agreements.

[2] Existing guarantees for equity affiliates' liquidity needs in normal operations.

XML

Financial Instruments (Notional Amounts of Derivatives) (Details) (USD $) In Millions, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Designated as Hedging Instrument [Member] | Interest Rate Swap [Member]
Derivative [Line Items]
Derivative notional amounts	$ 0	$ 1,000
Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member]
Derivative [Line Items]
Derivative notional amounts	71	434
Designated as Hedging Instrument [Member] | Commodity Contract [Member]
Derivative [Line Items]
Derivative notional amounts	265	388
Not Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member]
Derivative [Line Items]
Derivative notional amounts	8,959	10,586
Not Designated as Hedging Instrument [Member] | Commodity Contract [Member]
Derivative [Line Items]
Derivative notional amounts	$ 86	$ 166

XML

Summary of Significant Accounting Policies Venezuelan Foreign Currency Translation (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015
Venezuelan Foreign Currency Translation [Abstract]
SIMADI pre-tax charge	$ 3

XML

Commitments and Contingent Liabilities Commitments and Contingent Liabilities (Environmental) (Narrative) (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015
Environmental Remediation [Line Items]
Accrual for environmental remediation activities	482
Potential environmental liability in excess of accrued amount	1,100
Minimum [Member]
Environmental Remediation [Line Items]
Average time frame of disbursements of environmental site remediation	15 years
Maximum [Member]
Environmental Remediation [Line Items]
Average time frame of disbursements of environmental site remediation	20 years

XML

Other Intangible Assets (Tables)

3 Months Ended

Mar. 31, 2015

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Intangible Assets [Table Text Block]

The gross carrying amounts and accumulated amortization of other intangible assets by major class are as follows: 

	March 31, 2015							December 31, 2014
	Gross		Accumulated Amortization			Net		Gross		Accumulated Amortization			Net
Intangible assets subject to amortization (Definite-lived):
Customer lists	$	1,612	$	(475	)	$	1,137	$	1,706	$	(470	)	$	1,236
Patents	470		(202		)	268		493		(199		)	294
Purchased and licensed technology	1,772		(1,142		)	630		1,789		(1,074		)	715
Trademarks	31		(14		)	17		31		(14		)	17
Other 1	210		(90		)	120		207		(88		)	119
	4,095		(1,923		)	2,172		4,226		(1,845		)	2,381
Intangible assets not subject to amortization (Indefinite-lived):
In-process research and development	25		—			25		29		—			29
Microbial cell factories	306		—			306		306		—			306
Pioneer germplasm	1,063		—			1,063		1,064		—			1,064
Trademarks/tradenames	741		—			741		800		—			800
	2,135		—			2,135		2,199		—			2,199
Total	$	6,230	$	(1,923	)	$	4,307	$	6,425	$	(1,845	)	$	4,580

¹   Primarily consists of sales and grower networks, marketing and manufacturing alliances and noncompetition agreements.

XML

Condensed Consolidated Statements of Cash Flows (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Operating activities
Net income	$ 1,035	$ 1,445
Adjustments to reconcile net income to cash used for operating activities:
Depreciation	306	312
Amortization of intangible assets	140	125
Net periodic pension benefit cost	147	100
Contributions to pension plans	(124)	(101)
Other operating activities - net	(2)	212
Change in operating assets and liabilities - net	(3,625)	(4,514)
Cash used for operating activities	(2,123)	(2,421)
Investing activities
Purchases of property, plant and equipment	(565)	(320)
Investments in affiliates	(45)	(22)
Proceeds from sales of businesses - net	16	0
Proceeds from sales of assets, net	9	7
Purchases of short-term financial instruments	(125)	(57)
Proceeds from maturities and sales of short-term financial instruments	125	137
Foreign currency exchange contract settlements	442	15
Other investing activities - net	3	4
Cash used for investing activities	(140)	(236)
Financing activities
Dividends paid to stockholders	(429)	(420)
Net increase (decrease) in short-term (less than 90 days) borrowings	980	(8)
Long-term and other borrowings - receipts	120	61
Long-term and other borrowings - payments	(1,409)	(1,180)
Repurchase / prepayments of common stock	(282)	(1,061)
Proceeds from exercise of stock options	170	153
Other financing activities - net	(1)	(14)
Cash used for financing activities	(851)	(2,469)
Effect of exchange rate changes on cash	(174)	(33)
Decrease in cash and cash equivalents	(3,288)	(5,159)
Cash and cash equivalents at beginning of period	6,910	8,941
Cash and cash equivalents at end of period	$ 3,622	$ 3,782

XML

Divestitures and Other Transactions

3 Months Ended

Mar. 31, 2015

Discontinued Operations and Disposal Groups [Abstract]

Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]

Divestitures and Other Transactions

Performance Chemicals

On October 24, 2013, DuPont announced that it intends to separate its Performance Chemicals segment through a U.S. tax-free spin-off to shareholders, subject to customary closing conditions. The company expects to complete the separation on July 1, 2015, subject to final approval from DuPont's Board of Directors. During the three months ended March 31, 2015 and 2014, respectively, the company incurred $81 and $16 of costs associated with the transaction which were reported in other operating charges in the company's interim Consolidated Income Statements. These transaction costs primarily relate to professional fees associated with preparation of regulatory filings and separation activities within finance, legal and information system functions.

XML

Provision for Income Taxes

3 Months Ended

Mar. 31, 2015

Income Tax Disclosure [Abstract]

Provision for Income Taxes

Income Taxes

In the first quarter 2015, the company recorded a tax provision of $566, including $212 of tax expense associated with the company’s policy of hedging the foreign currency-denominated monetary assets and liabilities of its operations and gains or losses on foreign currency contracts.

In the first quarter 2014, the company recorded a tax provision of $357, including $28 of tax benefit associated with the company's policy of hedging the foreign currency-denominated monetary assets and liabilities of its operations and gains or losses on foreign currency contracts.

Each year the company files hundreds of tax returns in the various national, state and local income taxing jurisdictions in which it operates. These tax returns are subject to examination and possible challenge by the tax authorities. Positions challenged by the tax authorities may be settled or appealed by the company. As a result, there is an uncertainty in income taxes recognized in the company’s financial statements in accordance with accounting for income taxes and accounting for uncertainty in income taxes. It is reasonably possible that net reductions to the company’s global unrecognized tax benefits could be in the range of $100 to $125 within the next twelve months with the majority due to the settlement of uncertain tax positions with various tax authorities.

XML

Employee Separation / Asset Related Charges, Net

3 Months Ended

Mar. 31, 2015

Restructuring Charges [Abstract]

Employee Separation / Asset Related Charges, Net

Employee Separation / Asset Related Charges, Net

During first quarter of 2015, a $38 pre-tax impairment charge was recorded in employee separation / asset related charges, net within the Other segment. The majority relates to a cost basis investment in which the assessment resulted from the venture's revised operating plan reflecting underperformance of its European wheat based ethanol facility and deteriorating European ethanol market conditions. One of the primary investors has communicated they would not fund the revised operating plan of the investee. As a result, the carrying value of our 6 percent cost basis investment in this venture exceeded its fair value by $37, such that an impairment charge was required.

2014 Restructuring Program

At March 31, 2015, total liabilities related to the 2014 restructuring program were $223. A complete discussion of restructuring initiatives is included in the company's 2014 Annual Report in Note 3, "Employee Separation / Asset Related Charges, Net."

Account balances for the 2014 restructuring program are summarized below:

	Employee Separation Costs			Other Non-Personnel Charges 1			Total
Balance at December 31, 2014	$	264		$	4		$	268
Payments	(38		)	(1		)	(39		)
Net translation adjustment	(6		)	—			(6		)
Balance as of March 31, 2015	$	220		$	3		$	223

¹  Other non-personnel charges consist of contractual obligation costs.

XML

Commitments and Contingent Liabilities (Imprelis) (Narrative) (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015 actions	Dec. 31, 2013
Product Claims [Line Items]
Insurance program limits	$ 300
Imprelis [Member]
Product Claims [Line Items]
Plaintiffs' attorney fees to pay per proposed settlement		7
Claims filed and pending	37
Loss Contingency, number of claims settled	3
Accrual balance	231
Insurance receivables	25
Insurance recoveries for litigation	$ 35

XML

Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2015

Financial Instruments Disclosure [Abstract]

Schedule of Notional Amounts of Outstanding Derivative Positions

	March 31, 2015		December 31, 2014
Derivatives designated as hedging instruments:
Interest rate swaps	$	—	$	1,000
Foreign currency contracts	71		434
Commodity contracts	265		388
Derivatives not designated as hedging instruments:
Foreign currency contracts	8,959		10,586
Commodity contracts	86		166

Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)

	Three Months Ended
	March 31,
	2015			2014
Beginning balance	$	(6	)	$	(48	)
Additions and revaluations of derivatives designated as cash flow hedges	(16		)	24
Clearance of hedge results to earnings	4			11
Ending balance	$	(18	)	$	(13	)

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value

		Fair Value Using Level 2 Inputs
	Balance Sheet Location	March 31, 2015		December 31, 2014
Asset derivatives:
Derivatives designated as hedging instruments:
Interest rate swaps1	Accounts and notes receivable, net	$	—	$	1
Foreign currency contracts	Accounts and notes receivable, net	2		10
		2		11
Derivatives not designated as hedging instruments:
Foreign currency contracts2	Accounts and notes receivable, net	67		254
Total asset derivatives3		$	69	$	265
Cash collateral1,2	Other accrued liabilities	$	80	$	47
Liability derivatives:
Derivatives designated as hedging instruments:
Foreign currency contracts	Other accrued liabilities	$	3	$	10
Derivatives not designated as hedging instruments:
Foreign currency contracts	Other accrued liabilities	47		62
Commodity contracts	Other accrued liabilities	1		1
		48		63
Total liability derivatives3		$	51	$	73

¹  Cash collateral held as of March 31, 2015 and December 31, 2014 represents $0 and $6, respectively, related to interest rate swap derivatives designated as hedging instruments.

²  Cash collateral held as of March 31, 2015 and December 31, 2014 represents $80 and $41, respectively, related to foreign currency derivatives not designated as hedging instruments.

³  The company's derivative assets and liabilities subject to enforceable master netting arrangements totaled $45 at March 31, 2015 and $67 at December 31, 2014.

Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance

	Amount of Gain (Loss) Recognized in OCI1 (Effective Portion)						Amount of Gain (Loss) Recognized in Income2
Three Months Ended March 31,	2015			2014			2015			2014			Income Statement Classification
Derivatives designated as hedging instruments:
Fair value hedges:
Interest rate swaps	$	—		$	—		$	(1	)	$	(7	)	Interest expense
Cash flow hedges:
Foreign currency contracts	(2		)	(1		)	8			(1		)	Net sales
Commodity contracts	(20		)	39			(15		)	(17		)	Cost of goods sold
	(22		)	38			(8		)	(25		)
Derivatives not designated as hedging instruments:
Foreign currency contracts	—			—			268			(46		)	Other income, net3
Commodity contracts	—			—			2			(24		)	Cost of goods sold
	—			—			270			(70		)
Total derivatives	$	(22	)	$	38		$	262		$	(95	)

¹   OCI is defined as other comprehensive income (loss).

²   For cash flow hedges, this represents the effective portion of the gain (loss) reclassified from accumulated OCI into income during the period. For the three months ended March 31, 2015 and 2014, there was no material ineffectiveness with regard to the company's cash flow hedges.

³   Gain (loss) recognized in other income, net, was partially offset by the related gain (loss) on the foreign currency-denominated monetary assets and liabilities of the company's operations, which were $(204) and $(50) for the three months ended March 31, 2015 and 2014.

XML

Employee Separation / Asset Related Charges, Net (Narrative) (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015
Restructuring and Related Activities [Abstract]
Restructuring Reserve	$ 223
Impaired Long-Lived Assets Held and Used [Line Items]
Cost basis investment ownership	6.00%
Cost basis investment impairment [Member]
Impaired Long-Lived Assets Held and Used [Line Items]
Cost basis investment impairment	37
Other Segments [Member]
Impaired Long-Lived Assets Held and Used [Line Items]
Pre-tax impairment charge	$ 38

XML

Inventories (Details) (USD $) In Millions, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Inventory, Net [Abstract]
Finished products	$ 4,529	$ 4,628
Semifinished products	1,877	2,451
Raw materials, stores and supplies	1,138	1,255
Total inventories before LIFO adjustment	7,544	8,334
Adjustment of inventories to a last-in, first-out (LIFO) basis	(493)	(493)
Total	$ 7,051	$ 7,841

XML

Segment Information (Schedule of Segment Information) (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015		Mar. 31, 2014	Dec. 31, 2014
Segment sales	$ 9,241		$ 10,209
Less: Transfers	69		81
Net sales	9,172		10,128
PTOI	1,941		2,248
Agriculture [Member]
Segment sales	3,937		4,394
Less: Transfers	0		3
Net sales	3,937		4,391
PTOI	1,174	[1]	1,442
Segment net assets	9,005			6,695
Increase in net assets	2,310
Electronics and Communications [Member]
Segment sales	521		580
Less: Transfers	4		3
Net sales	517		577
PTOI	85		75
Industrial Biosciences [Member]
Segment sales	285		301
Less: Transfers	5		3
Net sales	280		298
PTOI	56		56
Nutrition & Health [Member]
Segment sales	813		861
Less: Transfers	0		0
Net sales	813		861
PTOI	89		93
Performance Chemicals [Member]
Segment sales	1,364		1,591
Less: Transfers	29		57
Net sales	1,335		1,534
PTOI	129		206
Performance Materials [Member]
Segment sales	1,411		1,534
Less: Transfers	30		14
Net sales	1,381		1,520
PTOI	327		293
Safety and Protection [Member]
Segment sales	909		947
Less: Transfers	1		1
Net sales	908		946
PTOI	184		175
Other [Member]
Segment sales	1		1
Less: Transfers	0		0
Net sales	1		1
PTOI	(103)	[2]	(92)
Imprelis [Member]
Insurance recoveries for litigation	35
Cost basis investment impairment [Member]
Cost basis investment impairment	$ (37)

[1] Included $35 of insurance recoveries during the three months ended March 31, 2015 recorded in other operating charges for recovery of costs for customer claims related to the use of the Imprelis® herbicide. See Note 9 for additional information.

[2] Included a $(37) pre-tax impairment charge during the three months ended March 31, 2015 recorded in employee separation / asset related charges, net for a cost basis investment. See Note 3 for additional information.

XML

Financial Instruments (Effect of Cash Flows Hedges on Accumulated Other Comprehensive Income (Loss)) (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Derivative [Line Items]
Portion of ending balance of gain (loss) expected to be reclassified into earnings over the next twelve months, after-tax	$ (4)
Cash Flow Hedging [Member]
Derivative [Line Items]
Beginning balance, after-tax	(6)	(48)
Additions and revaluations of derivatives designated as cash flow hedges, after-tax	(16)	24
Clearance of hedge results to earnings, after-tax	4	11
Ending balance, after-tax	$ (18)	$ (13)

XML

Stockholders' Equity (Schedule of Other Comprehensive Income) (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015		Mar. 31, 2014
Components of Other Comprehensive Income (Loss) [Line Items]
Cumulative translation adjustment, pre-tax	$ (1,189)	[1]	$ (72)	[1]
Cumulative translation adjustment, tax	0		0
Cumulative translation adjustment, after-tax	(1,189)	[1]	(72)	[1]
Additions and revaluations of derivatives designated as cash flow hedges, pre-tax	(22)	[2]	38	[2]
Additions and revaluations of derivatives designated as cash flow hedges, tax	6		(14)
Additions and revaluations of derivatives designated as cash flow hedges, after-tax	(16)		24
Clearance of hedge results to earnings, pre-tax	7		18
Net revaluation and clearance of cash flow hedges to earnings, pre-tax	(15)		56
Net revaluation and clearance of cash flow hedges to earnings, tax	3		(21)
Net revaluation and clearance of cash flow hedges to earnings, after-tax	(12)		35
Other comprehensive (loss) income, before tax	(929)		96
Income tax expense related to items of other comprehensive income	(86)		(57)
Other comprehensive (loss) income, net of tax	(1,015)		39
Net sales [Member] | Foreign Currency Contract [Member]
Components of Other Comprehensive Income (Loss) [Line Items]
Clearance of hedge results to earnings, pre-tax	(8)		1
Clearance of hedge results to earnings, tax	3		0
Clearance of hedge results to earnings, after-tax	(5)		1
Cost of goods sold [Member] | Commodity Contract [Member]
Components of Other Comprehensive Income (Loss) [Line Items]
Clearance of hedge results to earnings, pre-tax	15		17
Clearance of hedge results to earnings, tax	(6)		(7)
Clearance of hedge results to earnings, after-tax	9		10
Pension Plans [Member]
Components of Other Comprehensive Income (Loss) [Line Items]
Net (loss) gain, pre-tax	(4)	[2]	1	[2]
Net (loss) gain, tax	1		0
Net (loss) gain, after-tax	(3)		1
Effect of foreign exchange rates, pre-tax	100	[2]	0	[2]
Effect of foreign exchange rates, tax	(27)		0
Effect of foreign exchange rates, after-tax	73		0
Amortization of prior service (benefit) cost, pre-tax	(2)	[3]	1	[3]
Amortization of prior service (benefit) cost, tax	1		0
Amortization of prior service (benefit) cost, after tax	(1)		1
Amortization of loss, pre-tax	209	[3]	149	[3]
Amortization of loss, tax	(74)		(51)
Amortization of loss, after tax	135		98
Settlement loss, pre-tax	5	[3]	0	[3]
Settlement loss, tax	(2)		0
Settlement loss, after tax	3		0
Benefit plans, net, pre-tax	308		151
Benefit plans, net, tax	(101)		(51)
Benefit plans, net, after-tax	207		100
Other Long-Term Employee Benefit Plans [Member]
Components of Other Comprehensive Income (Loss) [Line Items]
Amortization of prior service (benefit) cost, pre-tax	(52)	[3]	(53)	[3]
Amortization of prior service (benefit) cost, tax	19		19
Amortization of prior service (benefit) cost, after tax	(33)		(34)
Amortization of loss, pre-tax	19	[3]	14	[3]
Amortization of loss, tax	(7)		(4)
Amortization of loss, after tax	12		10
Benefit plans, net, pre-tax	(33)		(39)
Benefit plans, net, tax	12		15
Benefit plans, net, after-tax	$ (21)		$ (24)

[1] The increase over prior year is primarily driven by the strengthening USD against the Euro and Brazilian real.

[2] These amounts represent changes in accumulated other comprehensive loss excluding changes due to reclassifying amounts to the interim Consolidated Income Statements.

[3] These accumulated other comprehensive loss components are included in the computation of net periodic benefit cost of the company's pension and other long-term employee benefit plans. See Note 12 for additional information.

XML

Consolidated Statements of Comprehensive Income (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015		Mar. 31, 2014
Net income	$ 1,035		$ 1,445
Cumulative translation adjustment	(1,189)	[1]	(72)	[1]
Additions and revaluations of derivatives designated as cash flow hedges	(22)	[2]	38	[2]
Clearance of hedge results to earnings	7		18
Net revaluation and clearance of cash flow hedges to earnings	(15)		56
Other comprehensive (loss) income, before tax	(929)		96
Income tax expense related to items of other comprehensive income	(86)		(57)
Other comprehensive (loss) income, net of tax	(1,015)		39
Comprehensive income	20		1,484
Less: comprehensive income attributable to noncontrolling interests	4		6
Comprehensive income attributable to DuPont	16		1,478
Pension Plans [Member]
Net (loss) gain	(4)	[2]	1	[2]
Effect of foreign exchange rates	100	[2]	0	[2]
Amortization of prior service (benefit) cost	(2)	[3]	1	[3]
Amortization of loss	209	[3]	149	[3]
Settlement loss	5	[3]	0	[3]
Benefit plans, net	308		151
Other Long-Term Employee Benefit Plans [Member]
Amortization of prior service (benefit) cost	(52)	[3]	(53)	[3]
Amortization of loss	19	[3]	14	[3]
Benefit plans, net	$ (33)		$ (39)

[1] The increase over prior year is primarily driven by the strengthening USD against the Euro and Brazilian real.

[2] These amounts represent changes in accumulated other comprehensive loss excluding changes due to reclassifying amounts to the interim Consolidated Income Statements.

[3] These accumulated other comprehensive loss components are included in the computation of net periodic benefit cost of the company's pension and other long-term employee benefit plans. See Note 12 for additional information.

XML

Other Intangible Assets

3 Months Ended

Mar. 31, 2015

Goodwill and Intangible Assets Disclosure [Abstract]

Other Intangible Assets

Other Intangible Assets

The gross carrying amounts and accumulated amortization of other intangible assets by major class are as follows: 

	March 31, 2015							December 31, 2014
	Gross		Accumulated Amortization			Net		Gross		Accumulated Amortization			Net
Intangible assets subject to amortization (Definite-lived):
Customer lists	$	1,612	$	(475	)	$	1,137	$	1,706	$	(470	)	$	1,236
Patents	470		(202		)	268		493		(199		)	294
Purchased and licensed technology	1,772		(1,142		)	630		1,789		(1,074		)	715
Trademarks	31		(14		)	17		31		(14		)	17
Other 1	210		(90		)	120		207		(88		)	119
	4,095		(1,923		)	2,172		4,226		(1,845		)	2,381
Intangible assets not subject to amortization (Indefinite-lived):
In-process research and development	25		—			25		29		—			29
Microbial cell factories	306		—			306		306		—			306
Pioneer germplasm	1,063		—			1,063		1,064		—			1,064
Trademarks/tradenames	741		—			741		800		—			800
	2,135		—			2,135		2,199		—			2,199
Total	$	6,230	$	(1,923	)	$	4,307	$	6,425	$	(1,845	)	$	4,580

¹   Primarily consists of sales and grower networks, marketing and manufacturing alliances and noncompetition agreements.       

The aggregate pre-tax amortization expense for definite-lived intangible assets was $140 and $125 for the three months ended March 31, 2015 and 2014, respectively. The estimated aggregate pre-tax amortization expense for the remainder of 2015 and each of the next five years is approximately $217, $353, $218, $218, $203 and $184, respectively.

XML

Condensed Consolidated Balance Sheets (Parenthetical) (USD $) In Millions, except Share data, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Statement of Financial Position [Abstract]
Accumulated depreciation	$ 20,057	$ 19,942
Common stock, par value	$ 0.30	$ 0.30
Common stock, shares authorized	1,800,000,000	1,800,000,000
Common stock, shares issued	992,224,000	992,020,000
Common stock held in treasury, shares	87,041,000	87,041,000

XML

Consolidated Income Statements (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Net sales	$ 9,172	$ 10,128
Other income, net	198	17
Total	9,370	10,145
Cost of goods sold	5,553	6,000
Other operating charges	283	286
Selling, general and administrative expenses	1,312	1,436
Research and development expense	499	518
Interest expense	84	103
Employee separation / asset related charges, net	38	0
Total	7,769	8,343
Income before income taxes	1,601	1,802
Provision for income taxes	566	357
Net income	1,035	1,445
Less: Net income attributable to noncontrolling interests	4	6
Net income attributable to DuPont	$ 1,031	$ 1,439
Basic earnings per share of common stock	$ 1.13	$ 1.56
Diluted earnings per share of common stock	$ 1.13	$ 1.54
Dividends per share of common stock	$ 0.47	$ 0.45

XML

Financial Instruments (Schedule of the Fair Value of Derivative Instruments) (Details) (USD $) In Millions, unless otherwise specified	Mar. 31, 2015		Dec. 31, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets and liabilities subject to master netting arrangement	$ 45		$ 67
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Asset derivatives	69	[1]	265	[1]
Liability derivatives	51	[1]	73	[1]
Designated as Hedging Instrument [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Asset derivatives	2		11
Not Designated as Hedging Instrument [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liability derivatives	48		63
Interest Rate Swap [Member] | Designated as Hedging Instrument [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash collateral	0		6
Foreign Currency Contract [Member] | Not Designated as Hedging Instrument [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash collateral	80		41
Accounts and Notes Receivable [Member] | Interest Rate Swap [Member] | Designated as Hedging Instrument [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Asset derivatives	0	[2]	1	[2]
Accounts and Notes Receivable [Member] | Foreign Currency Contract [Member] | Designated as Hedging Instrument [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Asset derivatives	2		10
Accounts and Notes Receivable [Member] | Foreign Currency Contract [Member] | Not Designated as Hedging Instrument [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Asset derivatives	67	[3]	254	[3]
Other accrued liabilities [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash collateral	80	[2],[3]	47	[2],[3]
Other accrued liabilities [Member] | Foreign Currency Contract [Member] | Designated as Hedging Instrument [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liability derivatives	3		10
Other accrued liabilities [Member] | Foreign Currency Contract [Member] | Not Designated as Hedging Instrument [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liability derivatives	47		62
Other accrued liabilities [Member] | Commodity Contract [Member] | Not Designated as Hedging Instrument [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liability derivatives	$ 1		$ 1

[1] The company's derivative assets and liabilities subject to enforceable master netting arrangements totaled $45 at March 31, 2015 and $67 at December 31, 2014.

[2] Cash collateral held as of March 31, 2015 and December 31, 2014 represents $0 and $6, respectively, related to interest rate swap derivatives designated as hedging instruments.

[3] Cash collateral held as of March 31, 2015 and December 31, 2014 represents $80 and $41, respectively, related to foreign currency derivatives not designated as hedging instruments.

XML

Long-Term Employee Benefits (Tables)

3 Months Ended

Mar. 31, 2015

General Discussion of Pension and Other Postretirement Benefits [Abstract]

Schedules of Net Periodic Benefit Cost

The following sets forth the components of the company’s net periodic benefit cost for pensions:  

	Three Months Ended
	March 31,
	2015			2014
Service cost	$	66		$	60
Interest cost	273			292
Expected return on plan assets	(404		)	(402		)
Amortization of loss	209			149
Amortization of prior service (benefit) cost	(2		)	1
Settlement loss	5			—
Net periodic benefit cost	$	147		$	100

The following sets forth the components of the company’s net periodic benefit cost for other long-term employee benefits:  

	Three Months Ended
	March 31,
	2015			2014
Service cost	$	4		$	4
Interest cost	28			31
Amortization of loss	19			14
Amortization of prior service benefit	(52		)	(53		)
Net periodic benefit cost	$	(1	)	$	(4	)

XML

Earnings Per Share of Common Stock (Tables)

3 Months Ended

Mar. 31, 2015

Earnings Per Share [Abstract]

Earnings Per Share of Common Stock Reconciliation Table

	Three Months Ended
	March 31,
	2015			2014
Numerator:
Net income attributable to DuPont	$	1,031		$	1,439
Preferred dividends	(2		)	(2		)
Net income available to common stockholders	$	1,029		$	1,437
Denominator:
Weighted-average number of common shares outstanding - Basic	906,835,000			923,461,000
Dilutive effect of the company’s employee compensation plans	6,984,000			7,271,000
Weighted-average number of common shares outstanding - Diluted	913,819,000			930,732,000

XML

Stockholders' Equity (Share Repurchase Program) (Narrative) (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended		14 Months Ended	1 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2015	Jan. 31, 2014
Equity, Class of Treasury Stock [Line Items]
Payments for repurchase of common stock	$ 282	$ 1,061
January 2014 Buyback Plan [Member]
Equity, Class of Treasury Stock [Line Items]
Share buyback plan, Authorized Amount					5,000
Repurchased and retired, shares			33.7
Payments for repurchase of common stock			$ 2,282
Q1 2015 Open Market Purchases [Member]
Equity, Class of Treasury Stock [Line Items]
Repurchased and retired, shares				3.6

XML

Long-Term Employee Benefits (Schedules of Net Periodic Benefit Cost) (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Defined Benefit Plan Disclosure [Line Items]
Net periodic benefit cost	$ 147	$ 100
Pension Plans [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	66	60
Interest cost	273	292
Expected return on plan assets	(404)	(402)
Amortization of loss	209	149
Amortization of prior service (benefit) cost	(2)	1
Settlement loss	5	0
Net periodic benefit cost	147	100
Other Long-Term Employee Benefit Plans [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	4	4
Interest cost	28	31
Amortization of loss	19	14
Amortization of prior service (benefit) cost	(52)	(53)
Net periodic benefit cost	$ (1)	$ (4)

XML

Other Intangible Assets (Narrative) (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Other Intangible Assets
Aggregate pre-tax amortization expense	$ 140	$ 125
Pre-tax amortization expense, 2015	217
Pre-tax amortization expense, 2016	353
Pre-tax amortization expense, 2017	218
Pre-tax amortization expense, 2018	218
Pre-tax amortization expense, 2019	203
Pre-tax amortization expense, 2020	$ 184

XML

Provision for Income Taxes (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Income Tax Disclosure [Abstract]
Provision for income taxes	$ 566	$ 357
Tax expense (benefit) associated with the company's policy of hedging the foreign currency-denominated monetary assets and liabilities	212	(28)
Low end of range estimate of reasonably possible net reduction in unrecognized tax benefits	100
High end of range estimate of reasonably possible net reduction in unrecognized tax benefits	$ 125

XML

Earnings Per Share of Common Stock (Earnings Per Share of Common Stock Reconciliation) (Details) (USD $) In Millions, except Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Earnings Per Share [Abstract]
Net income attributable to DuPont	$ 1,031	$ 1,439
Preferred dividends	(2)	(2)
Net income available to common stockholders	$ 1,029	$ 1,437
Weighted-average number of common shares outstanding - Basic	906,835,000	923,461,000
Dilutive effect of the company's employee compensation plans	6,984,000	7,271,000
Weighted average number of common shares outstanding - Diluted	913,819,000	930,732,000
Antidilutive stock options	0	0

XML

Inventories

3 Months Ended

Mar. 31, 2015

Inventory, Net [Abstract]

Inventories

Inventories

	March 31, 2015			December 31, 2014
Finished products	$	4,529		$	4,628
Semi-finished products	1,877			2,451
Raw materials, stores and supplies	1,138			1,255
	7,544			8,334
Adjustment of inventories to a last-in, first-out (LIFO) basis	(493		)	(493		)
Total	$	7,051		$	7,841

XML

Segment Information (Tables)

3 Months Ended

Mar. 31, 2015

Segment Reporting [Abstract]

Schedule of Segment Information

Three Months Ended March 31,	Agriculture1			Electronics & Communications		Industrial Biosciences		Nutrition & Health		Performance Chemicals		Performance Materials		Safety & Protection		Other				Total
2015
Segment sales	$	3,937		$	521	$	285	$	813	$	1,364	$	1,411	$	909	$	1			$	9,241
Less: Transfers	—			4		5		—		29		30		1		—				69
Net sales	3,937			517		280		813		1,335		1,381		908		1				9,172
PTOI	1,174		2	85		56		89		129		327		184		(103		)	3	1,941
2014
Segment sales	$	4,394		$	580	$	301	$	861	$	1,591	$	1,534	$	947	$	1			$	10,209
Less: Transfers	3			3		3		—		57		14		1		—				81
Net sales	4,391			577		298		861		1,534		1,520		946		1				10,128
PTOI	1,442			75		56		93		206		293		175		(92		)		2,248

¹  As of March 31, 2015, Agriculture net assets were $9,005, an increase of $2,310 from $6,695 at December 31, 2014. The increase was primarily due to higher trade receivables due to normal seasonality in the sales and cash collections cycle.

² Included $35 of insurance recoveries during the three months ended March 31, 2015 recorded in other operating charges for recovery of costs for customer claims related to the use of the Imprelis^® herbicide. See Note 9 for additional information.

³  Included a $(37) pre-tax impairment charge during the three months ended March 31, 2015 recorded in employee separation / asset related charges, net for a cost basis investment. See Note 3 for additional information.

Reconciliation to Consolidated Income Statements

	Three Months Ended March 31,
	2015			2014
Total segment PTOI	$	1,941		$	2,248
Non-operating pension and other postretirement employee benefit costs	(75		)	(30		)
Net exchange gains (losses)2	64			(96		)
Corporate expenses1	(245		)	(217		)
Interest expense	(84		)	(103		)
Income before income taxes	$	1,601		$	1,802

¹  Included transaction costs associated with the separation of the Performance Chemicals segment of $(81) and $(16) in the three months ended March 31, 2015 and 2014, respectively, which were recorded in other operating charges in the company's interim Consolidated Income Statements.

²  Included a charge of $(40) associated with remeasuring the company's Ukranian hryvnia net monetary assets in the three months ended March 31, 2015, which was recorded in other income, net in the company's interim Consolidated Income Statements.

XML

Commitments and Contingent Liabilities (Litigation) (Narrative) (Details) (USD $) In Millions, unless otherwise specified	12 Months Ended	3 Months Ended	1 Months Ended
	Dec. 31, 2004 resident	Mar. 31, 2015	Jul. 31, 2005	Jan. 31, 2012
PFOA Matters [Member]
Loss Contingencies [Line Items]
Accrual balance		14
PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Binding settlement agreement, class size	80,000
Loss contingency, potential additional loss		235
Escrow deposit				1
PFOA Matters: Additional Actions [Member]
Loss Contingencies [Line Items]
Lawsuits alleging personal injury - Filed		3,500
Lawsuits alleging personal injury, number of new claims filed		600
Lawsuits alleging wrongful death		32
PFOA MDL plaintiffs		6
Payment for Plaintiffs Attorney Fees [Member] | PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Settlement payments			23
Payment to fund community health project [Member] | PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Settlement payments			$ 70

XML

Stockholders' Equity

3 Months Ended

Mar. 31, 2015

Stockholders' Equity Note [Abstract]

Stockholders' Equity

Stockholders’Equity

Share Repurchase Program

In January 2014, the company's Board of Directors authorized a $5,000 share buyback plan that replaced the 2011 plan. In March 2015, the company purchased and retired 3.6 million shares in the open market which offset the dilution from employee compensation plans in the first quarter 2015. As of March 31, 2015, the company has purchased 33.7 million shares at a total cost of $2,282 under the plan. There is no required completion date for the remaining stock purchases.

Other Comprehensive (Loss) Income

A summary of the changes in other comprehensive (loss) income for the three months ended March 31, 2015 and 2014 is provided as follows:

	Three Months Ended									Three Months Ended									Affected Line Item in Consolidated Income Statements1
	March 31, 2015									March 31, 2014
	Pre-Tax			Tax			After-Tax			Pre-Tax			Tax			After-Tax
Cumulative translation adjustment	$	(1,189	)	$	—		$	(1,189	)	$	(72	)	$	—		$	(72	)	See (4) below
Net revaluation and clearance of cash flow hedges to earnings:
Additions and revaluations of derivatives designated as cash flow hedges	(22		)	6			(16		)	38			(14		)	24			See (2) below
Clearance of hedge results to earnings:
Foreign currency contracts	(8		)	3			(5		)	1			—			1			Net sales
Commodity contracts	15			(6		)	9			17			(7		)	10			Cost of goods sold
Net revaluation and clearance of cash flow hedges to earnings	(15		)	3			(12		)	56			(21		)	35
Pension benefit plans:
Net (loss) gain	(4		)	1			(3		)	1			—			1			See (2) below
Effect of foreign exchange rates	100			(27		)	73			—			—			—			See (2) below
Reclassifications to net income:
Amortization of prior service (benefit) cost	(2		)	1			(1		)	1			—			1			See (3) below
Amortization of loss	209			(74		)	135			149			(51		)	98			See (3) below
Settlement loss	5			(2		)	3			—			—			—			See (3) below
Pension benefit plans, net	308			(101		)	207			151			(51		)	100
Other benefit plans:
Reclassifications to net income:
Amortization of prior service benefit	(52		)	19			(33		)	(53		)	19			(34		)	See (3) below
Amortization of loss	19			(7		)	12			14			(4		)	10			See (3) below
Other benefit plans, net	(33		)	12			(21		)	(39		)	15			(24		)
Other comprehensive (loss) income	$	(929	)	$	(86	)	$	(1,015	)	$	96		$	(57	)	$	39

¹  Represents the income statement line item within the interim Consolidated Income Statement affected by the pre-tax reclassification out of other comprehensive (loss) income.

²  These amounts represent changes in accumulated other comprehensive loss excluding changes due to reclassifying amounts to the interim Consolidated Income Statements.

³  These accumulated other comprehensive loss components are included in the computation of net periodic benefit cost of the company's pension and other long-term employee benefit plans. See Note 12 for additional information.

⁴  The increase over prior year is primarily driven by the strengthening USD against the Euro and Brazilian real.

The changes and after-tax balances of components comprising accumulated other comprehensive loss are summarized below:

	Cumulative Translation Adjustment			Net Revaluation and Clearance of Cash Flow Hedges to Earnings			Pension Benefit Plans			Other Benefit Plans			Unrealized Gain on Securities		Total
2015
Balance January 1, 2015	$	(1,016	)	$	(6	)	$	(7,949	)	$	262		$	2	$	(8,707	)
Other comprehensive (loss) income before reclassifications	(1,189		)	(16		)	70			—			—		(1,135		)
Amounts reclassified from accumulated other comprehensive loss	—			4			137			(21		)	—		120
Balance March 31, 2015	$	(2,205	)	$	(18	)	$	(7,742	)	$	241		$	2	$	(9,722	)

	Cumulative Translation Adjustment			Net Revaluation and Clearance of Cash Flow Hedges to Earnings			Pension Benefit Plans			Other Benefit Plans			Unrealized Gain on Securities		Total
2014
Balance January 1, 2014	$	(140	)	$	(48	)	$	(5,749	)	$	494		$	2	$	(5,441	)
Other comprehensive (loss) income before reclassifications	(72		)	24			1			—			—		(47		)
Amounts reclassified from accumulated other comprehensive loss	—			11			99			(24		)	—		86
Balance March 31, 2014	$	(212	)	$	(13	)	$	(5,649	)	$	470		$	2	$	(5,402	)

XML

Earnings Per Share of Common Stock

3 Months Ended

Mar. 31, 2015

Earnings Per Share [Abstract]

Earnings Per Share of Common Stock

Earnings Per Share of Common Stock

Set forth below is a reconciliation of the numerator and denominator for basic and diluted earnings per share calculations for the periods indicated:

	Three Months Ended
	March 31,
	2015			2014
Numerator:
Net income attributable to DuPont	$	1,031		$	1,439
Preferred dividends	(2		)	(2		)
Net income available to common stockholders	$	1,029		$	1,437
Denominator:
Weighted-average number of common shares outstanding - Basic	906,835,000			923,461,000
Dilutive effect of the company’s employee compensation plans	6,984,000			7,271,000
Weighted-average number of common shares outstanding - Diluted	913,819,000			930,732,000

There were no antidilutive stock options in the three months ended March 31, 2015 and March 31, 2014, respectively.

XML

Summary of Significant Accounting Policies

3 Months Ended

Mar. 31, 2015

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Summary of Significant Accounting Policies

Summary of Significant Accounting Policies

Interim Financial Statements

The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (GAAP) for interim financial information and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X.  In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair statement of the results for interim periods have been included.  Results for interim periods should not be considered indicative of results for a full year.  These interim Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and Notes thereto contained in the company’s Annual Report on Form 10-K for the year ended December 31, 2014, collectively referred to as the “2014 Annual Report”.  The Consolidated Financial Statements include the accounts of the company and all of its subsidiaries in which a controlling interest is maintained, as well as variable interest entities for which DuPont is the primary beneficiary. 

Basis of Presentation

Certain reclassifications of prior year's data have been made to conform to current year's presentation.

The company’s cost structure has been impacted by the global, multi-year initiative to redesign its global organization and operating model to improve productivity and agility across all businesses and functions. Effective December 31, 2014, in order to better align to the transforming company’s organization and resulting cost structure, certain costs were reclassified from other operating charges to selling, general and administrative expenses. Prior year data has been reclassified to conform to current year presentation.   Other operating charges primarily include, costs associated with the Performance Chemical separation, product claim charges and non-capitalizable costs associated with capital projects. Selling, general and administrative expense primarily includes selling and marketing expenses, commissions, functional costs, and business management expenses.

Foreign Currency Translation

The company's worldwide operations utilize the U.S. dollar (USD) or local currency as the functional currency, where applicable. The company identifies its separate and distinct foreign entities and groups the foreign entities into two categories: 1) extension of the parent (USD functional currency) and 2) self-contained (local functional currency). If a foreign entity does not clearly align with either category, factors are evaluated and a judgment is made to determine the functional currency.

For foreign entities where the USD is the functional currency, all foreign currency asset and liability amounts are remeasured into USD at end-of-period exchange rates, except for inventories, prepaid expenses, property, plant and equipment, goodwill and other intangible assets, which are remeasured at historical rates. Foreign currency income and expenses are remeasured at average exchange rates in effect during the year, except for expenses related to balance sheet amounts remeasured at historical exchange rates. Exchange gains and losses arising from remeasurement of foreign currency-denominated monetary assets and liabilities are included in income in the period in which they occur.

For foreign entities where the local currency is the functional currency, assets and liabilities denominated in local currencies are translated into USD at end-of-period exchange rates and the resultant translation adjustments are reported, net of their related tax effects, as a component of accumulated other comprehensive income (loss) in equity. Assets and liabilities denominated in other than the local currency are remeasured into the local currency prior to translation into USD and the resultant exchange gains or losses are included in income in the period in which they occur. Income and expenses are translated into USD at average exchange rates in effect during the period.

The company changes the functional currency of its separate and distinct foreign entities only when significant changes in economic facts and circumstances indicate clearly that the functional currency has changed. As a result of the planned separation of its Performance Chemicals segment, coupled with the Company’s redesign initiative, the functional currency at certain of the company’s foreign entities is being re-evaluated which, in some cases, has resulted in a change in the foreign entities’ functional currency during the first quarter of 2015.

Venezuelan Foreign Currency

Venezuela is considered a highly inflationary economy under GAAP and the USD is the functional currency for the company's subsidiaries in Venezuela. The official exchange rate continues to be set through the National Center for Foreign Commerce (CENCOEX, previously CADIVI). Based on its evaluation of the restrictions and limitations affecting the availability of specific exchange rate mechanisms, management concluded in the second quarter of 2014 that the SICAD 2 auction process would be the most likely mechanism available. As a result, in the second quarter of 2014, the company changed from the official exchange rate to the SICAD 2 exchange rate.

During the first quarter of 2015, the Venezuelan government enacted additional changes to the country’s foreign exchange systems including the replacement of SICAD 2 and introduction of the SIMADI (Foreign Exchange Marginal System) auction process. Given the replacement of SICAD 2 with SIMADI, management has concluded that the SIMADI auction process would be the most likely exchange mechanism available. As a result, effective in the first quarter of 2015, the company changed from the SICAD 2 to the SIMADI exchange rate, to remeasure its Bolivar Fuertes (VEF) denominated net monetary assets which resulted in a pre-tax charge of $3 recorded within other income, net in the company’s interim Consolidated Income Statements for the three months ended March 31, 2015. The remaining net monetary assets and non-monetary assets are immaterial at March 31, 2015.

Recent Accounting Pronouncements

In February 2015, the FASB issued ASU No. 2015-02 Consolidation (Topic 810), Amendments to the Consolidation Analysis. The amendments under the new guidance modify the evaluation of whether limited partnerships and similar legal entities are variable interest entities (VIEs) or voting interest entities and eliminate the presumption that a general partner should consolidate a limited partnership. The ASU is effective for public business entities for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2015. Early adoption is permitted, including adoption in an interim period. A reporting entity also may apply the amendments retrospectively. The company is currently evaluating the impact of adopting this guidance on its financial position and results of operations.

In May 2014, the FASB and the International Accounting Standards Board (IASB) jointly issued ASU No. 2014-9, Revenue from Contracts with Customers (Topic 606), which clarifies the principles for recognizing revenue and develops a common revenue standard for GAAP and International Financial Reporting Standards (IFRS). The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. The ASU is effective for public entities for annual and interim periods beginning after December 15, 2016. The FASB proposed that a deferral of the effective date is necessary to provide adequate time to effectively implement the new revenue standard. It is important to note that the FASB’s proposed deferral is not a final decision. The company is currently evaluating the impact of adopting this guidance on its financial position and results of operations.

In April 2014, the FASB issued authoritative guidance amending existing requirements for reporting discontinued operations.  Under the new guidance, discontinued operations reporting will be limited to disposal transactions that represent strategic shifts having a major effect on operations and financial results. The amended guidance also enhances disclosures and requires assets and liabilities of a discontinued operation to be classified as such for all periods presented in the financial statements. Public entities will apply the amended guidance prospectively to all disposals occurring within annual periods beginning on or after December 15, 2014 and interim periods within those years. The company adopted this standard on January 1, 2015. Due to the change in requirements for reporting discontinued operations described above, presentation and disclosures of future disposal transactions after adoption may be different than under previous standards.

XML

Financial Instruments (Effect of Derivative Instruments) (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015		Mar. 31, 2014
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in OCI (effective portion)	$ (22)	[1]	$ 38	[1]
Amount of Gain (Loss) Recognized in Income	262		(95)
Other Income, net [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on foreign currency denominated monetary assets and liabilities	(204)		(50)
Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in OCI (effective portion)	(22)	[1]	38	[1]
Amount of Gain (Loss) Recognized in Income	(8)		(25)
Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member] | Cash Flow Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in OCI (effective portion)	(2)	[1]	(1)	[1]
Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member] | Net sales [Member] | Cash Flow Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Recognized in Income	8	[2]	(1)	[2]
Designated as Hedging Instrument [Member] | Commodity Contract [Member] | Cash Flow Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in OCI (effective portion)	(20)	[1]	39	[1]
Designated as Hedging Instrument [Member] | Commodity Contract [Member] | Cost of goods sold [Member] | Cash Flow Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Recognized in Income	(15)	[2]	(17)	[2]
Designated as Hedging Instrument [Member] | Interest Rate Swap [Member] | Fair Value Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in OCI (effective portion)	0	[1]	0	[1]
Designated as Hedging Instrument [Member] | Interest Rate Swap [Member] | Interest Expense [Member] | Fair Value Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Recognized in Income	(1)		(7)
Not Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in OCI (effective portion)	0	[1]	0	[1]
Amount of Gain (Loss) Recognized in Income	270		(70)
Not Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in OCI (effective portion)	0	[1]	0	[1]
Not Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member] | Other Income, net [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Recognized in Income	268	[3]	(46)	[3]
Not Designated as Hedging Instrument [Member] | Commodity Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in OCI (effective portion)	0	[1]	0	[1]
Not Designated as Hedging Instrument [Member] | Commodity Contract [Member] | Cost of goods sold [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Recognized in Income	$ 2		$ (24)

[1] OCI is defined as other comprehensive income (loss).

[2] For cash flow hedges, this represents the effective portion of the gain (loss) reclassified from accumulated OCI into income during the period. For the three months ended March 31, 2015 and 2014, there was no material ineffectiveness with regard to the company's cash flow hedges.

[3] Gain (loss) recognized in other income, net, was partially offset by the related gain (loss) on the foreign currency-denominated monetary assets and liabilities of the company's operations, which were $(204) and $(50) for the three months ended March 31, 2015 and 2014.

XML

Financial Instruments (Debt) (Narrative) (Details) (Fair Value, Inputs, Level 2 [Member], USD $) In Millions, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Fair Value, Inputs, Level 2 [Member]
Fair value of debt	$ 11,168	$ 11,394

XML

Employee Separation / Asset Related Charges, Net (2014 Restructuring Program schedule) (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2015		Dec. 31, 2014
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve	$ 223
2014 Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring reserve, payments	(39)
Restructuring reserve, Net translation adjustment	(6)
Restructuring Reserve	223		268
Employee Severance [Member] | 2014 Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring reserve, payments	(38)
Restructuring reserve, Net translation adjustment	(6)
Restructuring Reserve	220		264
Other Non-Personnel Charges [Member] | 2014 Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring reserve, payments	(1)	[1]
Restructuring reserve, Net translation adjustment	0	[1]
Restructuring Reserve	$ 3	[1]	$ 4	[1]

[1] Other non-personnel charges consist of contractual obligation costs.

XML

Segment Information

3 Months Ended

Mar. 31, 2015

Segment Reporting [Abstract]

Segment Information

Segment Information

Segment sales include transfers to another business segment. Segment pre-tax operating income (loss) (PTOI) is defined as income (loss) before income taxes excluding non-operating pension and other postretirement employee benefit costs, exchange gains (losses), corporate expenses and interest.

Viton^® fluoroelastomer products (Viton^®) will be included in the Performance Chemicals separation and therefore the results are reported within Performance Chemicals. Viton^® was previously reported within Performance Materials. Reclassifications of prior year data have been made to conform to current year classifications.

Three Months Ended March 31,	Agriculture1			Electronics & Communications		Industrial Biosciences		Nutrition & Health		Performance Chemicals		Performance Materials		Safety & Protection		Other				Total
2015
Segment sales	$	3,937		$	521	$	285	$	813	$	1,364	$	1,411	$	909	$	1			$	9,241
Less: Transfers	—			4		5		—		29		30		1		—				69
Net sales	3,937			517		280		813		1,335		1,381		908		1				9,172
PTOI	1,174		2	85		56		89		129		327		184		(103		)	3	1,941
2014
Segment sales	$	4,394		$	580	$	301	$	861	$	1,591	$	1,534	$	947	$	1			$	10,209
Less: Transfers	3			3		3		—		57		14		1		—				81
Net sales	4,391			577		298		861		1,534		1,520		946		1				10,128
PTOI	1,442			75		56		93		206		293		175		(92		)		2,248

¹  As of March 31, 2015, Agriculture net assets were $9,005, an increase of $2,310 from $6,695 at December 31, 2014. The increase was primarily due to higher trade receivables due to normal seasonality in the sales and cash collections cycle.

² Included $35 of insurance recoveries during the three months ended March 31, 2015 recorded in other operating charges for recovery of costs for customer claims related to the use of the Imprelis^® herbicide. See Note 9 for additional information.

³  Included a $(37) pre-tax impairment charge during the three months ended March 31, 2015 recorded in employee separation / asset related charges, net for a cost basis investment. See Note 3 for additional information.

Reconciliation to Consolidated Income Statements 

	Three Months Ended March 31,
	2015			2014
Total segment PTOI	$	1,941		$	2,248
Non-operating pension and other postretirement employee benefit costs	(75		)	(30		)
Net exchange gains (losses)2	64			(96		)
Corporate expenses1	(245		)	(217		)
Interest expense	(84		)	(103		)
Income before income taxes	$	1,601		$	1,802

¹  Included transaction costs associated with the separation of the Performance Chemicals segment of $(81) and $(16) in the three months ended March 31, 2015 and 2014, respectively, which were recorded in other operating charges in the company's interim Consolidated Income Statements.

²  Included a charge of $(40) associated with remeasuring the company's Ukranian hryvnia net monetary assets in the three months ended March 31, 2015, which was recorded in other income, net in the company's interim Consolidated Income Statements.

XML

Commitments and Contingent Liabilities

3 Months Ended

Mar. 31, 2015

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingent Liabilities

Commitments and Contingent Liabilities

Guarantees

Indemnifications

In connection with acquisitions and divestitures, the company has indemnified respective parties against certain liabilities that may arise in connection with these transactions and business activities prior to the completion of the transaction. The term of these indemnifications, which typically pertain to environmental, tax and product liabilities, is generally indefinite. In addition, the company indemnifies its duly elected or appointed directors and officers to the fullest extent permitted by Delaware law, against liabilities incurred as a result of their activities for the company, such as adverse judgments relating to litigation matters. If the indemnified party were to incur a liability or have a liability increase as a result of a successful claim, pursuant to the terms of the indemnification, the company would be required to reimburse the indemnified party. The maximum amount of potential future payments is generally unlimited.

Obligations for Equity Affiliates & Others

The company has directly guaranteed various debt obligations under agreements with third parties related to equity affiliates, customers and suppliers. At March 31, 2015 and December 31, 2014, the company had directly guaranteed $498 and $513, respectively, of such obligations. These amounts represent the maximum potential amount of future (undiscounted) payments that the company could be required to make under the guarantees. The company would be required to perform on these guarantees in the event of default by the guaranteed party.

The company assesses the payment/performance risk by assigning default rates based on the duration of the guarantees. These default rates are assigned based on the external credit rating of the counterparty or through internal credit analysis and historical default history for counterparties that do not have published credit ratings. For counterparties without an external rating or available credit history, a cumulative average default rate is used.

In certain cases, the company has recourse to assets held as collateral, as well as personal guarantees from customers and suppliers. Assuming liquidation, these assets are estimated to cover 47 percent of the $315 of guaranteed obligations of customers and suppliers. Set forth below are the company's guaranteed obligations at March 31, 2015:

	Short-Term		Long-Term		Total
Obligations for customers and suppliers1:
Bank borrowings (terms up to 7 years)	$	230	$	84	$	314
Leases on equipment and facilities (terms up to 4 years)	—		1		1
Obligations for equity affiliates2:
Bank borrowings (terms up to 1 year)	183		—		183
Total	$	413	$	85	$	498

¹  Existing guarantees for customers and suppliers, as part of contractual agreements.

² Existing guarantees for equity affiliates' liquidity needs in normal operations.

Imprelis^® 

The company has received claims and lawsuits alleging that the use of Imprelis^® herbicide caused damage to certain trees. Sales of Imprelis^® were suspended in August 2011 and the product was last applied during the 2011 spring application season. The lawsuits seeking class action status were consolidated in multidistrict litigation in federal court in Philadelphia, Pennsylvania. In February 2014, the court entered the final order dismissing these lawsuits as a result of the class action settlement.

As part of the settlement, DuPont paid about $7 in plaintiffs' attorney fees and expenses. In addition, DuPont is providing a warranty against new damage, if any, caused by the use of Imprelis^® on class members' properties through May 2015. Certain class members opted out of the class action settlement and made independent claims or filed suit in various state courts, the majority of which were removed to federal court in Philadelphia. In the third quarter 2014, the company settled or reached settlements in principle for the majority of these claims and lawsuits. About 37 lawsuits are pending claiming property and related damage at March 31, 2015. This represents a decrease of 3 from the number of lawsuits pending at December 31, 2014.

The company has established review processes to verify and evaluate damage claims. There are several variables that impact the evaluation process including the number of trees on a property, the species of tree with reported damage, the height of the tree, the extent of damage and the possibility for trees to naturally recover over time. Upon receiving claims, DuPont verifies their accuracy and validity which often requires physical review of the property.

DuPont recorded income of $35 for insurance recoveries, within other operating charges in the interim Consolidated Income Statements, for the three months ended March 31, 2015. At March 31, 2015, DuPont had an accrual balance of $231 related to these claims and insurance receivables of $25.

Insurance recoveries are recognized when collection of payment is considered probable. The remaining coverage under the insurance program is $300 for costs and expenses. DuPont has submitted requests for payment to its insurance carriers for costs associated with this matter. The timing and outcome remain uncertain.

Litigation

The company is subject to various legal proceedings arising out of the normal course of its business including product liability, intellectual property, commercial, environmental and antitrust lawsuits. It is not possible to predict the outcome of these various proceedings. Although considerable uncertainty exists, management does not anticipate that the ultimate disposition of these matters will have a material adverse effect on the company's results of operations, consolidated financial position or liquidity.  However, the ultimate liabilities could be material to results of operations in the period recognized.  

PFOA 

DuPont used PFOA (collectively, perfluorooctanoic acids and its salts, including the ammonium salt), as a processing aid to manufacture some fluoropolymer resins at various sites around the world including its Washington Works plant in West Virginia. At March 31, 2015, DuPont has an accrual balance of $14 related to the PFOA matters discussed below.

The accrual includes charges related to DuPont's obligations under agreements with the U.S. Environmental Protection Agency and voluntary commitments to the New Jersey Department of Environmental Protection.  These obligations and voluntary commitments include surveying, sampling and testing drinking water in and around certain company sites and offering treatment or an alternative supply of drinking water if tests indicate the presence of PFOA in drinking water at or greater than the national Provisional Health Advisory.

Drinking Water Actions

In August 2001, a class action, captioned Leach v DuPont, was filed in West Virginia state court alleging that residents living near the Washington Works facility had suffered, or may suffer, deleterious health effects from exposure to PFOA in drinking water.

DuPont and attorneys for the class reached a settlement in 2004 that binds about 80,000 residents. In 2005, DuPont paid the plaintiffs’ attorneys’ fees and expenses of $23 and made a payment of $70, which class counsel designated to fund a community health project.  The company funded a series of health studies which were completed in October 2012 by an independent science panel of experts (the C8 Science Panel). The studies were conducted in communities exposed to PFOA to evaluate available scientific evidence on whether any probable link exists, as defined in the settlement agreement, between exposure to PFOA and human disease.

The C8 Science Panel found probable links, as defined in the settlement agreement, between exposure to PFOA and pregnancy-induced hypertension, including preeclampsia; kidney cancer; testicular cancer; thyroid disease; ulcerative colitis; and diagnosed high cholesterol.

In May 2013, a panel of three independent medical doctors released its initial recommendations for screening and diagnostic testing of eligible class members. In September 2014, the medical panel recommended follow-up screening and diagnostic testing three years after initial testing, based on individual results. The medical panel has not communicated its anticipated schedule for completion of its protocol. The company is obligated to fund up to $235 for a medical monitoring program for eligible class members and, in addition, administrative costs associated with the program, including class counsel fees.  In January 2012, the company put $1 in an escrow account to fund medical monitoring as required by the settlement agreement.  The court appointed Director of Medical Monitoring has established the program to implement the medical panel's recommendations and the registration process, as well as eligibility screening, is ongoing. Diagnostic screening and testing has begun and associated payments to service providers are being disbursed from the escrow account.

In addition, under the settlement agreement, the company must continue to provide water treatment designed to reduce the level of PFOA in water to six area water districts, including the Little Hocking Water Association (LHWA), and private well users.

Class members may pursue personal injury claims against DuPont only for those human diseases for which the C8 Science Panel determined a probable link exists. At March 31, 2015, there were approximately 3,500 lawsuits filed in various federal and state courts in Ohio and West Virginia, an increase of about 600 over December 31, 2014. In accordance with a stipulation reached in the third quarter 2014 and other court procedures, these lawsuits have been or will be served and consolidated in multi-district litigation in Ohio federal court (MDL). Based on information currently available to the company the majority of the lawsuits allege personal injury claims associated with high cholesterol and thyroid disease from exposure to PFOA in drinking water.  There are 32 lawsuits alleging wrongful death. While attorneys for the plaintiffs have indicated that additional lawsuits may be filed, the company expects the rate of such filings to substantially decrease. In 2014, six plaintiffs from the MDL were selected for individual trial. The first trial is scheduled to begin in September 2015, and the second in November 2015. DuPont denies the allegations in these lawsuits and is defending itself vigorously.

Additional Actions

An Ohio action brought by the LHWA is ongoing. In addition to general claims of PFOA contamination of drinking water, the action claims “imminent and substantial endangerment to health and or the environment” under the Resource Conservation and Recovery Act (RCRA). In the second quarter 2014, DuPont filed a motion for summary judgment and LHWA moved for partial summary judgment. In the first quarter of 2015, the court granted in part and denied in part both parties’ motions. As a result, the litigation process will continue with respect to certain of the plaintiffs’ claims.

PFOA Summary

While it is probable that the company will incur costs related to funding the medical monitoring program, such costs cannot be reasonably estimated due to uncertainties surrounding the level of participation by eligible class members and the scope of testing. DuPont believes that it is reasonably possible that it could incur losses related to the other PFOA matters discussed above; however, a range of such losses, if any, cannot be reasonably estimated at this time, due to the uniqueness of the individual MDL plaintiff's claims and the company's defenses to those claims both as to potential liability and damages on an individual claims basis, among other factors.

Environmental

The company is also subject to contingencies pursuant to environmental laws and regulations that in the future may require the company to take further action to correct the effects on the environment of prior disposal practices or releases of chemical or petroleum substances by the company or other parties. The company accrues for environmental remediation activities consistent with the policy as described in the company's 2014 Annual Report in Note 1, “Summary of Significant Accounting Policies.” Much of this liability results from the Comprehensive Environmental Response, Compensation and Liability Act (CERCLA, often referred to as Superfund), Resource Conservation and Recovery Act (RCRA) and similar state and global laws. These laws require the company to undertake certain investigative, remediation and restoration activities at sites where the company conducts or once conducted operations or at sites where company-generated waste was disposed. The accrual also includes estimated costs related to a number of sites identified by the company for which it is probable that environmental remediation will be required, but which are not currently the subject of enforcement activities.

Remediation activities vary substantially in duration and cost from site to site. These activities, and their associated costs, depend on the mix of unique site characteristics, evolving remediation technologies, diverse regulatory agencies and enforcement policies, as well as the presence or absence of potentially responsible parties. At March 31, 2015, the Condensed Consolidated Balance Sheet included a liability of $482, relating to these matters and, in management's opinion, is appropriate based on existing facts and circumstances. The average time frame over which the accrued or presently unrecognized amounts may be paid, based on past history, is estimated to be 15-20 years. Considerable uncertainty exists with respect to these costs and, under adverse changes in circumstances, the potential liability may range up to $1,100 above the amount accrued as of March 31, 2015.

XML

Other Income, Net (Tables)

3 Months Ended

Mar. 31, 2015

Other Income and Expenses [Abstract]

Schedule of Other Income

	Three Months Ended
	March 31,
	2015		2014
Royalty income	$	39	$	39
Interest income	25		28
Equity in earnings of affiliates, net	9		13
Net gain on sales of other assets	6		7
Net exchange gains (losses)1	64		(96		)
Miscellaneous income and expenses, net 2	55		26
Other income, net	$	198	$	17

¹ The company routinely uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes on net monetary asset positions. The net pre-tax exchange gains (losses) are recorded in other income, net and the related tax impact is recorded in provision for income taxes on the company's interim Consolidated Income Statements. The increase in pre-tax exchange gains over prior year was driven by gains on foreign currency contracts due to strengthening of the USD versus global currencies partially offset by losses on the related foreign currency-denominated monetary assets and liabilities. The $64 net exchange gain for the three months ended March 31, 2015, includes a $(40) pre-tax exchange loss, $(38) after-tax, associated with the devaluation of the Ukrainian hryvnia. The $(96) net exchange loss for the three months ended March 31, 2014, includes a $(39) pre-tax exchange loss, $(27) after-tax, associated with the devaluation of the Ukrainian hryvnia.

²   Miscellaneous income and expenses, net, includes interest items, certain insurance recoveries and litigation settlements and other items.

XML

Summary of Significant Accounting Policies Summary of Significant Accounting Policies (Policies)

3 Months Ended

Mar. 31, 2015

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Accounting, Policy [Policy Text Block]

Interim Financial Statements

The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (GAAP) for interim financial information and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X.  In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair statement of the results for interim periods have been included.  Results for interim periods should not be considered indicative of results for a full year.  These interim Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and Notes thereto contained in the company’s Annual Report on Form 10-K for the year ended December 31, 2014, collectively referred to as the “2014 Annual Report”.  The Consolidated Financial Statements include the accounts of the company and all of its subsidiaries in which a controlling interest is maintained, as well as variable interest entities for which DuPont is the primary beneficiary. 

Basis of Presentation

Certain reclassifications of prior year's data have been made to conform to current year's presentation.

The company’s cost structure has been impacted by the global, multi-year initiative to redesign its global organization and operating model to improve productivity and agility across all businesses and functions. Effective December 31, 2014, in order to better align to the transforming company’s organization and resulting cost structure, certain costs were reclassified from other operating charges to selling, general and administrative expenses. Prior year data has been reclassified to conform to current year presentation.   Other operating charges primarily include, costs associated with the Performance Chemical separation, product claim charges and non-capitalizable costs associated with capital projects. Selling, general and administrative expense primarily includes selling and marketing expenses, commissions, functional costs, and business management expenses.

Foreign Currency Translations Policy [Policy Text Block]

Foreign Currency Translation

The company's worldwide operations utilize the U.S. dollar (USD) or local currency as the functional currency, where applicable. The company identifies its separate and distinct foreign entities and groups the foreign entities into two categories: 1) extension of the parent (USD functional currency) and 2) self-contained (local functional currency). If a foreign entity does not clearly align with either category, factors are evaluated and a judgment is made to determine the functional currency.

For foreign entities where the USD is the functional currency, all foreign currency asset and liability amounts are remeasured into USD at end-of-period exchange rates, except for inventories, prepaid expenses, property, plant and equipment, goodwill and other intangible assets, which are remeasured at historical rates. Foreign currency income and expenses are remeasured at average exchange rates in effect during the year, except for expenses related to balance sheet amounts remeasured at historical exchange rates. Exchange gains and losses arising from remeasurement of foreign currency-denominated monetary assets and liabilities are included in income in the period in which they occur.

For foreign entities where the local currency is the functional currency, assets and liabilities denominated in local currencies are translated into USD at end-of-period exchange rates and the resultant translation adjustments are reported, net of their related tax effects, as a component of accumulated other comprehensive income (loss) in equity. Assets and liabilities denominated in other than the local currency are remeasured into the local currency prior to translation into USD and the resultant exchange gains or losses are included in income in the period in which they occur. Income and expenses are translated into USD at average exchange rates in effect during the period.

The company changes the functional currency of its separate and distinct foreign entities only when significant changes in economic facts and circumstances indicate clearly that the functional currency has changed. As a result of the planned separation of its Performance Chemicals segment, coupled with the Company’s redesign initiative, the functional currency at certain of the company’s foreign entities is being re-evaluated which, in some cases, has resulted in a change in the foreign entities’ functional currency during the first quarter of 2015.

Venezuelan Foreign Currency

Venezuela is considered a highly inflationary economy under GAAP and the USD is the functional currency for the company's subsidiaries in Venezuela. The official exchange rate continues to be set through the National Center for Foreign Commerce (CENCOEX, previously CADIVI). Based on its evaluation of the restrictions and limitations affecting the availability of specific exchange rate mechanisms, management concluded in the second quarter of 2014 that the SICAD 2 auction process would be the most likely mechanism available. As a result, in the second quarter of 2014, the company changed from the official exchange rate to the SICAD 2 exchange rate.

During the first quarter of 2015, the Venezuelan government enacted additional changes to the country’s foreign exchange systems including the replacement of SICAD 2 and introduction of the SIMADI (Foreign Exchange Marginal System) auction process. Given the replacement of SICAD 2 with SIMADI, management has concluded that the SIMADI auction process would be the most likely exchange mechanism available. As a result, effective in the first quarter of 2015, the company changed from the SICAD 2 to the SIMADI exchange rate, to remeasure its Bolivar Fuertes (VEF) denominated net monetary assets which resulted in a pre-tax charge of $3 recorded within other income, net in the company’s interim Consolidated Income Statements for the three months ended March 31, 2015. The remaining net monetary assets and non-monetary assets are immaterial at March 31, 2015.

Recent Accounting Pronouncements, Policy [Policy Text Block]

Recent Accounting Pronouncements

In February 2015, the FASB issued ASU No. 2015-02 Consolidation (Topic 810), Amendments to the Consolidation Analysis. The amendments under the new guidance modify the evaluation of whether limited partnerships and similar legal entities are variable interest entities (VIEs) or voting interest entities and eliminate the presumption that a general partner should consolidate a limited partnership. The ASU is effective for public business entities for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2015. Early adoption is permitted, including adoption in an interim period. A reporting entity also may apply the amendments retrospectively. The company is currently evaluating the impact of adopting this guidance on its financial position and results of operations.

In May 2014, the FASB and the International Accounting Standards Board (IASB) jointly issued ASU No. 2014-9, Revenue from Contracts with Customers (Topic 606), which clarifies the principles for recognizing revenue and develops a common revenue standard for GAAP and International Financial Reporting Standards (IFRS). The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. The ASU is effective for public entities for annual and interim periods beginning after December 15, 2016. The FASB proposed that a deferral of the effective date is necessary to provide adequate time to effectively implement the new revenue standard. It is important to note that the FASB’s proposed deferral is not a final decision. The company is currently evaluating the impact of adopting this guidance on its financial position and results of operations.

In April 2014, the FASB issued authoritative guidance amending existing requirements for reporting discontinued operations.  Under the new guidance, discontinued operations reporting will be limited to disposal transactions that represent strategic shifts having a major effect on operations and financial results. The amended guidance also enhances disclosures and requires assets and liabilities of a discontinued operation to be classified as such for all periods presented in the financial statements. Public entities will apply the amended guidance prospectively to all disposals occurring within annual periods beginning on or after December 15, 2014 and interim periods within those years. The company adopted this standard on January 1, 2015. Due to the change in requirements for reporting discontinued operations described above, presentation and disclosures of future disposal transactions after adoption may be different than under previous standards.

XML

Document and Entity Information	3 Months Ended
	Mar. 31, 2015	Apr. 15, 2015
Entity Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2015
Entity Registrant Name	DUPONT E I DE NEMOURS & CO
Entity Central Index Key	0000030554
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q1
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		905,237,000

XML

Employee Separation / Asset Related Charges, Net (Tables)

3 Months Ended

Mar. 31, 2015

Restructuring Charges [Abstract]

Schedule of Restructuring Program

	Employee Separation Costs			Other Non-Personnel Charges 1			Total
Balance at December 31, 2014	$	264		$	4		$	268
Payments	(38		)	(1		)	(39		)
Net translation adjustment	(6		)	—			(6		)
Balance as of March 31, 2015	$	220		$	3		$	223

¹  Other non-personnel charges consist of contractual obligation costs.